Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3006270	fb-folaat	nmol/l (nmol/l)	2578	2993	0.00%
3006270	fb-folaat	— (—)	535	583	100.00%	Distribution not available
3006270	fb-folat	nmol/l (nmol/l)	218	247	0.00%
3006270	fb-folaatti	nmol/l (nmol/l)	39	40	0.00%
3006270	fb-folat	— (—)	10	10	100.00%	Distribution not available
3006270	fb-folaatti(k-pks:n)(ko)	nmol/l (nmol/l)	9	9	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Speech therapy

358

828

4.43

140.86

1.2

283.09

355.74

nmol/l

8.13

260

699

Anaemias

216

291

4.99

85.69

1.2

1.0

391.25

392.06

nmol/l

0.02

189

278

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

734

2407

2.20

80.18

1.2

1.1

353.78

372.00

nmol/l

1.28

594

2049

Other anaemias

383

1376

2.72

70.41

1.3

1.2

326.42

333.94

nmol/l

0.25

299

1083

Aplastic and other anaemias

400

1454

2.64

69.13

1.3

1.2

325.50

336.04

nmol/l

0.40

314

1152

Other and unspecified anaemias

373

1366

2.67

66.45

1.2

325.01

334.06

nmol/l

0.32

290

1074

Dementia, including avohilmo

380

988

2.68

62.91

1.3

1.2

309.76

311.33

nmol/l

0.05

296

737

Diseases of oesophagus, stomach and duodenum

753

2302

2.00

61.90

1.2

1.1

348.82

378.33

nmol/l

2.91

630

1945

Fitting and adjustment of other devices

316

1099

2.71

57.32

1.3

1.2

279.91

330.84

nmol/l

4.03

220

915

Dementia

353

960

2.57

53.71

1.3

1.2

313.37

310.47

nmol/l

0.08

277

713

Organic, including symptomatic, mental disorders

389

1167

2.43

53.49

1.3

1.2

310.50

322.89

nmol/l

0.53

309

897

Other antidepressants

706

1932

1.92

49.78

1.2

1.1

383.11

358.10

nmol/l

2.15

605

1634

Glucagon-like peptide-1 (GLP-1) analogues

394

1433

2.28

48.59

1.2

311.67

346.22

nmol/l

2.09

255

1241

Nutritional anaemias

383

1677

2.24

46.85

1.3

1.2

352.71

345.82

nmol/l

0.23

317

1353

Type 2 diabetes, wide definition

538

1747

2.02

46.48

1.2

329.56

364.81

nmol/l

2.97

371

1545

Unspecific neurodegenerative disorder

338

975

2.42

45.46

1.3

1.2

317.54

305.16

nmol/l

0.46

267

708

Iron deficiency anaemia

320

1419

2.25

39.89

1.2

351.58

347.54

nmol/l

0.13

263

1149

Other and unspecified iron deficiency

264

1095

2.43

39.37

1.2

359.08

349.69

nmol/l

0.31

217

890

Persons encountering health services for specific procedures and health care

682

2397

1.77

39.30

1.2

1.1

350.74

379.36

nmol/l

2.62

528

2114

Recurrent or chronic depression

257

743

2.51

38.39

1.2

1.1

390.79

380.23

nmol/l

0.33

234

665

Presence of cardiac and vascular implants and grafts

322

1090

2.25

38.10

1.2

307.87

342.41

nmol/l

2.03

231

869

Bacterial infection, other or unspecified

368

1594

2.10

37.77

1.2

317.56

351.42

nmol/l

2.14

278

1315

Gastro-oesophageal reflux disease

435

1964

1.97

37.70

1.3

1.1

337.94

374.79

nmol/l

3.40

376

1636

Autoimmune diseases

708

2073

1.75

37.65

1.2

1.1

366.71

373.69

nmol/l

0.34

609

1777

Other nutritional deficiencies

408

2004

2.00

37.46

1.2

1.1

385.43

378.74

nmol/l

0.26

324

1776

Endocrine, nutritional and metabolic diseases

504

1323

1.95

37.21

1.2

1.1

376.90

385.50

nmol/l

0.38

442

1219

Medical observation and evaluation for suspected diseases and conditions

458

1180

2.00

36.39

1.2

1.1

347.07

393.07

nmol/l

4.11

381

986

Used for control exclusion in common control thyroid runs

669

1934

1.76

36.20

1.2

1.1

371.82

374.66

nmol/l

0.11

563

1663

Other special examinations and investigations of persons without complaint or reported diagnosis

462

1182

1.99

36.09

1.2

1.1

353.93

392.83

nmol/l

3.20

391

987

Depression or dysthymia

428

1204

2.00

34.91

1.2

1.1

376.33

360.01

nmol/l

0.77

364

1019

Covid-19 suspected case

166

584

2.87

34.60

1.1

386.82

389.92

nmol/l

0.05

546

Care involving use of rehabilitation procedures

411

2023

1.94

34.39

1.1

1.2

358.54

370.41

nmol/l

0.46

271

1768

Autoimmune diseases excluding thyroid diseases

643

2063

1.74

34.00

1.2

1.1

363.75

373.57

nmol/l

0.55

532

1767

Other diseases of intestines

652

2217

1.72

33.43

1.2

1.1

358.05

380.74

nmol/l

1.83

555

1910

Biguanides

597

2107

1.75

33.43

1.2

351.23

366.60

nmol/l

0.89

426

1878

Other (not insulin) diabetes medications

609

2117

1.74

33.15

1.2

352.18

368.49

nmol/l

0.96

438

1894

Psychiatric diseases

678

1995

1.71

33.03

1.2

1.1

360.11

375.83

nmol/l

1.05

574

1718

Unspecified dementia

124

337

3.37

32.92

1.3

1.2

292.92

302.72

nmol/l

0.17

249

Hypothyroidism (congenital or acquired)

167

320

3.02

32.70

1.1

389.40

397.82

nmol/l

0.19

154

306

N06DA Anticholinesterases

265

954

2.27

32.44

1.3

1.2

335.38

302.23

nmol/l

1.52

207

701

Use of anticholinesterases

265

954

2.27

32.44

1.3

1.2

335.38

302.23

nmol/l

1.52

207

701

Autoimmune diseases excluding thyroid diseases, strict definition

620

2011

1.72

32.07

1.2

1.1

360.23

374.18

nmol/l

0.88

514

1725

Symptoms and signs involving cognition, perception, emotional state and behaviour

604

2489

1.71

31.68

1.2

1.1

367.02

368.00

nmol/l

0.04

497

2118

Malaise and fatigue

336

1383

2.04

31.61

1.2

336.35

353.45

nmol/l

0.72

248

1171

Depression medications

184

327

2.85

31.26

1.1

410.99

397.46

nmol/l

0.35

171

313

Obesity due to excess calories

288

1368

2.12

31.12

1.2

1.1

368.86

375.30

nmol/l

0.20

219

1217

Diaphragmatic hernia

259

1185

2.20

30.85

1.2

323.91

349.72

nmol/l

1.27

225

944

Hypothyroidism, levothyroxine purchases

163

320

2.95

30.76

1.1

391.90

397.82

nmol/l

0.12

151

306

Hypothyroidism and >3 levothyroxin purchases

163

320

2.95

30.76

1.1

391.90

397.82

nmol/l

0.12

151

306

Combinations of oral blood glucose lowering drugs

191

774

2.49

30.13

1.1

1.2

351.55

349.38

nmol/l

0.04

130

681

Obesity and other hyperalimentation

375

1960

1.90

29.98

1.2

1.1

378.13

379.25

nmol/l

0.03

295

1740

Diabetes medication

623

2274

1.67

29.40

1.2

355.45

372.98

nmol/l

1.12

454

2044

Selective serotonin reuptake inhibitors

618

1935

1.69

29.26

1.2

1.1

378.83

357.70

nmol/l

1.59

531

1637

Use of donepezil

182

702

2.53

29.23

1.3

1.2

332.48

311.46

nmol/l

0.60

147

510

Any dementia, excluding more controls

265

844

2.20

29.10

1.3

1.2

309.20

312.18

nmol/l

0.08

201

644

Use of other anti-dementia drugs

215

805

2.35

28.98

1.3

1.2

332.25

306.14

nmol/l

0.93

169

583

Use of memantine

215

805

2.35

28.98

1.3

1.2

332.25

306.14

nmol/l

0.93

169

583

Diverticular disease of intestine

450

1655

1.81

28.80

1.3

1.1

346.55

363.88

nmol/l

0.87

361

1379

Obesity

370

1953

1.89

28.79

1.2

1.1

379.05

379.09

nmol/l

0.00

290

1733

Alzheimer disease, excluding more controls

135

296

3.08

28.63

1.2

316.62

315.13

nmol/l

0.02

108

217

Any dementia

282

946

2.12

28.38

1.3

1.2

305.94

310.66

nmol/l

0.13

211

703

Any mental disorder

685

2107

1.63

28.37

1.2

1.1

357.25

373.03

nmol/l

1.08

570

1812

Hypothyroidism, strict autoimmune

466

1738

1.78

28.16

1.2

1.1

367.63

370.06

nmol/l

0.08

397

1488

Hyperlipidaemia, other/unspecified

264

1198

2.10

27.67

1.3

1.2

309.66

337.90

nmol/l

1.32

182

967

Diabetes, insulin treatment (Kela reimbursement)

610

2269

1.65

27.53

1.2

351.33

370.50

nmol/l

1.27

433

2014

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

573

2098

1.67

27.29

1.2

349.73

370.98

nmol/l

1.44

411

1880

Other functional intestinal disorders

288

1367

2.02

27.17

1.2

1.1

329.80

357.62

nmol/l

1.39

226

1135

Other degenerative diseases of the nervous system

194

614

2.41

27.07

1.2

311.69

337.50

nmol/l

0.86

157

488

Type 2 diabetes, definitions combined, including avohilmo

570

2023

1.67

26.98

1.2

356.45

371.13

nmol/l

0.79

428

1808

Constipation

536

2288

1.68

26.97

1.2

1.1

363.09

358.99

nmol/l

0.15

415

1952

Type 2 diabetes, strict (exclude DM1)

571

2049

1.67

26.82

1.2

353.57

370.21

nmol/l

0.96

423

1832

Type 2 diabetes

589

2121

1.65

26.71

1.2

360.98

372.72

nmol/l

0.60

437

1902

Pain in throat and chest

524

1889

1.70

26.54

1.2

1.1

347.93

375.98

nmol/l

2.16

423

1626

Type 2 diabetes, definitions combined

568

2043

1.67

26.41

1.2

354.39

369.98

nmol/l

0.86

421

1827

Other gastritis (incl. Duodenitis)

164

662

2.50

26.18

1.3

1.1

323.49

357.41

nmol/l

1.22

149

532

Undefined dementia

125

402

2.90

26.05

1.3

290.97

299.11

nmol/l

0.15

308

Other soft tissue disorders, not elsewhere classified

547

2046

1.66

25.21

1.2

1.1

359.81

376.11

nmol/l

0.99

457

1736

Parasetamol

483

1430

1.73

24.93

1.2

1.1

369.90

389.40

nmol/l

1.01

412

1235

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

553

2303

1.64

24.81

1.2

1.1

338.25

380.48

nmol/l

4.21

454

1990

Insulin medication

353

1653

1.83

24.69

1.2

325.48

357.22

nmol/l

1.96

245

1467

Continuous positive airway pressure

125

385

2.82

24.63

1.3

1.1

341.99

366.39

nmol/l

0.56

101

343

Diseases of the digestive system

302

1587

1.91

24.53

1.2

344.82

343.44

nmol/l

0.04

240

1290

Benign neoplasm: Colon

316

1284

1.90

24.02

1.3

1.2

310.10

358.71

nmol/l

3.95

251

1061

Diabetes, varying definitions

592

2209

1.61

24.01

1.2

1.1

363.63

373.78

nmol/l

0.49

441

1987

Diabetes mellitus

594

2216

1.60

23.98

1.2

1.1

362.86

374.46

nmol/l

0.59

443

1994

Dizziness and giddiness

451

2169

1.69

23.83

1.2

1.1

360.05

357.56

nmol/l

0.08

359

1822

Neurological diseases

514

1547

1.68

23.76

1.2

1.1

371.69

379.38

nmol/l

0.33

449

1334

Benign neoplasm of colon, rectum, anus and anal canal

375

1917

1.77

23.71

1.3

1.2

319.12

347.59

nmol/l

1.85

292

1560

Sleep disorders (combined)

573

2346

1.61

23.66

1.2

1.1

361.00

371.12

nmol/l

0.52

484

1991

Episodal and paroxysmal disorders

668

2194

1.56

23.49

1.2

1.1

362.18

372.94

nmol/l

0.62

568

1863

Benign neoplasm of colon, rectum, anus and anal canal

352

1386

1.82

23.38

1.3

1.2

318.70

363.65

nmol/l

3.69

279

1158

Hypothyroidism, other/unspecified

543

2228

1.61

22.95

1.2

370.97

369.02

nmol/l

0.07

458

1894

Hypothyreosis and Thyroxine purchase for inclusion criteria

562

2326

1.60

22.90

1.2

370.00

367.59

nmol/l

0.09

474

1974

General symptoms and signs

651

2091

1.56

22.79

1.2

1.1

369.37

375.73

nmol/l

0.30

543

1824

Gastrointestinal diseases

349

944

1.86

22.74

1.1

387.81

388.10

nmol/l

0.01

314

844

Obesity, other/unspecified

212

1017

2.10

22.52

1.2

1.1

402.72

380.89

nmol/l

0.79

169

917

Metabolic disorders

557

2173

1.60

22.31

1.2

1.1

355.07

369.23

nmol/l

0.80

449

1866

Presence of other functional implants

336

1321

1.81

21.79

1.2

314.82

347.94

nmol/l

1.63

248

1074

Disorders of the thyroid gland

567

2365

1.57

21.46

1.2

367.71

367.69

nmol/l

0.00

477

2012

Autoimmune diseases related-to ILD

492

2707

1.60

21.34

1.2

355.52

372.99

nmol/l

1.05

403

2310

Alzheimer’s disease, wide definition, excluding more controls

114

276

2.84

21.29

1.3

1.2

310.40

314.99

nmol/l

0.08

202

Hypothyroidism, strict autoimmune, 3 medication purchases required

513

2190

1.60

21.26

1.2

368.99

366.66

nmol/l

0.08

433

1857

Condition for Implicit Sepsis (Organ dysfunction codes)

487

2193

1.62

21.24

1.2

1.1

346.46

366.33

nmol/l

1.17

382

1855

Alzheimer’s disease (Late onset), excluding more controls

108

249

2.92

21.14

1.3

1.2

291.38

299.01

nmol/l

0.13

179

Persons encountering health services for examination and investigation

407

1182

1.73

21.14

1.2

1.1

351.28

392.83

nmol/l

2.93

350

987

Other bacterial diseases

535

2346

1.58

21.03

1.2

1.1

336.15

370.18

nmol/l

3.03

419

2002

Benign neoplasm: Colon

319

1761

1.78

20.88

1.3

1.2

313.36

344.49

nmol/l

1.94

253

1416

Persons encountering health services for other counselling and medical advice, not elsewhere classified

648

2431

1.52

20.83

1.2

1.1

358.47

371.74

nmol/l

0.81

552

2052

Examination and observation for other reasons

339

1158

1.79

20.48

1.2

1.1

367.17

395.32

nmol/l

1.56

294

970

Sensorineural hearing loss

449

1925

1.64

20.45

1.2

309.50

364.64

nmol/l

6.46

339

1597

Inflammatory bowel disease treatment related agents

672

2548

1.50

20.21

1.2

369.40

370.60

nmol/l

0.05

565

2159

Complications of medical and surgical care

424

2492

1.62

19.50

1.2

349.46

363.78

nmol/l

0.70

341

2103

Persons encountering health services in other circumstances, wide

705

2477

1.48

19.43

1.2

1.1

362.37

370.53

nmol/l

0.43

603

2087

ILD medications: prednisolone, methylprednisolone, prednisone

643

2435

1.50

18.99

1.2

1.1

376.53

369.92

nmol/l

0.31

548

2055

Nerve, nerve root and plexus disorders

615

2578

1.50

18.95

1.2

1.1

363.28

368.13

nmol/l

0.22

521

2168

Chronic gastritis

181

878

2.08

18.79

1.3

1.2

323.91

352.89

nmol/l

0.77

148

675

Implicit Sepsis

419

2014

1.62

18.78

1.2

334.95

358.25

nmol/l

1.35

319

1679

Oral corticosteroids

616

2490

1.50

18.74

1.2

369.42

368.71

nmol/l

0.03

519

2103

Sleep apnoea

510

2229

1.56

18.73

1.2

356.55

369.83

nmol/l

0.70

425

1896

Anxiety disorders, excluding more controls

450

1867

1.60

18.65

1.2

1.1

380.61

382.73

nmol/l

0.08

395

1622

Insulin, intermediate and long-acting

324

1860

1.72

18.63

1.2

322.82

355.03

nmol/l

1.92

227

1558

Abnormalities of heart beat

221

1144

1.93

18.56

1.2

350.89

356.48

nmol/l

0.14

175

958

Codes for special purposes

261

1442

1.82

18.39

1.1

1.2

345.16

373.47

nmol/l

1.07

134

1278

Provisional assignment of new diseases of uncertain etiology

260

1439

1.82

18.22

1.1

1.2

345.16

373.78

nmol/l

1.09

134

1274

First line medication for Crohn's disease

646

2388

1.48

17.97

1.2

1.1

375.03

371.64

nmol/l

0.14

555

2017

Soft tissue disorders

601

2082

1.50

17.88

1.2

1.1

360.28

375.46

nmol/l

0.97

517

1763

Hypertensive Heart Disease

150

556

2.22

17.85

1.3

1.2

276.68

329.39

nmol/l

2.63

126

450

Presence of other devices

157

737

2.15

17.78

1.4

1.2

293.13

337.66

nmol/l

2.18

151

577

Intracranial trauma

304

1307

1.74

17.75

1.2

1.1

347.60

383.03

nmol/l

2.33

250

1135

Sleep apnoea, including avohilmo

533

2280

1.52

17.56

1.2

1.1

358.69

370.06

nmol/l

0.59

450

1937

Conductive and sensorineural hearing loss

455

2011

1.57

17.55

1.2

313.60

367.71

nmol/l

6.43

351

1679

Infections, IBD-co-morbidities

227

2.87

17.52

1.2

1.1

332.41

387.67

nmol/l

1.63

209

Disorders of lipoprotein metabolism and other lipidaemias

467

1878

1.57

17.51

1.2

346.30

363.33

nmol/l

0.92

369

1587

Codeine

547

1982

1.52

17.41

1.2

1.1

376.93

374.64

nmol/l

0.09

476

1686

Benign neoplasms

567

2109

1.51

17.25

1.2

1.1

369.75

377.52

nmol/l

0.34

483

1790

Symptoms and signs involving the urinary system

436

2150

1.57

17.19

1.2

330.63

357.97

nmol/l

1.87

339

1797

Complications of surgical and medical care, not elsewhere classified

552

2657

1.49

17.01

1.2

1.1

352.28

368.82

nmol/l

1.00

452

2250

Insulin, combination of fast acting with intermediate-acting or long-acting

357

2021

1.63

16.98

1.2

326.17

354.90

nmol/l

1.71

247

1695

Disorders of gallbladder, biliary tract and pancreas

565

2452

1.49

16.81

1.2

1.1

352.70

368.65

nmol/l

0.99

459

2079

Opioids

573

2015

1.50

16.79

1.2

1.1

381.88

373.81

nmol/l

0.38

501

1712

ILD medications

650

2456

1.46

16.77

1.2

1.1

372.26

370.74

nmol/l

0.06

557

2073

Neurological diseases, wide definition

162

375

2.18

16.33

1.1

388.55

408.06

nmol/l

0.53

152

355

Symptoms and signs involving the circulatory and respiratory systems

581

1964

1.49

16.33

1.2

1.1

372.86

377.77

nmol/l

0.21

501

1698

Abnormalities of breathing

499

1958

1.52

16.08

1.2

1.1

362.58

377.77

nmol/l

0.84

424

1693

Pain in limb

426

1981

1.56

16.08

1.2

1.1

359.38

374.75

nmol/l

0.78

343

1676

Functional dyspepsia

158

775

2.05

16.00

1.2

1.1

324.12

376.76

nmol/l

2.83

128

651

Other and unspecified polyneuropathies, also in other diseases

129

587

2.22

15.90

1.3

1.2

352.75

337.95

nmol/l

0.34

112

471

Other disorders of ear

510

2273

1.50

15.82

1.2

1.1

323.10

372.98

nmol/l

6.23

407

1924

Mood disorders, excluding more controls

500

2020

1.51

15.80

1.2

1.1

373.17

377.68

nmol/l

0.18

429

1738

Hypertensive heart and/or renal disease

156

586

2.08

15.57

1.3

1.2

279.55

330.81

nmol/l

2.57

128

478

Non-selective monoamine reuptake inhibitors

222

1193

1.81

15.54

1.2

360.83

350.83

nmol/l

0.27

181

997

Other disorders of urethra and urinary system

414

2008

1.55

15.32

1.2

346.30

369.75

nmol/l

1.43

344

1684

Symptoms and signs involving the digestive system and abdomen

580

1986

1.47

15.30

1.2

1.1

366.19

372.64

nmol/l

0.29

498

1679

Polycystic ovarian syndrome, consortium definition

403

1551

1.57

15.25

1.2

1.1

362.97

388.98

nmol/l

1.71

359

1349

Codeine or tramadol medication

652

2536

1.43

15.22

1.2

371.87

368.05

nmol/l

0.17

566

2133

Sulfonylureas

218

956

1.83

15.19

1.2

336.86

319.19

nmol/l

0.51

146

804

Neurotic, stress-related and somatoform disorders

467

2209

1.51

15.06

1.2

1.1

381.03

381.84

nmol/l

0.03

411

1916

Polyneuropathies and other disorders of the peripheral nervous system

139

671

2.09

14.77

1.3

1.2

354.83

342.71

nmol/l

0.28

121

545

Headache

353

1866

1.59

14.72

1.1

387.31

380.38

nmol/l

0.24

298

1635

Other dorsopathies, not elsewhere classified

572

2087

1.45

14.39

1.2

1.1

367.50

377.99

nmol/l

0.51

497

1765

Spondylopathies

454

1834

1.51

14.30

1.2

341.83

370.24

nmol/l

2.09

378

1523

Non-invasive ventilation

115

488

2.23

14.27

1.1

343.01

381.94

nmol/l

1.27

447

Anxiety disorders

469

2240

1.49

14.25

1.2

1.1

380.31

381.29

nmol/l

0.04

413

1939

Hypertension, essential

413

1533

1.54

14.22

1.2

1.1

370.27

382.21

nmol/l

0.52

341

1371

Arthropathies

511

1763

1.48

14.13

1.2

1.1

377.41

379.85

nmol/l

0.09

440

1512

Gastroduodenal ulcer

161

832

1.94

14.03

1.3

1.2

309.22

342.70

nmol/l

1.38

134

643

Gastric ulcer

114

523

2.20

13.83

1.3

1.2

319.18

342.94

nmol/l

0.65

101

400

Renal tubulo-interstitial diseases

465

2423

1.48

13.76

1.2

1.1

338.13

367.11

nmol/l

1.81

354

2066

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

333

2118

1.57

13.75

1.2

347.53

355.75

nmol/l

0.29

268

1771

Pain (limb, back, neck, head abdominally)

432

1426

1.52

13.67

1.2

1.1

361.68

373.80

nmol/l

0.50

374

1198

Benign neoplasms

427

1598

1.52

13.63

1.2

1.1

376.74

388.48

nmol/l

0.48

380

1388

Certain infectious and parasitic diseases

568

1982

1.44

13.62

1.2

1.1

363.19

375.55

nmol/l

0.66

478

1727

Alzheimer disease, including avohilmo

228

944

1.75

13.60

1.2

307.83

307.91

nmol/l

0.00

174

697

Heart failure, not strict

393

1777

1.53

13.57

1.2

1.1

306.60

365.92

nmol/l

7.33

320

1475

Disorders of thyroid, IBD co-morbidities

288

2.42

13.50

1.1

382.60

406.03

nmol/l

0.52

270

Antihypertensive medication - note that there are other indications

318

1076

1.62

13.46

1.1

396.16

394.77

nmol/l

0.04

293

987

Complications of procedures, not elsewhere classified

438

2569

1.48

13.30

1.2

1.1

357.03

368.55

nmol/l

0.52

355

2179

Depression

505

2409

1.45

13.30

1.2

1.1

373.09

377.49

nmol/l

0.18

433

2076

Irritable bowel syndrome

154

801

1.93

13.29

1.2

1.1

354.52

379.35

nmol/l

0.83

133

701

Syncope and collapse

248

1311

1.68

13.27

1.2

338.96

349.43

nmol/l

0.31

185

1098

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

206

564

1.84

13.25

1.1

381.84

390.02

nmol/l

0.21

193

512

Acute gastritis

193

2.99

13.05

1.4

1.1

303.82

372.05

nmol/l

1.61

163

Concussion

245

1269

1.68

12.90

1.1

349.94

382.46

nmol/l

1.75

198

1103

GASTRO-related operations

471

1608

1.47

12.82

1.2

1.1

363.36

389.03

nmol/l

1.67

411

1348

Any gastric operation

471

1608

1.47

12.82

1.2

1.1

363.36

389.03

nmol/l

1.67

411

1348

Cardiovascular diseases

307

1040

1.61

12.74

1.1

403.53

412.31

nmol/l

0.31

281

974

Dysphagia

146

758

1.94

12.71

1.2

339.74

337.76

nmol/l

0.04

118

612

Bacterial Sepsis

257

1395

1.65

12.66

1.2

300.22

339.60

nmol/l

2.28

185

1118

Abdominal and pelvic pain

560

1986

1.42

12.61

1.2

1.1

363.80

372.64

nmol/l

0.43

481

1679

Hernia

502

2381

1.43

12.59

1.2

351.38

370.31

nmol/l

1.18

423

1988

Benign neoplasm: Ascending colon

378

2.35

12.56

1.3

1.2

329.73

355.38

nmol/l

0.58

302

Hypertensive diseases

413

1565

1.50

12.50

1.2

1.1

382.55

382.91

nmol/l

0.01

347

1400

Hypertension

413

1565

1.50

12.48

1.2

1.1

382.55

382.91

nmol/l

0.01

347

1400

Degenerative diseases of the nervous system

222

978

1.72

12.47

1.2

302.21

314.56

nmol/l

0.37

170

725

Polyarthropathies

361

1581

1.53

12.33

1.2

1.1

343.60

371.94

nmol/l

1.69

287

1338

Angina pectoris

326

1418

1.56

12.24

1.2

324.98

344.04

nmol/l

0.81

230

1183

Shoulder lesions

421

1752

1.48

12.06

1.2

1.1

347.05

367.45

nmol/l

1.24

367

1460

Myalgia

130

661

1.98

12.05

1.2

1.1

369.14

382.96

nmol/l

0.32

110

566

Diseases of arteries, arterioles and capillaries (FINNGEN)

128

442

2.03

11.98

1.2

1.1

325.05

377.23

nmol/l

1.90

392

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

310

2012

1.55

11.96

1.2

352.43

358.01

nmol/l

0.17

248

1675

Other infectious diseases

231

2.72

11.95

1.2

339.35

368.99

nmol/l

0.44

192

Follow-up examination after treatment for conditions other than malignant neoplasms

245

969

1.66

11.92

1.2

1.1

345.38

395.49

nmol/l

3.23

211

808

Somatoform disorder

103

483

2.15

11.90

1.2

1.1

388.74

386.08

nmol/l

0.05

430

Oxycodone

200

1131

1.72

11.77

1.3

1.2

333.54

344.28

nmol/l

0.28

155

901

Dorsopathies

570

2090

1.39

11.66

1.2

1.1

368.95

378.01

nmol/l

0.42

501

1767

Other symptoms and signs involving cognitive functions and awareness

247

1433

1.62

11.66

1.2

355.13

340.12

nmol/l

0.51

203

1159

Migraine

245

1282

1.63

11.63

1.1

405.02

393.20

nmol/l

0.38

220

1151

Benign neoplasm: Ascending colon

393

2.26

11.51

1.3

1.2

329.73

345.36

nmol/l

0.32

314

Implicit bacterial Sepsis

226

1257

1.66

11.50

1.2

296.60

335.36

nmol/l

1.98

163

996

Dyspnoea

474

2567

1.42

11.46

1.2

1.1

346.35

366.00

nmol/l

1.20

383

2166

Menorrhagia

206

658

1.74

11.40

1.2

1.1

353.04

386.89

nmol/l

1.43

184

540

Triptan medication for migraine, single purchase ok

372

1701

1.48

11.23

1.1

423.89

385.51

nmol/l

3.23

345

1509

Migraine, single triptan purchase ok & required. ICD-code if available is included

372

1701

1.48

11.23

1.1

423.89

385.51

nmol/l

3.23

345

1509

Other abnormal uterine and vaginal bleeding

138

513

1.93

11.22

1.2

1.1

346.32

376.07

nmol/l

0.95

123

407

General examination and investigation of persons without complaint and reported diagnosis

337

1175

1.53

11.22

1.2

1.1

341.34

393.60

nmol/l

4.16

319

983

Benign neoplasm: Caecum

298

2.44

11.22

1.3

1.2

331.93

344.30

nmol/l

0.20

242

Postmenopausal atrophic vaginitis

148

470

1.91

11.18

1.2

1.1

383.97

375.92

nmol/l

0.15

127

369

Other disorders of fluid, electrolyte and acid-base balance

172

945

1.76

11.13

1.2

335.75

338.05

nmol/l

0.04

130

762

Bleeding

433

2204

1.43

11.03

1.2

348.68

356.65

nmol/l

0.32

343

1829

Other neurological diseases

385

2130

1.46

10.92

1.3

1.2

328.47

354.13

nmol/l

1.61

310

1743

Heart failure and antihypertensive medication

126

422

1.98

10.90

1.3

1.1

307.38

353.93

nmol/l

1.88

102

363

Hypothyroidism, drug reimbursement

230

2.40

10.88

1.1

1.0

363.31

393.11

nmol/l

0.62

219

Benign neoplasm: Caecum

303

2.40

10.83

1.3

1.2

331.93

355.51

nmol/l

0.45

246

Other diseases of the digestive system

188

1110

1.70

10.79

1.2

332.56

343.26

nmol/l

0.28

145

886

Tramadol

415

1855

1.44

10.73

1.2

1.1

370.98

369.41

nmol/l

0.05

358

1558

Excessive, frequent and irregular menstruation

219

729

1.68

10.72

1.2

1.1

358.76

390.14

nmol/l

1.30

196

609

Coxarthrosis

278

1212

1.56

10.63

1.2

1.1

343.08

359.71

nmol/l

0.62

220

991

Mood [affective] disorders

533

2558

1.37

10.50

1.2

375.74

373.97

nmol/l

0.07

457

2182

Pain, not elsewhere classified

147

816

1.81

10.47

1.3

1.2

338.53

368.75

nmol/l

1.00

126

712

Injuries to the head

573

2756

1.36

10.44

1.2

350.27

373.24

nmol/l

1.87

467

2355

Benzodiazepine use

529

2752

1.37

10.43

1.2

1.1

359.95

370.11

nmol/l

0.51

453

2322

Fall on same level

599

2478

1.35

10.43

1.2

1.1

350.73

381.02

nmol/l

2.68

503

2130

Polyuria

132

711

1.87

10.38

1.3

1.2

339.87

347.78

nmol/l

0.15

101

572

Noninfective enteritis and colitis

240

1520

1.58

10.37

1.2

361.35

366.34

nmol/l

0.15

207

1293

Mood disorders

533

2560

1.37

10.36

1.2

375.23

374.35

nmol/l

0.03

457

2184

Migraine without aura

103

510

2.03

10.36

1.1

440.83

399.77

nmol/l

1.17

480

Rotator cuff syndrome

325

1621

1.49

10.32

1.2

1.1

356.89

364.59

nmol/l

0.28

283

1340

Cholelithiasis, broad definition with cholecystitis

470

2312

1.40

10.31

1.2

345.29

364.15

nmol/l

1.15

379

1955

Factors influencing health status and contact with health services

172

484

1.79

10.29

1.2

1.1

376.17

387.24

nmol/l

0.22

148

419

Other heart diseases, wide

464

2057

1.40

10.25

1.2

1.1

378.16

381.49

nmol/l

0.12

401

1797

Dorsalgia

529

2087

1.38

10.17

1.2

1.1

361.12

378.02

nmol/l

0.96

457

1764

Pure hypercholesterolaemia

376

1743

1.45

10.17

1.2

338.05

356.35

nmol/l

0.94

305

1460

Hypokalaemia

350

2.25

10.14

1.1

362.34

366.62

nmol/l

0.06

297

Oxicams

154

482

1.83

10.13

1.2

1.1

400.39

339.90

nmol/l

2.26

121

369

Coeliac disease

331

2.28

10.13

1.3

1.1

324.77

379.71

nmol/l

1.78

296

Intracranial injury

300

1942

1.50

10.04

1.2

341.96

358.48

nmol/l

0.73

237

1621

Migraine without aura and triptan purchases

391

2.16

9.96

1.1

459.99

397.07

nmol/l

1.90

364

Coxarthrosis [arthrosis of hip](FG)

298

1433

1.51

9.92

1.2

1.1

342.96

359.97

nmol/l

0.68

235

1166

Other external causes of accidental injury

473

1698

1.40

9.88

1.2

1.1

363.13

382.68

nmol/l

1.02

410

1455

Any reimbursement code in KELA

293

958

1.54

9.86

1.2

1.1

392.53

404.46

nmol/l

0.43

267

892

Soft tissue disorders related to use, overuse and pressure

140

782

1.80

9.81

1.3

1.1

377.54

360.93

nmol/l

0.40

121

646

Coxibs

173

529

1.75

9.75

1.2

1.1

386.92

350.78

nmol/l

1.22

146

415

Finngen Rheumatological endpoints

509

2120

1.37

9.74

1.2

1.1

360.51

379.70

nmol/l

1.19

436

1816

Parkinson's disease, excluding more controls

303

2.30

9.72

1.2

305.60

329.56

nmol/l

0.45

229

Parkinson's disease, strict definition, excluding more controls

287

2.34

9.71

1.2

312.61

328.13

nmol/l

0.25

215

Cardiovascular diseases (excluding rheumatic etc)

311

1201

1.50

9.65

1.1

402.77

408.11

nmol/l

0.17

281

1122

Genitourinary diseases

309

1028

1.51

9.65

1.2

1.1

372.28

387.23

nmol/l

0.57

271

868

Diseases of the eye and adnexa

432

1533

1.41

9.65

1.2

1.1

374.63

390.69

nmol/l

0.86

387

1350

Other intervertebral disc disorders

445

1955

1.40

9.62

1.2

1.1

350.19

375.34

nmol/l

1.78

386

1642

Adjustment and management of implanted device

112

588

1.92

9.58

1.2

341.89

335.02

nmol/l

0.11

477

Alzheimer disease

192

879

1.66

9.54

1.2

315.48

305.78

nmol/l

0.24

146

643

Renal failure

241

1426

1.55

9.45

1.3

1.2

306.43

330.72

nmol/l

0.78

179

1122

Chronic kidney disease

173

1033

1.68

9.42

1.3

1.2

312.67

330.84

nmol/l

0.39

133

810

Temporomandibular joint disorders

420

2.08

9.42

1.1

382.85

387.76

nmol/l

0.08

365

Dentinal caries

122

660

1.85

9.35

1.2

1.1

347.67

368.03

nmol/l

0.47

571

Hypertensive diseases (excluding secondary)

263

994

1.54

9.33

1.1

405.30

405.99

nmol/l

0.02

232

921

Cardiac arrhythmias

295

1311

1.49

9.18

1.2

1.1

404.76

391.85

nmol/l

0.51

266

1209

Cholelithiasis

447

2282

1.38

9.12

1.2

347.32

363.88

nmol/l

0.91

362

1926

Rheumatoid arthritis

179

990

1.65

9.11

1.2

1.1

343.56

361.80

nmol/l

0.55

145

812

External causes of morbidity and mortality

386

1359

1.43

9.07

1.2

1.1

363.69

382.69

nmol/l

0.85

335

1180

Misadventures to patients during surgical and medical care

427

2.05

9.05

1.2

1.1

375.55

366.11

nmol/l

0.15

368

Irregular menses

235

1236

1.55

9.01

1.1

375.83

400.84

nmol/l

1.16

218

1121

Diabetic neuropathy

386

2.11

8.99

1.3

1.2

365.07

328.20

nmol/l

0.79

265

Other joint disorders

455

1759

1.38

8.99

1.2

1.1

377.31

380.32

nmol/l

0.10

407

1509

Diseases of pulp and periapical tissues

183

1129

1.63

8.95

1.2

1.1

333.74

366.34

nmol/l

1.36

141

969

Other arrhythmias

319

1686

1.45

8.94

1.2

1.1

358.75

370.05

nmol/l

0.42

264

1448

Accidents

465

1698

1.37

8.84

1.2

1.1

360.50

382.68

nmol/l

1.22

401

1455

Other diseases of urinary system

543

2290

1.34

8.84

1.2

1.1

358.50

372.90

nmol/l

0.74

454

1944

Non-rheumatic valve diseases

235

1117

1.54

8.70

1.2

1.1

315.18

349.37

nmol/l

1.85

199

916

Cerebrovascular diseases

378

1935

1.40

8.69

1.2

314.40

350.28

nmol/l

2.29

298

1575

Valvular heart disease excluding rheumatic fever

235

1119

1.54

8.67

1.2

1.1

315.18

349.53

nmol/l

1.87

199

917

Other retinal disorders

323

1811

1.44

8.62

1.3

1.2

315.50

343.80

nmol/l

1.56

246

1470

All anxiety disorders

282

1544

1.47

8.61

1.2

1.1

376.18

392.71

nmol/l

0.73

255

1385

Atrial fibrillation and flutter with reimbursement

127

449

1.82

8.60

1.3

1.1

395.74

385.19

nmol/l

0.22

103

397

Noninflammatory disorders of female genital tract

229

736

1.57

8.56

1.1

383.31

390.70

nmol/l

0.20

215

615

Barrett oesophagus

3.30

8.50

1.2

336.63

366.10

nmol/l

0.28

Coxarthrosis, primary

306

1847

1.44

8.44

1.2

336.45

338.98

nmol/l

0.07

238

1488

Familial hypercholesterolemia

487

1.94

8.42

1.3

1.2

304.67

336.39

nmol/l

0.72

381

Diseases of the musculoskeletal system and connective tissue

287

973

1.48

8.30

1.2

1.1

382.62

389.14

nmol/l

0.20

257

839

Heart failure,strict

261

1267

1.49

8.30

1.3

1.2

294.29

345.17

nmol/l

3.68

210

1008

Senile cataract

309

1326

1.45

8.29

1.3

1.1

321.40

359.55

nmol/l

2.46

238

1113

Dental caries

130

742

1.74

8.25

1.2

1.1

347.64

368.01

nmol/l

0.51

646

Unspecified urinary incontinence

271

2.27

8.21

1.3

1.1

320.27

370.66

nmol/l

1.19

230

Use of hypnotics and sedatives

553

2433

1.32

8.20

1.2

374.61

368.30

nmol/l

0.29

470

2063

Diseases of the ear and mastoid process

608

2364

1.30

8.18

1.2

1.1

342.84

384.26

nmol/l

5.09

515

2038

Other CVD (FINNGEN)

215

2.28

8.09

1.2

1.1

322.91

354.30

nmol/l

0.53

179

Other mental disorders due to brain damage and dysfunction and to physical disease

326

2.13

7.99

1.3

1.2

316.97

338.51

nmol/l

0.34

261

Benign neoplasm of other and ill-defined parts of digestive system

102

553

1.86

7.99

1.2

359.13

345.45

nmol/l

0.18

449

STROKE

278

1324

1.46

7.96

1.2

1.1

331.76

377.98

nmol/l

3.56

229

1156

Obesity related asthma

167

1040

1.61

7.93

1.2

1.1

373.45

370.62

nmol/l

0.06

139

888

Other heart diseases

226

981

1.53

7.93

1.2

1.1

392.04

406.35

nmol/l

0.49

197

911

Oedema, not elsewhere classified

163

1004

1.62

7.92

1.3

1.2

327.75

356.46

nmol/l

0.94

126

838

Dentofacial anomalies [including malocclusion]

138

813

1.69

7.80

1.1

397.33

388.51

nmol/l

0.21

113

737

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

144

2.52

7.79

1.1

315.86

361.28

nmol/l

0.68

128

Anxiety (asthma-related co-morbidities)

278

1517

1.45

7.79

1.2

1.1

376.02

393.43

nmol/l

0.78

252

1362

Inflammatory bowel disease

157

968

1.63

7.77

1.2

1.1

348.18

381.32

nmol/l

1.32

135

842

Disorders of lens

328

1467

1.41

7.76

1.2

1.1

332.05

368.36

nmol/l

2.33

257

1245

Disorders of other endocrine glands

222

1459

1.50

7.70

1.1

1.2

351.37

363.00

nmol/l

0.36

180

1228

Preparation and fitting of bite rail to mouth

371

2.03

7.70

1.1

432.29

397.31

nmol/l

0.78

342

Falls/tendency to fall

570

2193

1.30

7.69

1.2

1.1

357.34

384.14

nmol/l

2.04

488

1897

Other headache syndromes

202

1326

1.53

7.64

1.2

1.1

412.94

376.66

nmol/l

1.67

179

1151

Pneumonia, organism unspecified

444

2407

1.34

7.63

1.2

1.1

338.32

372.69

nmol/l

2.37

363

2055

Deforming dorsopathies

143

866

1.66

7.61

1.2

1.1

333.66

375.35

nmol/l

1.93

132

720

All-cause Heart Failure

294

1485

1.43

7.61

1.3

1.2

300.41

335.95

nmol/l

1.78

238

1165

Spinal stenosis

262

1413

1.46

7.59

1.2

334.74

353.14

nmol/l

0.77

223

1136

Alzheimer’s disease, wide definition

152

779

1.64

7.54

1.3

1.2

317.50

308.56

nmol/l

0.21

123

565

Low back pain

361

2026

1.37

7.53

1.2

1.1

373.37

378.72

nmol/l

0.19

320

1715

Fever of other and unknown origin

258

1651

1.45

7.53

1.2

1.1

338.67

362.33

nmol/l

1.02

207

1420

Vitamin B12 deficiency anaemia

361

2.04

7.52

1.3

1.2

347.36

331.37

nmol/l

0.18

291

Acute pancreatitis

105

586

1.80

7.51

1.2

325.02

350.87

nmol/l

0.68

483

Other reaction to severe stress, and adjustment disorders

165

1040

1.59

7.48

1.1

383.95

397.90

nmol/l

0.40

143

945

GI-bleeding

176

1129

1.57

7.41

1.2

333.56

343.12

nmol/l

0.23

134

901

Benign neoplasm: Descending colon

154

2.62

7.37

1.5

1.2

327.71

365.35

nmol/l

0.56

128

Cerebrovascular diseases (FINNGEN)

153

671

1.64

7.37

1.2

1.1

354.19

398.92

nmol/l

1.96

128

613

TMD related operations

468

1.89

7.35

1.1

424.58

390.98

nmol/l

0.87

428

Other cataract

208

1065

1.52

7.34

1.3

1.1

300.16

348.10

nmol/l

3.08

162

879

Other diseases of pancreas

178

2.50

7.33

1.2

1.1

352.77

354.01

nmol/l

0.01

151

Cholecystectomy

364

2370

1.36

7.27

1.2

337.74

361.86

nmol/l

1.41

297

1979

ILD medications: immunosuppressive drugs

290

1977

1.41

7.25

1.2

1.1

347.16

373.79

nmol/l

1.43

251

1687

Heart failure, strict

293

1495

1.41

7.16

1.3

1.2

299.43

336.59

nmol/l

1.91

237

1174

Benign neoplasm of other and ill-defined parts of digestive system

102

574

1.79

7.13

1.2

359.13

348.04

nmol/l

0.14

478

Traumatic subdural haemorrhage

349

2.01

7.09

1.3

1.2

317.22

321.56

nmol/l

0.06

271

Neoplasms

386

1524

1.36

7.09

1.2

1.1

379.72

387.37

nmol/l

0.26

343

1334

Asthma, unspecified (mode), excluding more controls

258

1409

1.44

7.09

1.2

1.1

355.00

380.22

nmol/l

1.19

209

1220

Alzheimer’s disease (Late onset)

139

727

1.65

7.07

1.3

1.2

307.78

302.39

nmol/l

0.11

113

522

Behavioural syndromes associated with physiological disturbances and physical factors

147

914

1.61

7.06

1.1

394.40

388.72

nmol/l

0.13

140

809

Disturbances of skin sensation

136

831

1.64

7.04

1.1

344.96

385.59

nmol/l

1.61

120

737

Colectomy operation

540

1.81

7.03

1.2

322.12

345.06

nmol/l

0.46

442

Other arthrosis

261

1303

1.44

6.96

1.2

1.1

384.69

368.38

nmol/l

0.61

215

1087

Temporomandibular joint disorders, including avohilmo

190

1256

1.51

6.95

1.2

1.1

422.99

385.88

nmol/l

1.96

169

1137

Other systemic involvement of connective tissue (FG)

142

875

1.62

6.92

1.2

351.66

358.93

nmol/l

0.14

114

715

Additional codes for the location of defect, injury or illness

142

2.63

6.89

1.1

1.2

320.49

384.42

nmol/l

1.02

126

Influenza and pneumonia

512

2609

1.29

6.87

1.2

1.1

342.13

378.14

nmol/l

3.05

419

2245

Chronic diseases of tonsils and adenoids

374

1754

1.35

6.85

1.1

419.23

377.72

nmol/l

3.60

340

1530

Other diseases of oesophagus

247

2.20

6.83

1.2

1.1

306.00

363.67

nmol/l

1.11

202

Chronic periapical parodontitis

107

619

1.74

6.81

1.2

1.1

343.18

365.00

nmol/l

0.50

533

Female genital prolapse

159

575

1.60

6.78

1.2

1.1

320.57

379.61

nmol/l

2.91

139

460

Glaucoma

284

1786

1.40

6.76

1.2

340.66

336.68

nmol/l

0.12

229

1426

Septicaemia

202

1309

1.49

6.76

1.2

310.04

343.83

nmol/l

1.68

164

1063

Anaemia in chronic diseases classified elsewhere

3.56

6.75

1.1

386.43

359.13

nmol/l

0.19

Disturbance of activity and attention

189

2.36

6.72

1.1

409.23

415.80

nmol/l

0.07

184

Vocal cord dysfunction

285

2.06

6.70

1.1

399.39

380.00

nmol/l

0.30

262

Other or unspecified ileus, impaction or obstruction

541

1.78

6.69

1.2

338.77

346.33

nmol/l

0.13

430

Other septicaemia

184

1199

1.51

6.65

1.3

1.2

312.30

339.99

nmol/l

1.13

151

971

Conduction disorders

152

800

1.59

6.64

1.3

1.2

316.66

331.31

nmol/l

0.38

124

637

Weight loss

270

2.13

6.63

1.3

1.2

355.22

359.54

nmol/l

0.05

233

Acute tubulo-interstitial nephritis

306

1977

1.38

6.60

1.2

345.38

356.87

nmol/l

0.42

237

1664

Arthrosis

367

1494

1.35

6.60

1.2

1.1

355.48

369.00

nmol/l

0.59

310

1256

Abnormal weight loss

238

2.20

6.60

1.3

1.2

331.02

355.37

nmol/l

0.38

206

Insulin, fast-acting

179

1184

1.52

6.59

1.2

327.69

361.17

nmol/l

1.35

124

997

Benign neoplasm: Transverse colon

271

2.12

6.57

1.3

1.2

305.73

354.62

nmol/l

1.19

222

Transient ischemic attack

266

1569

1.41

6.54

1.3

1.2

305.40

338.55

nmol/l

1.99

215

1237

Other disorders of teeth and supporting structures

111

657

1.70

6.53

1.1

362.54

357.63

nmol/l

0.07

559

Paralytic ileus and intestinal obstruction

132

817

1.62

6.52

1.2

341.22

349.33

nmol/l

0.17

100

660

Pneumonias (Asthma/COPD co-morbidities)

483

2596

1.29

6.51

1.2

1.1

340.58

376.30

nmol/l

2.80

395

2229

Chronic pancreatitis

327

2.00

6.44

1.2

367.79

360.09

nmol/l

0.10

275

Dipeptidyl peptidase 4 (DPP-4) inhibitors

314

2.02

6.41

1.2

317.42

343.37

nmol/l

0.37

270

Myocardial infarction, without ST-elevation

211

1339

1.46

6.37

1.3

1.2

301.55

326.34

nmol/l

0.95

153

1039

All pneumoniae

484

2600

1.29

6.37

1.2

1.1

339.33

376.77

nmol/l

3.06

394

2233

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

218

947

1.46

6.32

1.1

369.95

404.18

nmol/l

1.61

186

876

453

2189

1.30

6.32

1.2

1.1

340.32

374.79

nmol/l

2.45

372

1879

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

453

2189

1.30

6.32

1.2

1.1

340.32

374.79

nmol/l

2.45

372

1879

Paroxysmal tachycardia

105

519

1.72

6.29

1.2

1.1

351.75

385.76

nmol/l

0.84

468

Generalized anxiety disorder

379

1.91

6.26

1.2

1.1

390.28

404.62

nmol/l

0.22

359

Disorders of choroid and retina

395

2187

1.32

6.26

1.2

332.40

357.51

nmol/l

1.49

306

1811

Endometriosis

172

667

1.54

6.26

1.2

1.1

380.32

388.68

nmol/l

0.20

161

555

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

471

2576

1.29

6.23

1.2

1.1

337.24

374.89

nmol/l

3.03

385

2207

Symptoms and signs concerning food and fluid intake

290

2.05

6.23

1.3

1.2

341.82

351.28

nmol/l

0.13

253

Other blood glucose lowering drugs, excl. Insulins

496

1.78

6.18

1.2

342.85

345.03

nmol/l

0.03

426

Iron deficiency anaemia secondary to blood loss (chronic)

563

1.73

6.16

1.2

304.77

339.33

nmol/l

0.95

457

Asthma, unspecified (mode)

266

1516

1.39

6.15

1.2

1.1

352.07

374.30

nmol/l

1.00

217

1309

Hyperkinetic disorders

204

2.24

6.10

1.1

406.27

415.11

nmol/l

0.10

199

Diseases of arteries, arterioles and capillaries

333

1853

1.34

6.08

1.2

330.88

340.21

nmol/l

0.32

239

1513

Other diseases of anus and rectum

146

942

1.55

6.06

1.2

340.90

354.13

nmol/l

0.36

118

767

Rheumatism, unspecified

392

1.87

6.00

1.2

1.1

340.00

364.56

nmol/l

0.54

339

Benign neoplasm: Rectum

538

1.74

5.99

1.4

1.2

320.57

340.91

nmol/l

0.43

434

Trochanteric bursitis

379

1.88

5.95

1.4

1.1

361.77

361.24

nmol/l

0.01

322

Other disorders of nervous system

160

2.40

5.88

1.2

301.19

375.89

nmol/l

1.28

139

IBD patients in KELA-register

108

654

1.66

5.87

1.2

1.1

362.95

389.86

nmol/l

0.74

590

Explicit Sepsis

212

1425

1.43

5.85

1.2

311.38

346.45

nmol/l

1.81

171

1154

Cough

192

1270

1.45

5.80

1.2

1.1

366.47

363.02

nmol/l

0.08

157

1062

Acute pancreatitis (for exclusion)

105

634

1.66

5.78

1.2

325.02

349.35

nmol/l

0.63

518

Other noninflammatory disorders of uterus, except cervix

114

472

1.65

5.78

1.2

1.1

338.27

371.33

nmol/l

0.81

368

Benign neoplasm: Rectum

544

1.72

5.77

1.4

1.2

320.57

342.10

nmol/l

0.46

435

Degeneration of macula and posterior pole

237

1398

1.40

5.73

1.3

1.2

295.40

323.97

nmol/l

1.42

188

1080

Cervical disc disorders

178

1215

1.47

5.71

1.2

1.1

338.48

371.90

nmol/l

1.40

151

997

Injury, poisoning and certain other consequences of external causes

303

1117

1.36

5.66

1.1

366.68

382.68

nmol/l

0.66

266

979

Implicit fungal Sepsis

3.14

5.63

1.2

294.93

396.31

nmol/l

0.83

Rheumatoid arthritis, including avohilmo

190

1318

1.45

5.61

1.2

343.36

354.72

nmol/l

0.32

155

1093

Inflammatory bowel disease, strict (require KELA)

108

663

1.64

5.59

1.2

1.1

362.95

388.42

nmol/l

0.69

597

Personal history of malignant neoplasm

2.96

5.59

1.0

1.1

330.12

408.61

nmol/l

0.91

Symptoms and signs involving the skin and subcutaneous tissue

325

2450

1.32

5.58

1.2

1.1

340.50

368.68

nmol/l

1.78

273

2073

Peripheral artery disease

230

1325

1.40

5.54

1.2

323.84

323.45

nmol/l

0.01

160

1048

Carpal tunnel syndrome

293

1973

1.34

5.53

1.2

358.11

367.99

nmol/l

0.38

253

1655

Other pulmonary diagnosis

425

1651

1.29

5.52

1.2

1.1

376.35

377.77

nmol/l

0.04

359

1429

Asthma (mode)

389

1643

1.30

5.48

1.2

1.1

377.45

377.68

nmol/l

0.01

331

1425

Unstable angina pectoris

200

1162

1.43

5.45

1.2

315.27

329.12

nmol/l

0.38

139

913

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

211

2.15

5.44

1.2

1.1

406.77

385.12

nmol/l

0.26

185

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

464

1.75

5.43

1.2

1.1

373.16

394.29

nmol/l

0.28

422

Fungal Sepsis

2.98

5.43

1.2

294.93

392.18

nmol/l

0.80

Spondylosis

256

1608

1.37

5.42

1.2

335.85

367.90

nmol/l

1.67

209

1322

158

942

1.49

5.38

1.3

1.2

281.73

314.54

nmol/l

1.29

124

698

Intestinal stricture

153

1027

1.50

5.37

1.2

348.37

340.93

nmol/l

0.16

116

824

Diseases of the respiratory system

352

1339

1.32

5.36

1.2

1.1

377.94

370.61

nmol/l

0.25

301

1150

Disorder of lipoprotein metabolism, unspecified

393

1.82

5.35

1.3

1.2

292.49

337.56

nmol/l

1.21

311

L04AX Other immunosuppressants

247

1809

1.37

5.34

1.2

1.1

349.92

371.28

nmol/l

0.92

218

1546

Nausea and vomiting

129

822

1.55

5.32

1.2

338.82

349.56

nmol/l

0.22

671

Unspecified haematuria

198

1194

1.42

5.31

1.2

336.27

345.22

nmol/l

0.22

142

969

Benign neoplasm: Transverse colon

295

1.95

5.30

1.3

1.2

305.73

343.37

nmol/l

0.83

246

Dementia due to Parkinsons disease, excluding more controls

3.90

5.28

1.3

1.2

330.75

304.16

nmol/l

—

Second line medication for Crohn's disease

252

1855

1.36

5.28

1.2

1.1

349.30

371.58

nmol/l

1.00

222

1590

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

102

627

1.63

5.28

1.2

1.1

345.04

379.73

nmol/l

0.86

573

Asthma

393

1632

1.29

5.27

1.2

1.1

374.40

378.08

nmol/l

0.13

335

1417

Ischaemic heart disease, wide definition

357

1715

1.31

5.25

1.2

348.17

359.49

nmol/l

0.43

274

1462

Osteopathies and chondropathies

261

1835

1.35

5.20

1.2

331.22

360.13

nmol/l

1.39

209

1527

Asthma (only as main-diagnosis), excluding more controls

335

1519

1.32

5.19

1.1

376.43

383.71

nmol/l

0.26

290

1323

Visual disturbances and blindness

239

1751

1.37

5.18

1.2

351.02

358.79

nmol/l

0.22

205

1446

Dementia in Alzheimer disease

511

1.65

5.13

1.3

1.2

292.96

308.59

nmol/l

0.27

369

Disorders of sclera, cornea, iris and ciliary body

249

1842

1.35

5.08

1.2

363.26

367.35

nmol/l

0.11

204

1557

Tinnitus

110

696

1.59

5.08

1.2

1.1

340.94

370.20

nmol/l

0.91

101

596

Acetic acid derivatives and related substances

152

525

1.51

5.07

1.2

1.1

385.11

348.57

nmol/l

1.17

134

411

Vitamin deficiency

128

2.45

5.05

1.3

1.1

396.64

386.76

nmol/l

0.08

113

Vitamin deficiency, wide

128

2.45

5.05

1.3

1.1

396.64

386.76

nmol/l

0.08

113

Asthma, excluding more controls

369

1519

1.30

5.05

1.2

1.1

377.67

383.71

nmol/l

0.22

318

1323

Other sleep disorders

279

1.95

5.05

1.1

413.26

374.48

nmol/l

0.64

237

Other specific joint derangements/joint disorders

327

1676

1.31

5.03

1.2

1.1

373.16

384.00

nmol/l

0.42

297

1445

Benign neoplasm: Sigmoid colon

567

1.65

5.00

1.3

1.2

297.45

342.20

nmol/l

1.42

453

Benign neoplasm: Descending colon

186

2.17

4.98

1.5

1.2

327.71

346.00

nmol/l

0.23

159

Stroke, excluding SAH

286

1602

1.33

4.95

1.2

310.24

339.86

nmol/l

1.31

217

1275

Other bacterial intestinal infections

592

1.63

4.94

1.2

320.15

343.82

nmol/l

0.58

486

Other systemic involvement of connective tissue

144

973

1.49

4.93

1.2

350.64

351.08

nmol/l

0.01

115

801

Erysipelas

254

1725

1.35

4.93

1.2

331.57

355.36

nmol/l

0.97

183

1436

Insulin, fast-acting or short human

179

1260

1.42

4.92

1.2

327.69

357.96

nmol/l

1.17

124

1053

Asthma (only as main-diagnosis)

350

1632

1.30

4.89

1.2

1.1

374.28

378.08

nmol/l

0.13

299

1417

Osteoporosis

137

875

1.50

4.88

1.2

294.67

333.22

nmol/l

1.51

107

691

Disorders of eyelid, lacrimal system and orbit

411

2557

1.26

4.87

1.2

360.77

361.77

nmol/l

0.03

342

2146

Other/unspecified dorsalgia

180

1266

1.42

4.85

1.2

340.27

368.63

nmol/l

0.78

142

1050

Disorders of synovium and tendon

240

1599

1.35

4.85

1.2

1.1

379.95

375.58

nmol/l

0.12

203

1356

Benign neoplasm: Rectum, anus and anal canal

100

626

1.60

4.85

1.4

1.2

326.00

344.75

nmol/l

0.40

499

Benign neoplasm: Sigmoid colon

572

1.63

4.85

1.3

1.2

297.45

343.04

nmol/l

1.48

458

Purpura and other haemorrhagic conditions

384

1.78

4.84

1.3

1.2

317.12

357.12

nmol/l

0.80

330

Alzheimer’s disease (Early onset), excluding more controls

2.67

4.83

1.1

1.2

345.95

344.28

nmol/l

0.01

Total colectomy

2.66

4.83

1.0

1.1

321.78

384.55

nmol/l

0.82

Total colectomy operation

2.66

4.83

1.0

1.1

321.78

384.55

nmol/l

0.82

Excluding asthma or asthma-COPD overlap

418

1651

1.27

4.83

1.2

1.1

371.33

377.77

nmol/l

0.22

354

1429

Benign neoplasm: Rectum, anus and anal canal

100

627

1.60

4.82

1.4

1.2

326.00

346.06

nmol/l

0.44

508

Progressive vascular leukoencephalopathy

107

2.56

4.82

1.1

1.2

298.59

286.17

nmol/l

0.11

Candidiasis

407

1.75

4.81

1.3

1.1

355.47

375.41

nmol/l

0.32

364

Bacterial intestinal infections, IBD co-morbidities

612

1.61

4.80

1.2

316.84

344.63

nmol/l

0.74

502

Seropositive rheumatoid arthritis

129

855

1.51

4.80

1.2

330.54

358.25

nmol/l

0.80

106

695

Post-traumatic stress disorder

202

2.09

4.80

1.1

437.61

423.95

nmol/l

0.16

194

Injuries to the knee and lower leg

579

2720

1.22

4.78

1.2

358.77

371.86

nmol/l

0.79

482

2313

Triptan medication for migraine, min. 3 purchases

243

1421

1.35

4.78

1.1

430.01

396.60

nmol/l

1.91

230

1305

Systemic connective tissue disorders

173

1220

1.42

4.75

1.2

351.58

355.42

nmol/l

0.08

143

1002

Polyarthrosis

101

610

1.59

4.75

1.2

1.1

288.63

343.99

nmol/l

2.69

489

Exclusions for E4_PCOS_CONSORTIUM

351

1710

1.29

4.75

1.2

1.1

381.45

382.79

nmol/l

0.04

310

1490

Other diseases of upper respiratory tract

559

2382

1.23

4.74

1.2

388.03

358.79

nmol/l

2.47

475

1984

Oesophageal obstruction

2.82

4.73

1.4

1.2

357.88

359.68

nmol/l

0.01

Radiculopathy

530

1.65

4.72

1.2

307.97

348.24

nmol/l

1.08

420

COPD differential diagnosis

415

1643

1.27

4.71

1.2

1.1

372.58

377.68

nmol/l

0.17

349

1425

Alzheimer’s disease (Atypical or mixed), excluding more controls

163

2.14

4.69

1.1

1.2

241.94

298.09

nmol/l

0.84

116

Personality disorders, excluding more controls

101

641

1.58

4.63

1.2

1.1

355.10

409.22

nmol/l

1.97

597

ILD differential diagnosis

414

1643

1.26

4.62

1.2

1.1

372.58

377.68

nmol/l

0.17

349

1425

Use of pramipexole

112

729

1.54

4.61

1.2

337.67

339.48

nmol/l

0.03

589

Spondyloarthritis

595

1.60

4.61

1.2

343.41

372.73

nmol/l

0.64

513

Other anxiety disorders

186

1181

1.40

4.61

1.2

1.1

368.36

395.28

nmol/l

1.10

170

1069

Budesonide

390

1.75

4.61

1.1

357.13

380.34

nmol/l

0.40

351

Sulfasalazine

135

914

1.48

4.61

1.2

337.08

364.72

nmol/l

0.88

116

788

Fracture of lower leg, including ankle

251

1882

1.33

4.60

1.2

348.19

369.99

nmol/l

0.93

205

1588

Ischaemic Stroke, excluding all haemorrhages

270

1545

1.32

4.59

1.2

303.33

338.12

nmol/l

1.63

207

1219

Stroke, including SAH

296

1680

1.31

4.57

1.2

308.50

342.78

nmol/l

1.72

223

1346

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

122

801

1.51

4.57

1.2

1.1

367.45

400.56

nmol/l

1.10

105

746

Benign neoplasm: Colon, unspecified

119

787

1.52

4.56

1.2

309.35

338.56

nmol/l

0.78

623

Unspecified misadventure during surgical and medical care

141

2.29

4.55

1.1

1.2

323.26

387.47

nmol/l

1.05

125

Myocardial infarction, strict

224

1205

1.36

4.53

1.2

310.23

340.62

nmol/l

1.24

164

993

Myocardial infarction

238

1272

1.35

4.51

1.2

313.29

341.10

nmol/l

1.15

177

1051

Other and unspecified nerve root and plexus disorders, also in other diseases

522

1.63

4.48

1.2

1.1

328.51

384.41

nmol/l

2.02

448

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

472

2495

1.23

4.46

1.2

344.10

368.51

nmol/l

1.55

394

2095

Disorders of conjunctiva

373

2481

1.26

4.44

1.2

1.1

384.38

374.32

nmol/l

0.44

336

2108

Atherosclerosis, excluding cerebral and coronary sclerosis

214

1261

1.36

4.40

1.2

310.93

321.50

nmol/l

0.30

147

990

Other diseases of hard tissues of teeth

301

1735

1.30

4.40

1.2

1.1

388.25

372.68

nmol/l

0.69

264

1503

Right hemicolectomy

163

2.17

4.38

1.3

1.2

321.42

345.69

nmol/l

0.21

135

Sleep disorders

596

1.58

4.36

1.1

385.04

384.98

nmol/l

0.00

531

Lesion of ulnar nerve

382

1.74

4.36

1.2

1.1

388.37

381.03

nmol/l

0.09

333

Ischemic heart diseases

356

1758

1.27

4.34

1.2

344.48

362.27

nmol/l

0.81

273

1498

Major coronary heart disease event excluding revascularizations

306

1639

1.29

4.31

1.2

321.37

343.10

nmol/l

0.95

226

1328

Crohn disease

361

1.75

4.31

1.2

1.1

326.15

389.69

nmol/l

1.81

330

Benign neoplasm: Stomach

296

1.84

4.29

1.4

1.2

365.80

357.42

nmol/l

0.06

250

Visual disturbances

212

1576

1.35

4.27

1.2

356.24

358.96

nmol/l

0.07

182

1308

Migraine with aura

631

1.56

4.26

1.1

382.76

395.65

nmol/l

0.26

582

Hard cardiovascular diseases

355

1805

1.26

4.19

1.2

340.80

360.94

nmol/l

1.03

283

1515

Exposure to unspecified factor

451

2856

1.23

4.19

1.2

368.38

370.90

nmol/l

0.09

376

2430

Delirium, not induced by alcohol and other psychoactive substances

327

1.78

4.19

1.4

1.2

310.19

329.46

nmol/l

0.29

257

Abnormal spermatozoa

313

1.80

4.18

1.1

1.2

290.73

318.35

nmol/l

0.49

238

Other symptoms and signs involving the digestive system and abdomen

486

1.63

4.17

1.2

1.1

287.61

358.53

nmol/l

3.07

416

Gout

125

775

1.47

4.16

1.3

1.2

290.78

334.90

nmol/l

1.61

600

Thyrotoxicosis, other and/or unspecified

580

1.57

4.15

1.1

380.89

373.75

nmol/l

0.12

508

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

149

1052

1.42

4.13

1.1

1.2

374.29

368.37

nmol/l

0.13

121

904

Tongue abnormality

154

2.16

4.12

1.3

1.2

369.50

387.13

nmol/l

0.16

137

Female infertility

127

530

1.48

4.10

1.1

406.42

408.44

nmol/l

0.04

121

472

Ovarian cyst

168

691

1.41

4.10

1.1

383.83

392.20

nmol/l

0.19

147

578

Chronic periodontitis

435

1.66

4.09

1.2

1.1

361.88

355.71

nmol/l

0.09

364

Allergic contact dermatitis

383

1.70

4.05

1.1

351.26

397.77

nmol/l

1.04

353

Open wound of head

230

1719

1.32

4.04

1.2

346.45

356.77

nmol/l

0.31

178

1422

Anterior Iridocyclitis

624

1.54

4.03

1.2

1.1

369.76

366.26

nmol/l

0.06

537

Fentanyl

339

1.75

4.02

1.3

1.2

299.77

331.34

nmol/l

0.58

268

Other and unspecified disorders of skin and subcutaneous tissue

169

2.09

4.02

1.2

1.1

312.70

380.55

nmol/l

1.16

149

Benign neoplasm: Colon, unspecified

119

806

1.47

4.02

1.2

309.35

338.15

nmol/l

0.78

650

Asthma, including avohilmo

570

2767

1.20

4.01

1.2

379.26

367.16

nmol/l

0.71

479

2343

Sequelae of cerebrovascular disease

178

1141

1.37

3.99

1.3

1.2

274.45

328.84

nmol/l

3.23

130

883

203

1.98

3.98

1.3

1.2

343.92

323.47

nmol/l

0.22

163

Paracetamol of NSAID medication

267

1.63

3.98

1.2

1.1

359.30

352.03

nmol/l

0.12

215

Small fibre neuropathy

2.85

3.97

1.1

1.2

310.46

383.43

nmol/l

0.62

Familial hypercholesterolemia, with ischemic heart disease

304

1.79

3.96

1.2

284.74

312.18

nmol/l

0.44

238

Superficial injury of hip and thigh

485

1.61

3.96

1.3

1.2

343.51

338.52

nmol/l

0.07

402

Lumbar disc prolapse

289

1796

1.28

3.95

1.2

1.1

366.75

378.82

nmol/l

0.45

250

1506

severe traumatic brain injury, does not include concussion

110

740

1.49

3.94

1.2

336.85

343.11

nmol/l

0.11

580

Lower back pain or/and sciatica

489

2806

1.21

3.94

1.2

368.25

369.75

nmol/l

0.06

424

2366

AV-block

533

1.56

3.91

1.2

328.10

319.11

nmol/l

0.15

410

Coxarthrosis, primary, with hip surgery

218

1564

1.32

3.91

1.2

345.87

332.42

nmol/l

0.43

172

1236

Retention of urine

161

981

1.39

3.90

1.3

1.2

297.56

336.70

nmol/l

1.55

125

785

Other ulcerative colitis

138

2.19

3.89

1.2

1.1

344.22

399.03

nmol/l

0.84

129

Acute and subacute iridocyclitis

582

1.55

3.88

1.2

1.1

366.51

366.81

nmol/l

0.00

500

Polyp of the female genital tract

150

615

1.42

3.88

1.2

1.1

392.21

384.30

nmol/l

0.18

134

499

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

293

2138

1.27

3.88

1.2

342.47

351.07

nmol/l

0.28

219

1768

Amputation

306

1.77

3.88

1.1

1.2

372.25

322.65

nmol/l

0.79

241

Duodenal ulcer

292

1.79

3.85

1.3

1.2

261.31

342.75

nmol/l

2.26

228

Benign neoplasm: Stomach

307

1.77

3.85

1.4

1.2

365.80

355.53

nmol/l

0.08

260

Disorders of lacrimal system

193

1442

1.34

3.82

1.2

373.55

359.69

nmol/l

0.36

166

1201

Complications of internal orthopaedic prosthetic devices, implants and grafts

111

754

1.48

3.81

1.3

1.2

336.14

341.56

nmol/l

0.09

581

Diarrhoea and gastroenteritis of presumed infectious origin

320

2318

1.26

3.81

1.2

359.36

368.70

nmol/l

0.35

257

1972

Heart failure and coronary heart disease

170

923

1.38

3.81

1.3

1.2

298.51

314.85

nmol/l

0.44

128

702

Intestinal infectious diseases

435

2784

1.22

3.80

1.2

360.92

368.40

nmol/l

0.32

349

2369

Reimbursement for rheumatic diseases

262

2039

1.28

3.79

1.2

350.70

364.64

nmol/l

0.52

221

1714

Exclusions for E4_PCOS_BROAD

483

1.60

3.79

1.1

367.47

378.22

nmol/l

0.16

433

Nontoxic single thyroid nodule

194

1.97

3.77

1.2

1.1

307.27

385.34

nmol/l

1.50

174

Injuries to the hip and thigh

224

1566

1.31

3.76

1.2

340.06

342.54

nmol/l

0.05

176

1251

Enterocolitis due to Clostridium difficile

339

1.72

3.76

1.2

300.24

348.07

nmol/l

1.03

282

Propionic acid derivatives

150

532

1.42

3.75

1.2

1.1

358.44

349.48

nmol/l

0.19

133

418

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

383

1.64

3.75

1.1

419.54

413.53

nmol/l

0.09

367

Papulosquamous disorders

174

1284

1.36

3.74

1.2

363.86

362.09

nmol/l

0.03

125

1098

Primary open-angle glaucoma

160

1135

1.38

3.74

1.3

1.2

330.18

318.91

nmol/l

0.27

124

856

Mycoses

120

831

1.45

3.74

1.2

355.79

362.14

nmol/l

0.11

707

COPD/asthma related infections

525

2191

1.20

3.73

1.2

1.1

370.42

374.85

nmol/l

0.16

441

1881

COPD/asthma/ILD related infections

525

2191

1.20

3.73

1.2

1.1

370.42

374.85

nmol/l

0.16

441

1881

112

726

1.47

3.68

1.2

271.95

312.96

nmol/l

1.39

532

Coronary atherosclerosis

300

1530

1.27

3.66

1.2

355.99

349.63

nmol/l

0.17

237

1283

Internal derangement of knee

164

1202

1.36

3.63

1.3

1.1

340.80

372.57

nmol/l

1.21

145

1018

Disorders of mineral metabolism

204

1.92

3.62

1.1

376.00

366.77

nmol/l

0.08

180

Thyroiditis, ILD-related definition

328

1.72

3.61

1.1

382.83

380.34

nmol/l

0.03

294

Ulcerative colitis

109

747

1.46

3.60

1.2

353.73

379.14

nmol/l

0.69

652

Peripheral artery operations in Hilmo

405

1.64

3.57

1.2

1.3

337.55

322.48

nmol/l

0.21

324

Eating disorder

212

1.89

3.56

1.3

1.1

443.33

415.11

nmol/l

0.44

204

Seronegative rheumatoid arthritis

368

1.67

3.54

1.2

1.1

367.36

358.19

nmol/l

0.13

306

Vascular disorders of the intestines

171

2.00

3.53

1.1

1.2

263.32

337.78

nmol/l

1.71

133

Gonarthrosis [arthrosis of knee](FG)

366

1748

1.23

3.53

1.2

1.1

355.22

370.02

nmol/l

0.64

303

1459

Pain in joint

254

1311

1.28

3.52

1.2

1.1

370.05

379.90

nmol/l

0.31

228

1108

Follow-up care involving plastic surgery

112

2.25

3.49

1.1

447.16

386.86

nmol/l

0.87

103

Haemorrhoids and perianal venous thrombosis

131

934

1.41

3.49

1.2

1.1

314.00

348.53

nmol/l

1.29

113

752

5-aminosalicylic acid

622

1.50

3.48

1.2

1.1

383.47

381.65

nmol/l

0.03

549

Calcific aortic valvular stenosis, including rheumatic fever

153

1096

1.37

3.47

1.3

1.2

331.45

317.80

nmol/l

0.33

114

835

Gonarthrosis

310

1419

1.25

3.47

1.2

1.1

343.16

366.97

nmol/l

1.22

262

1185

Other and unspecified dermatitis

227

1761

1.29

3.47

1.2

1.1

362.37

367.68

nmol/l

0.14

184

1482

Implicit viral Sepsis

599

1.51

3.45

1.2

309.41

346.48

nmol/l

0.93

485

Viral Sepsis

599

1.51

3.45

1.2

309.41

346.48

nmol/l

0.93

485

Postmenopausal bleeding

129

497

1.43

3.44

1.2

1.1

367.95

371.01

nmol/l

0.05

105

389

Fissure and fistula of anal and rectal regions

103

705

1.47

3.44

1.2

1.1

341.68

372.52

nmol/l

0.79

601

Type 1 diabetes

105

721

1.46

3.42

1.2

358.27

382.50

nmol/l

0.58

651

Abrasion of teeth

118

605

1.44

3.42

1.3

1.1

383.35

366.64

nmol/l

0.42

107

536

Somnolence, stupor and coma

113

2.23

3.42

1.3

1.2

264.28

369.09

nmol/l

1.32

Other disorders of glucose regulation and pancreatic internal secretion

230

1.84

3.41

1.2

373.88

377.18

nmol/l

0.03

203

Diseases of oral cavity, salivary glands and jaws

476

2037

1.20

3.41

1.2

362.85

362.49

nmol/l

0.01

392

1728

Secondary hypertension

165

1.99

3.40

1.2

1.1

349.42

371.24

nmol/l

0.29

143

Conjunctivitis

320

2258

1.24

3.36

1.2

1.1

382.58

377.97

nmol/l

0.16

298

1947

Endometriosis of ovary

458

1.57

3.35

1.2

1.1

397.45

391.97

nmol/l

0.08

386

Prolonged pregnancy

393

0.44

3.35

1.0

1.1

454.37

426.54

nmol/l

0.25

380

Other noninfective gastroenteritis and colitis

116

816

1.42

3.35

1.2

370.94

358.03

nmol/l

0.31

100

690

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

127

909

1.40

3.34

1.2

332.57

350.43

nmol/l

0.44

104

750

Chronic sinusitis

184

1395

1.32

3.33

1.1

1.2

379.30

366.64

nmol/l

0.42

160

1192

Iridocyclitis

103

710

1.46

3.33

1.2

1.1

362.49

362.78

nmol/l

0.00

603

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

254

1.78

3.33

1.2

301.97

336.88

nmol/l

0.56

207

Use of rasagiline

2.65

3.32

1.4

1.2

360.92

383.67

nmol/l

0.20

Other bullous disorders

2.64

3.31

1.2

318.58

377.63

nmol/l

0.48

Other/unspecified seropositive rheumatoid arthritis

129

928

1.39

3.30

1.2

330.54

351.08

nmol/l

0.54

106

764

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

517

1.53

3.29

1.2

1.1

387.91

384.00

nmol/l

0.06

468

Other and unspecified injuries of head

162

1.99

3.29

1.2

1.1

325.56

365.37

nmol/l

0.69

144

Other Crohn's disease

162

1.99

3.29

1.2

1.1

315.74

393.82

nmol/l

1.42

151

Diseases of salivary glands

606

1.49

3.28

1.2

336.50

363.63

nmol/l

0.72

528

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

219

1669

1.29

3.27

1.1

1.2

378.42

363.50

nmol/l

0.49

188

1421

Operations 2 for CAVS

151

1092

1.36

3.27

1.3

1.2

328.52

318.36

nmol/l

0.23

112

834

Calcific aortic valvular stenosis, diagnosis (helper)

151

1092

1.36

3.27

1.3

1.2

328.52

318.36

nmol/l

0.23

112

834

Calcific aortic valvular stenosis, operated

151

1093

1.36

3.26

1.3

1.2

328.52

318.80

nmol/l

0.22

112

835

Calcific aortic valvular stenosis

151

1093

1.36

3.26

1.3

1.2

328.52

318.80

nmol/l

0.22

112

835

Fenamates

329

1.56

3.25

1.1

377.03

358.71

nmol/l

0.30

254

Diseases of liver

144

1060

1.36

3.21

1.1

1.2

359.68

361.16

nmol/l

0.03

111

900

Inflammatory diseases of female pelvic organs

273

1643

1.25

3.21

1.2

1.1

376.83

385.72

nmol/l

0.27

254

1433

Dermatitis

270

2163

1.25

3.20

1.2

366.80

367.83

nmol/l

0.03

220

1823

Superficial injury of head

105

733

1.44

3.19

1.2

359.49

360.61

nmol/l

0.02

611

Symptoms and signs involving speech and voice

148

1097

1.35

3.17

1.2

380.96

361.10

nmol/l

0.57

119

918

Disorders of calcium metabolism

137

2.06

3.16

1.1

383.70

379.40

nmol/l

0.03

120

Extrapyramidal and movement disorders

169

1278

1.33

3.16

1.2

332.55

342.80

nmol/l

0.29

136

1035

Neuromuscular dysfunction of bladder

266

1.74

3.15

1.2

1.1

345.00

368.71

nmol/l

0.26

225

Other disorders of skin and subcutaneous tissue, not elsewhere classified

467

1.55

3.15

1.2

323.21

349.49

nmol/l

0.47

387

Heart failure and bmi 25plus

170

881

1.33

3.14

1.3

1.2

313.29

331.96

nmol/l

0.41

139

703

Thrombocytopenia, unspecified

179

1.91

3.14

1.3

1.2

325.66

368.57

nmol/l

0.54

154

Spondylopathies (FG)

404

1.59

3.14

1.2

1.1

377.98

389.15

nmol/l

0.15

361

Mandibular retrognathia

144

2.02

3.13

1.0

1.1

409.43

396.65

nmol/l

0.14

137

Episcleritis

131

2.08

3.12

1.3

1.1

356.91

404.18

nmol/l

0.49

121

Use of levodopa decarboxylase inhibitor

429

1.57

3.11

1.2

330.60

321.08

nmol/l

0.14

332

Primary coxarthrosis, bilateral

135

990

1.37

3.10

1.3

1.2

345.09

328.95

nmol/l

0.40

106

760

Correction of physiology of bite - demanding therapy visit

180

1.90

3.09

1.1

378.25

394.67

nmol/l

0.20

168

Other eating disorders

105

2.20

3.09

1.3

1.0

432.09

409.10

nmol/l

0.24

100

Seropositive rheumatoid arthritis, wide

129

940

1.38

3.09

1.2

330.54

349.75

nmol/l

0.49

106

775

Diseases of male genital organs

208

810

1.30

3.07

1.2

357.29

363.28

nmol/l

0.14

164

670

Dermatitis and eczema

504

2810

1.18

3.07

1.2

364.73

370.96

nmol/l

0.27

420

2389

Other bursopathies

360

1.62

3.06

1.2

1.1

374.76

358.12

nmol/l

0.23

290

Epilepsy

132

964

1.37

3.06

1.2

306.92

370.39

nmol/l

3.25

804

Elevated blood glucose level

217

1.81

3.05

1.1

1.2

411.43

371.24

nmol/l

0.63

194

Atrial fibrillation and flutter

130

614

1.38

3.04

1.2

1.1

392.07

398.34

nmol/l

0.13

115

557

Hypotension

568

1.48

3.03

1.3

1.2

326.34

320.56

nmol/l

0.08

437

Other (seronegative) rheumatoid arthritis, wide

634

1.46

3.02

1.2

339.50

352.17

nmol/l

0.24

526

Fracture of femur

134

900

1.36

3.00

1.2

339.39

321.00

nmol/l

0.32

109

684

Other diseases of lip and oral mucosa

498

1.51

2.97

1.3

1.1

364.69

350.09

nmol/l

0.26

426

Tonsillectomy and adenotomy

221

1210

1.27

2.96

1.1

409.27

400.46

nmol/l

0.26

209

1109

Chronic lower respiratory diseases

574

2670

1.16

2.96

1.2

1.1

373.71

370.25

nmol/l

0.15

480

2277

Benign leiomyoma with endometriosis

515

1.50

2.95

1.2

1.1

383.78

360.14

nmol/l

0.45

437

Synovial cyst of popliteal space [Baker]

205

1.82

2.94

1.3

1.1

373.22

366.47

nmol/l

0.06

175

Orthopaedic devices associated with adverse incidents

2.87

2.93

1.7

1.2

330.23

368.93

nmol/l

0.26

Other enthesopathies

124

906

1.37

2.93

1.1

363.34

380.34

nmol/l

0.41

108

778

Malignant neoplasm of colon

500

1.51

2.92

1.3

1.2

309.40

331.44

nmol/l

0.38

394

Noninfectious colitis NAS

412

1.56

2.92

1.3

1.1

354.77

369.99

nmol/l

0.26

362

Other disorders of lacrimal gland

150

1130

1.33

2.91

1.2

360.06

357.53

nmol/l

0.06

132

953

Fibromyalgia

228

1.76

2.90

1.2

1.1

420.17

400.79

nmol/l

0.24

208

Psoriatic and enteropathic arthropathies

327

1.63

2.88

1.1

350.16

381.23

nmol/l

0.54

291

Injuries to the elbow and forearm

302

2240

1.22

2.86

1.2

337.76

373.73

nmol/l

2.25

240

1906

Other postsurgical states

136

2.00

2.85

1.2

350.45

387.19

nmol/l

0.38

120

Female infertility, cervigal, vaginal, other or unspecified origin

108

514

1.41

2.84

1.1

419.88

408.87

nmol/l

0.23

103

456

Dementia in other diseases classified elsewhere

123

2.05

2.82

1.3

1.2

341.33

352.86

nmol/l

0.08

Artrosis, including avohilmo

405

1866

1.19

2.82

1.2

1.1

361.99

368.44

nmol/l

0.25

340

1572

Other diseases of pericardium

103

2.15

2.81

1.2

330.63

344.65

nmol/l

0.12

Diseases of tongue

194

1.82

2.80

1.3

1.1

355.46

363.93

nmol/l

0.07

165

Asthma, hospital admission 2, infections

260

2075

1.23

2.80

1.2

373.59

362.56

nmol/l

0.39

218

1734

Asthma-related infections

260

2075

1.23

2.80

1.2

373.59

362.56

nmol/l

0.39

218

1734

Schizophrenia

452

0.51

2.79

1.1

330.38

389.79

nmol/l

0.90

414

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

202

1239

1.27

2.77

1.3

1.2

340.35

340.16

nmol/l

0.00

159

1001

Other menopausal disorders

113

467

1.40

2.77

1.1

440.07

387.01

nmol/l

1.82

105

384

557

2539

1.16

2.76

1.2

1.1

363.80

367.69

nmol/l

0.16

466

2149

Other CVD

680

1.42

2.75

1.3

1.2

315.37

329.96

nmol/l

0.26

523

Lateral epicondylitis

347

1.59

2.75

1.2

1.1

362.82

392.39

nmol/l

0.50

309

Vascular dementia

261

1.67

2.73

1.4

1.3

277.17

304.36

nmol/l

0.35

193

Abnormal findings on diagnostic imaging of other body structures

380

1.56

2.71

1.2

1.1

360.94

362.94

nmol/l

0.02

329

Gilbert syndrome

6.11

2.71

1.2

312.83

437.70

nmol/l

—

Impingement syndrome of shoulder

674

1.41

2.70

1.2

1.1

337.37

367.71

nmol/l

0.76

570

Symptoms and signs involving the nervous and musculoskeletal systems

251

2037

1.23

2.70

1.2

370.88

355.24

nmol/l

0.61

205

1693

Hyperparathyroidism

658

1.42

2.70

1.2

303.11

343.76

nmol/l

1.16

534

Artificial joint operation, meniscal resection

420

2371

1.18

2.69

1.2

355.99

362.18

nmol/l

0.24

361

1955

Acquired absence of limb

3.83

2.69

1.2

373.00

363.74

nmol/l

—

Seropositive rheumatoid arthritis, strict definition

469

1.50

2.69

1.2

1.1

301.95

360.38

nmol/l

1.78

400

Phlebitis and thrombophlebitis (not including DVT)

104

751

1.39

2.68

1.3

1.2

333.88

353.83

nmol/l

0.29

621

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

667

1.41

2.68

1.3

1.2

315.59

338.79

nmol/l

0.47

519

Anti-inflammatory and antirheumatic products, non-steroids

142

532

1.34

2.68

1.2

1.1

371.42

349.48

nmol/l

0.58

125

418

Parkinson's disease, strict definition

454

1.50

2.66

1.2

312.61

320.31

nmol/l

0.12

357

Hallux valgus (acquired)

157

869

1.31

2.66

1.2

1.1

354.76

368.53

nmol/l

0.33

125

724

Psoriatic arthropathies

265

1.67

2.65

1.2

1.1

364.49

376.10

nmol/l

0.14

236

Abnormal findings on examination of blood, without diagnosis

204

1517

1.26

2.65

1.2

366.54

346.18

nmol/l

0.65

152

1255

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

106

2.09

2.63

1.0

1.3

410.00

329.05

nmol/l

0.80

Other diseases of liver

512

1.47

2.63

1.1

1.2

365.89

368.60

nmol/l

0.04

445

Benign leiomyoma with endometriosis

529

1.46

2.62

1.2

383.78

361.10

nmol/l

0.43

441

Bronchitis, not specified as acute or chronic

251

1.68

2.61

1.2

387.65

357.94

nmol/l

0.35

219

Carbimazole or st.post thyroidectomy, condition for graves disease

621

1.42

2.60

1.1

398.21

379.34

nmol/l

0.39

548

Allergic conjunctivitis

236

1884

1.23

2.58

1.2

1.1

401.66

380.07

nmol/l

0.96

228

1641

Other problems related to primary support group, including family circumstances

283

1.62

2.57

1.1

378.58

410.73

nmol/l

0.52

266

All influenza

109

800

1.37

2.56

1.2

317.76

361.43

nmol/l

1.55

663

Multiple myeloma, excluding all cancers (controls excluding all cancers)

128

1.97

2.56

1.2

356.68

330.66

nmol/l

0.22

109

Enthesopathies of lower limb, excluding foot

640

1.41

2.55

1.1

367.60

381.68

nmol/l

0.29

548

Dermatitis due to substances taken internally

128

1.96

2.55

1.2

1.1

278.50

390.37

nmol/l

2.66

113

Speech disturbances, not elsewhere classified

253

1.67

2.55

1.3

1.2

334.80

361.38

nmol/l

0.29

215

Injuries to the neck

657

1.40

2.55

1.1

340.94

383.10

nmol/l

1.21

580

Degeneration of the brain due to alcohol

2.53

2.54

1.2

1.1

213.89

367.74

nmol/l

—

Chronic ulcer of skin, not elsewhere classified

186

1.78

2.53

1.2

345.59

349.76

nmol/l

0.03

155

Gonarthrosis, primary, with knee surgery

255

1704

1.22

2.52

1.2

334.45

347.29

nmol/l

0.45

209

1362

Scleritis and episcleritis

150

1.88

2.51

1.3

1.1

349.83

399.68

nmol/l

0.55

138

Mouth breathing

159

1235

1.29

2.51

1.1

378.66

373.08

nmol/l

0.13

140

1060

Postprocedural endocrine and metabolic disorders, not elsewhere classified

332

1.57

2.50

1.1

415.70

385.50

nmol/l

0.47

298

Unspecified jaundice

129

1.95

2.50

1.1

1.2

330.56

379.81

nmol/l

0.44

108

Amputation of toe

209

1.73

2.50

1.1

1.2

355.30

344.49

nmol/l

0.09

168

Ulcerative colitis (strict definition, require KELA)

469

1.48

2.49

1.2

1.1

376.98

385.04

nmol/l

0.12

425

Other disorders of skin and subcutaneous tissue

304

2324

1.20

2.49

1.2

338.22

357.77

nmol/l

0.93

240

1929

Ulcerative proctitis

165

1.83

2.49

1.2

1.1

367.58

399.87

nmol/l

0.34

153

Diseases of the skin and subcutaneous tissue

503

2179

1.16

2.49

1.2

1.1

350.54

375.11

nmol/l

1.71

418

1879

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

225

1794

1.23

2.48

1.2

1.1

400.53

381.56

nmol/l

0.79

218

1567

Other metabolic disorders

357

1.55

2.47

1.1

409.23

382.39

nmol/l

0.41

321

Other/unspecified synovitis and tenosynovitis

318

1.58

2.45

1.2

1.1

351.07

384.78

nmol/l

0.56

273

Chronic iridocyclitis

123

1.96

2.45

1.3

1.1

359.78

388.79

nmol/l

0.31

108

Psoriasis

119

893

1.34

2.44

1.2

1.1

360.28

363.61

nmol/l

0.06

769

Benign neoplasm: Rectosigmoid junction

103

2.05

2.42

1.2

379.92

362.94

nmol/l

0.09

Cervicalgia

647

1.39

2.42

1.2

1.1

357.58

362.86

nmol/l

0.08

531

Collapsed vertebra, not elsewhere classified

3.41

2.41

1.1

1.2

347.22

338.91

nmol/l

—

Degenerative macular diseases

416

1.50

2.41

1.4

1.2

308.12

328.98

nmol/l

0.38

324

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

242

1.66

2.41

1.1

1.2

302.03

341.03

nmol/l

0.57

205

Supplementary factors related to causes of morbidity and mortality classified elsewhere

126

956

1.32

2.40

1.2

330.32

369.11

nmol/l

1.25

814

Adenomyosis (Endometriosis of uterus)

360

1.53

2.39

1.3

1.1

347.08

385.43

nmol/l

0.76

288

Anankastic personality disorder

2.13

2.39

1.3

1.1

407.63

408.35

nmol/l

0.01

185

1464

1.26

2.38

1.1

1.2

380.52

369.90

nmol/l

0.31

154

1248

Oter anti-inflammatory and antirheumatic agents, non-steroids

110

448

1.37

2.38

1.3

1.2

372.48

331.88

nmol/l

1.12

338

Anomalies of dental arch relationship, including avohilmo

447

1.45

2.37

1.1

434.23

396.76

nmol/l

0.78

414

Circumscribed brain atrophy

2.64

2.37

1.3

1.2

253.92

327.34

nmol/l

0.76

Major coronary heart disease event

309

1726

1.20

2.36

1.2

335.39

344.39

nmol/l

0.29

229

1409

Asthma (diagnoses ohter than nonallergic)

387

2833

1.17

2.36

1.2

364.96

368.42

nmol/l

0.12

327

2396

Superficial injury of thorax

459

1.46

2.35

1.2

333.14

360.85

nmol/l

0.55

390

Arthropathies in other diseases classified elsewhere

2.16

2.35

1.3

1.2

345.40

389.16

nmol/l

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

402

1.50

2.35

1.2

296.00

355.45

nmol/l

1.60

334

Dislocation, sprain and strain of joints and ligaments at neck level

402

1.50

2.35

1.1

346.42

392.50

nmol/l

1.15

370

Keratitis

143

1108

1.29

2.34

1.2

374.35

365.25

nmol/l

0.19

118

947

Fracture of forearm

236

1814

1.22

2.33

1.2

328.29

370.92

nmol/l

2.43

185

1541

Parkinson's disease

493

1.45

2.33

1.2

305.60

323.67

nmol/l

0.33

384

Dementia due to Parkinson's disease

2.33

2.32

1.3

1.1

330.75

347.96

nmol/l

—

Gonarthrosis,primary

415

2245

1.16

2.29

1.2

344.04

360.40

nmol/l

0.84

345

1850

Panic disorder

380

1.50

2.29

1.1

381.40

401.85

nmol/l

0.37

359

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

269

1.61

2.28

1.2

313.41

371.34

nmol/l

0.96

236

Unspecified fall

209

1687

1.23

2.27

1.2

341.12

355.95

nmol/l

0.47

167

1387

Use of galantamine

254

1.62

2.27

1.3

1.2

330.78

288.03

nmol/l

0.61

195

Other and unspecified drugs and medicaments

223

1.67

2.27

1.1

366.68

396.99

nmol/l

0.34

201

Thyrotoxicosis with diffuse goitre

381

1.50

2.27

1.1

420.22

385.89

nmol/l

0.69

343

Diseases of the myoneural junction and muscle

357

1.52

2.26

1.3

1.2

364.91

354.77

nmol/l

0.14

301

Missing teeth due to accident, extraction or parodontitis

349

1.52

2.26

1.1

382.83

358.38

nmol/l

0.33

295

Parkinson's disease, including avohilmo

513

1.43

2.26

1.2

307.70

323.23

nmol/l

0.29

401

Diseases of inner ear

235

1896

1.22

2.25

1.2

329.34

354.98

nmol/l

1.18

194

1557

Vascular dementia (undefined)

126

1.90

2.25

1.3

306.91

326.20

nmol/l

0.15

Type of accident

118

897

1.32

2.24

1.2

332.37

370.33

nmol/l

1.12

762

Injuries to the thorax

191

1544

1.24

2.22

1.2

340.17

356.12

nmol/l

0.51

159

1265

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

718

1.35

2.21

1.1

382.14

402.92

nmol/l

0.48

657

Other general symptoms and signs

106

1.97

2.19

1.1

369.29

397.36

nmol/l

0.31

Disorders of parathyroid gland

103

761

1.34

2.19

1.2

303.29

342.20

nmol/l

1.24

616

Glaucoma, exfoliation

401

1.48

2.18

1.4

1.2

323.49

309.80

nmol/l

0.17

306

Polymyalgia rheumatica

467

1.44

2.18

1.2

329.98

328.37

nmol/l

0.02

363

Multiple myeloma and malignant plasma cell neoplasms

122

1.90

2.16

1.3

1.2

346.12

354.44

nmol/l

0.06

103

Hernia of abdominal wall, postoperative

526

1.41

2.16

1.2

1.1

310.57

354.90

nmol/l

1.16

419

Benign neoplasm: Rectosigmoid junction

108

1.96

2.16

1.2

379.92

361.40

nmol/l

0.10

Inflammatory diseases of prostate (prostatitis)

337

1.52

2.16

1.3

1.2

337.39

338.28

nmol/l

0.01

265

Degeneration of nervous system due to alcohol

2.32

2.15

1.2

1.1

213.89

360.16

nmol/l

—

Thyroiditis

196

1.69

2.15

1.1

397.85

391.07

nmol/l

0.07

174

Psoriatic arthropathies, ICD10

282

1.57

2.13

1.2

1.1

364.49

381.60

nmol/l

0.22

254

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

235

1.62

2.13

1.1

360.93

383.07

nmol/l

0.24

211

Spinal instabilities

2.12

2.13

1.5

1.1

322.75

403.63

nmol/l

0.82

Leisure time condition

536

1.40

2.13

1.3

1.1

321.57

363.39

nmol/l

0.92

464

Decubitus ulcer and pressure area

167

1.75

2.11

1.1

1.2

321.09

341.25

nmol/l

0.19

136

Diplopia

388

1.47

2.10

1.2

1.1

343.82

359.57

nmol/l

0.26

335

Asthma/COPD (KELA code 203)

434

2663

1.15

2.10

1.2

1.1

381.43

369.98

nmol/l

0.54

366

2271

Gout, unspecified

631

1.37

2.09

1.3

1.2

262.72

333.06

nmol/l

2.78

494

Pacemaker

153

1181

1.26

2.09

1.2

322.85

319.42

nmol/l

0.07

111

907

Personality disorders

101

760

1.33

2.08

1.2

1.1

355.10

397.46

nmol/l

1.37

698

Carcinoma in situ of other and unspecified digestive organs

2.28

2.08

1.0

1.1

265.29

397.67

nmol/l

—

Other/unspecified rheumatoid arthritis

422

1.45

2.08

1.3

1.2

349.12

352.04

nmol/l

0.04

352

Malignant neoplasm of respiratory system and intrathoracic organs

691

0.68

2.07

1.2

266.61

323.24

nmol/l

1.24

522

Benign neoplasm of other and unspecified endocrine glands

373

1.48

2.07

1.2

334.94

367.75

nmol/l

0.53

327

Speech and linguistic disorders, excluding more controls

130

1.82

2.07

1.2

1.1

379.11

397.36

nmol/l

0.15

123

Myocardial infarction, with ST-elevation

590

1.38

2.07

1.2

308.37

324.49

nmol/l

0.26

451

Asthma, hospital admissions , main diagnosis only

363

2804

1.16

2.06

1.2

369.67

369.25

nmol/l

0.01

310

2376

Sequelae of tuberculosis

2.34

2.05

1.2

302.00

331.45

nmol/l

—

Arthropathic psoriasis

317

1.52

2.05

1.2

1.1

366.38

375.65

nmol/l

0.11

289

Palmar fascial fibromatosis [Dupuytren]

473

1.42

2.05

1.2

310.49

337.24

nmol/l

0.61

362

Malignant melanoma, excluding all cancers (controls excluding all cancers)

592

0.64

2.05

1.1

1.2

352.73

343.53

nmol/l

0.12

472

Fibroblastic disorders

737

1.33

2.04

1.2

319.22

352.44

nmol/l

0.94

588

Restless leg syndrome

350

1.49

2.04

1.2

328.55

363.47

nmol/l

0.64

304

Schizophrenia or delusion

992

0.72

2.02

1.2

1.1

341.17

384.35

nmol/l

1.00

878

Hyperplasia of prostate

150

675

1.27

2.02

1.2

328.82

346.36

nmol/l

0.45

112

543

Coagulation defects, purpura and other haemorrhagic conditions

610

1.36

2.01

1.3

1.2

332.57

363.33

nmol/l

0.65

519

Other diseases of blood and blood-forming organs, wide

670

1.35

2.01

1.1

1.2

323.05

354.99

nmol/l

0.75

562

Malignant neoplasm of bronchus and lung

608

0.66

2.01

1.2

258.75

322.01

nmol/l

1.42

456

Mixed hyperlipidaemia

2.01

2.00

1.3

1.2

384.23

365.08

nmol/l

0.14

Peripheral arterial reconstruction

560

1.38

1.99

1.3

1.2

292.26

315.57

nmol/l

0.45

423

Primary_lymphoid and hematopoietic malignant neoplasms

101

766

1.32

1.99

1.2

354.79

334.91

nmol/l

0.37

619

Other hammer toe(s) (acquired)

517

1.38

1.98

1.2

1.1

366.15

343.27

nmol/l

0.39

408

Statin medication

314

1500

1.17

1.98

1.2

1.1

385.84

379.01

nmol/l

0.23

272

1320

Dental operations

345

1518

1.17

1.98

1.2

351.66

360.06

nmol/l

0.31

280

1262

Endometriosis ASRM stages 3,4

750

1.32

1.97

1.2

1.1

380.26

375.16

nmol/l

0.08

665

Other disorders of conjunctiva

452

1.42

1.97

1.2

415.45

346.82

nmol/l

1.49

374

Heartburn

280

1.54

1.97

1.3

1.1

357.97

377.38

nmol/l

0.28

246

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

452

1.42

1.97

1.2

1.1

364.94

385.13

nmol/l

0.36

409

Recurring oral aphthae, including avohilmo

394

1.45

1.97

1.4

1.1

341.98

367.53

nmol/l

0.44

345

Adhesive capsulitis of shoulder

478

1.41

1.95

1.1

337.51

362.97

nmol/l

0.47

395

Subjective visual disturbances

743

1.32

1.95

1.3

1.1

364.30

360.20

nmol/l

0.06

634

Sicca syndrome [Sjögren]

265

1.55

1.95

1.1

350.26

385.27

nmol/l

0.44

232

Haemorrhage from respiratory passages

145

1072

1.26

1.94

1.2

334.80

341.69

nmol/l

0.15

119

866

Deviated nasal septum

129

1014

1.27

1.94

1.2

1.1

343.89

359.07

nmol/l

0.37

102

851

Other disorders of bladder

354

1.47

1.94

1.3

1.2

375.22

344.53

nmol/l

0.38

286

Multiple myeloma and malignant plasma cell neoplasms

127

1.82

1.94

1.3

1.2

346.12

328.27

nmol/l

0.13

107

Leiomyoma of uterus

218

1015

1.21

1.94

1.2

1.1

373.39

390.16

nmol/l

0.60

194

884

Meniscus derangement

239

1368

1.20

1.93

1.2

1.1

376.65

370.60

nmol/l

0.16

203

1145

Other noninflammatory disorders of cervix uteri

120

1.84

1.93

1.4

1.1

326.57

393.27

nmol/l

0.71

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

463

1.41

1.92

1.1

1.2

349.46

341.64

nmol/l

0.12

379

Bullous disorders

150

1.74

1.91

1.3

1.2

343.48

381.23

nmol/l

0.45

125

Hypo-osmolality and hyponatraemia

555

1.37

1.90

1.4

1.2

312.75

337.16

nmol/l

0.45

447

Asthma-related pneumonia

161

1302

1.24

1.90

1.2

346.01

347.58

nmol/l

0.03

134

1043

Medical abortion

209

1369

0.83

1.90

1.1

1.2

383.22

378.69

nmol/l

0.12

182

1187

Injury of muscle and tendon at forearm level

0.00

1.89

0.0

1.2

—

410.56

—

Benign neoplasm of other and unspecified endocrine glands

381

1.45

1.89

1.2

334.94

358.71

nmol/l

0.35

333

Prolapse and hernia of ovary and fallopian tube

127

1.80

1.89

1.1

1.2

218.94

329.71

nmol/l

2.06

Gout, idiopatic and unspecified

104

800

1.30

1.88

1.3

1.2

289.14

332.42

nmol/l

1.42

628

Cardiac arrest

129

1.74

1.88

1.2

1.1

299.65

339.45

nmol/l

0.37

112

Asthma-related pneumonia or sepsis

161

1305

1.23

1.86

1.2

346.01

347.14

nmol/l

0.02

134

1046

Asthma, hospital admissions 3, pneumonia

161

1305

1.23

1.86

1.2

346.01

347.14

nmol/l

0.02

134

1046

Seborrhoeic dermatitis

260

1.54

1.86

1.2

389.74

375.82

nmol/l

0.15

226

Otalgia

197

1.63

1.86

1.2

1.1

393.46

395.51

nmol/l

0.02

176

Schizophrenia, schizotypal and delusional disorders

1000

0.74

1.86

1.1

342.80

383.24

nmol/l

0.96

882

Hernia of abdominal wall

187

1542

1.21

1.86

1.2

336.27

357.64

nmol/l

0.73

155

1278

Primary gonarthrosis, bilateral

224

1642

1.20

1.85

1.3

1.2

330.94

349.67

nmol/l

0.69

175

1319

Cystitis

389

2074

1.15

1.85

1.2

368.34

371.35

nmol/l

0.09

337

1746

Gout, FINNGEN

125

987

1.27

1.85

1.3

1.2

290.78

329.72

nmol/l

1.38

770

Enlarged lymph nodes

458

1.40

1.85

1.1

396.55

366.29

nmol/l

0.52

399

Myeloid leukaemia

2.22

1.84

1.1

1.2

394.62

372.77

nmol/l

—

Malignant neoplasm of head and neck

221

1.59

1.84

1.3

1.2

332.41

340.86

nmol/l

0.08

181

ILD medications: azathioprine

408

1.43

1.84

1.3

1.1

335.29

385.02

nmol/l

1.04

366

Bell's palsy

342

1.47

1.84

1.2

1.1

377.16

371.40

nmol/l

0.07

297

Dental caries 1 and operation codes, only avohilmo

587

0.75

1.83

1.2

1.1

380.95

376.49

nmol/l

0.08

495

Azathioprine

409

1.42

1.82

1.3

1.1

335.29

382.15

nmol/l

0.96

364

Non-ischemic cardiomyopathy

126

817

1.27

1.81

1.3

1.2

277.85

334.76

nmol/l

2.92

106

666

COPD, hospital admissions 3, with asthma pneumonia sepsis

857

0.74

1.81

1.2

295.40

325.95

nmol/l

0.67

655

Excessive attrition of teeth

155

676

1.25

1.81

1.2

1.1

393.90

368.69

nmol/l

0.82

135

598

Cervicocranial syndrome

303

1.49

1.79

1.2

1.1

383.59

379.49

nmol/l

0.04

258

Myeloproliferative diseases

231

1.56

1.78

1.4

1.2

360.74

358.23

nmol/l

0.02

197

Other skin changes

547

1.36

1.77

1.2

341.67

339.91

nmol/l

0.02

451

Intestinal adhesions without obstruction

224

1.57

1.76

1.1

298.77

370.15

nmol/l

1.35

188

Infections of the skin and subcutaneous tissue

226

1902

1.18

1.74

1.2

1.1

338.79

372.81

nmol/l

1.62

184

1631

Leiomyoma of uterus

286

1394

1.17

1.73

1.2

1.1

375.95

375.36

nmol/l

0.02

250

1200

Stomatitis and related lesions

241

1.54

1.73

1.2

1.1

330.74

377.97

nmol/l

0.81

217

Flat foot [pes planus] (acquired)

249

1.53

1.73

1.2

1.1

376.97

368.22

nmol/l

0.10

216

Infarction of spleen

3.92

1.72

1.0

1.2

224.60

362.25

nmol/l

—

Hydronephrosis

339

1.45

1.72

1.2

327.14

348.90

nmol/l

0.24

282

Myeloproliferative diseases (CML excluded)

202

1.59

1.71

1.4

1.2

339.67

359.43

nmol/l

0.21

172

Malignant neoplasm of digestive organs

169

1373

1.21

1.69

1.2

343.12

329.51

nmol/l

0.34

133

1067

Inguinal hernia

246

1410

1.18

1.69

1.2

347.85

364.19

nmol/l

0.60

217

1147

Disorders of psychological development

209

1.55

1.69

1.2

1.1

373.50

401.76

nmol/l

0.31

198

Other psoriatic arthropathies

275

1.50

1.68

1.1

367.73

379.55

nmol/l

0.14

250

Vasomotor and allergic rhinitis

137

1091

1.24

1.68

1.2

1.1

371.36

380.39

nmol/l

0.21

118

962

Specific development disorders of speech and language

107

1.81

1.67

1.2

1.1

323.86

383.38

nmol/l

0.63

Ganglion

605

1.32

1.66

1.2

1.1

385.23

387.41

nmol/l

0.03

530

Bipolar affective disorders

502

1.36

1.66

1.2

1.1

352.14

407.01

nmol/l

1.64

467

Other specified/unspecified systemic involvement of connective tissue

157

1.66

1.65

1.3

1.1

337.22

395.18

nmol/l

0.75

144

Ventral hernia

100

781

1.28

1.65

1.2

306.18

352.78

nmol/l

1.50

635

malignant neoplasm of male genital organs

164

855

1.22

1.64

1.1

1.2

342.43

319.34

nmol/l

0.69

125

666

Thyrotoxicosis

104

817

1.28

1.64

1.1

1.2

382.29

366.07

nmol/l

0.33

709

Hyperkalaemia

127

1.74

1.64

1.1

1.2

277.93

348.33

nmol/l

0.81

106

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

495

0.66

1.64

1.2

290.08

324.25

nmol/l

0.49

383

Hypoglycaemia, other or unspecified

181

1.61

1.63

1.2

1.1

358.18

379.53

nmol/l

0.18

160

Other extrapyramidal and movement disorders in other diseases

730

1.29

1.63

1.1

1.2

319.15

344.72

nmol/l

0.66

602

Colorectal cancer, excluding all cancers (controls excluding all cancers)

123

955

1.25

1.61

1.3

1.2

322.83

331.08

nmol/l

0.15

752

Other disorders of eyelid

193

1567

1.19

1.61

1.2

335.95

336.96

nmol/l

0.02

148

1259

Cyst of kidney

174

1.62

1.61

1.1

1.2

412.20

364.69

nmol/l

0.36

146

Ulcerative colitis (strict definition, all Crohn cases excluded)

403

1.39

1.60

1.2

1.1

374.18

385.40

nmol/l

0.16

365

Disorders of adult personality and behaviour

102

802

1.27

1.60

1.2

1.1

354.43

401.96

nmol/l

1.64

736

Other disorders of thyroid

2.53

1.60

1.5

1.2

203.12

385.81

nmol/l

—

Dental caries 3 and operation codes, only avohilmo

104

664

0.79

1.60

1.3

1.1

364.35

381.41

nmol/l

0.40

569

Primary open-angle glaucoma, strict

117

934

1.25

1.60

1.2

336.60

321.53

nmol/l

0.32

709

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

756

0.73

1.60

1.1

1.2

315.48

337.72

nmol/l

0.34

612

Streptococcal septicaemia

222

1.54

1.59

1.3

1.2

311.92

347.14

nmol/l

0.47

189

Diseases of external ear

136

1107

1.23

1.59

1.1

1.2

343.68

361.89

nmol/l

0.41

107

922

Chronic laryngitis and laryngotracheitis

404

1.39

1.59

1.2

383.58

351.29

nmol/l

0.60

338

Sequelae of injuries, of poisoning and of other consequences of external causes

707

1.29

1.58

1.3

1.1

387.15

378.28

nmol/l

0.14

614

Lyme disease

752

1.28

1.56

1.2

1.1

377.60

360.05

nmol/l

0.36

637

Non-small cell lung cancer

519

0.67

1.56

1.2

290.08

326.42

nmol/l

0.53

398

Convulsions, not elsewhere classified

656

1.30

1.55

1.1

354.42

373.79

nmol/l

0.36

573

Colonic or urogenital fistula

109

868

1.26

1.55

1.2

1.1

343.34

366.14

nmol/l

0.55

736

Substance abuse, excluding more controls

199

1472

1.18

1.55

1.2

1.1

349.48

373.47

nmol/l

0.93

156

1276

Myeloid leukaemia

2.05

1.54

1.1

1.2

394.63

376.35

nmol/l

—

Asthma mixed form (mode)

158

0.44

1.54

1.1

379.86

346.14

nmol/l

—

140

Carcinoma in situ of other and unspecified digestive organs

1.99

1.54

1.0

1.1

265.29

391.28

nmol/l

—

Asthma mixed form (mode), excluding more controls

158

0.44

1.54

1.1

379.86

349.83

nmol/l

—

137

therapeutic use

1.99

1.54

1.6

1.2

331.29

405.23

nmol/l

0.69

Primary_lymphoid and hematopoietic malignant neoplasms

101

798

1.27

1.54

1.2

354.79

335.57

nmol/l

0.36

637

Injuries to the shoulder and upper arm

351

2596

1.13

1.53

1.2

373.71

360.98

nmol/l

0.52

299

2165

Any event in cancer register

417

2199

1.13

1.53

1.1

1.2

347.02

379.49

nmol/l

2.63

356

1879

Assault by unspecified means

0.00

1.53

0.0

1.1

—

417.92

—

Wet age-related macular degeneration

620

1.30

1.52

1.3

1.2

295.49

312.04

nmol/l

0.34

460

Sciatica+with lumbago

204

1645

1.18

1.52

1.2

1.1

363.19

378.36

nmol/l

0.49

172

1387

Mixed connective tissue disease

169

1.60

1.52

1.3

1.1

351.20

395.31

nmol/l

0.53

157

Glucosamine medication

218

1484

1.17

1.51

1.3

1.2

331.75

335.10

nmol/l

0.08

170

1164

Presbycusis

491

1.34

1.51

1.3

1.2

297.69

331.94

nmol/l

0.80

374

Orchitis and epididymitis

217

1.52

1.51

1.2

323.08

333.49

nmol/l

0.08

170

Volume depletion

266

1.47

1.50

1.4

1.2

328.57

334.44

nmol/l

0.05

212

Colon adenocarcinoma

400

1.38

1.50

1.2

312.00

325.50

nmol/l

0.17

316

Chronic rhinitis, nasopharyngitis and pharyngitis

115

926

1.24

1.50

1.2

1.1

380.82

360.43

nmol/l

0.51

103

806

Explicit bacterial Sepsis

291

1.45

1.50

1.3

1.2

310.42

350.57

nmol/l

0.68

242

Voice disturbances

107

855

1.25

1.49

1.2

391.94

362.52

nmol/l

0.88

733

Osteomyelitis

170

1.59

1.49

1.1

1.2

389.67

373.73

nmol/l

0.10

142

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

401

1.38

1.48

1.2

312.00

331.91

nmol/l

0.27

310

Open wound of ankle and foot

259

1.47

1.48

1.3

1.1

273.39

386.79

nmol/l

3.43

229

Transport accidents

178

1328

1.19

1.47

1.2

1.1

387.81

383.92

nmol/l

0.09

162

1148

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

632

0.74

1.47

1.2

296.79

322.15

nmol/l

0.45

493

Mixed conductive and sensorineural hearing loss

376

1.39

1.47

1.2

320.12

365.46

nmol/l

0.82

307

Specific personality disorders

644

1.29

1.47

1.2

1.1

355.95

399.88

nmol/l

1.28

594

Unspecified kidney failure

309

1.43

1.47

1.3

1.2

243.00

323.01

nmol/l

2.59

246

Other diseases of biliary tract

243

1.49

1.47

1.1

333.41

353.69

nmol/l

0.22

206

Fall on same level involving ice and snow

231

1990

1.16

1.47

1.2

338.36

366.71

nmol/l

1.43

182

1683

Autoimmune hyperthyroidism

163

1.60

1.46

1.1

353.76

385.05

nmol/l

0.33

149

Varicose veins

286

1887

1.15

1.46

1.2

339.22

357.54

nmol/l

0.81

232

1553

Cervicobrachial syndrome

682

1.28

1.43

1.1

354.37

377.34

nmol/l

0.49

581

Mental disorders, not otherwise specified

228

1.50

1.43

1.1

341.89

408.08

nmol/l

1.01

216

Abnormal findings on diagnostic imaging of lung

195

1617

1.18

1.43

1.2

330.45

339.35

nmol/l

0.24

143

1313

Other obstetric trauma

152

0.46

1.43

1.0

1.1

478.57

412.29

nmol/l

—

146

Viral pneumonia

353

1.39

1.43

1.1

348.94

360.39

nmol/l

0.14

302

Benign neoplasm: Adrenal gland

188

1.55

1.42

1.1

1.2

304.96

386.02

nmol/l

1.00

165

Reactive arthropathies

253

1.47

1.42

1.2

1.1

308.03

364.31

nmol/l

0.81

228

Benign lipomatous neoplasm

118

960

1.23

1.42

1.2

324.26

355.30

nmol/l

0.92

814

Gout, strict definition

534

1.31

1.42

1.3

1.2

306.73

323.25

nmol/l

0.29

412

Other disorders of kidney and ureter

371

1.38

1.41

1.2

353.00

354.72

nmol/l

0.02

311

Other spirochaetal diseases

764

1.26

1.41

1.2

1.1

377.60

359.19

nmol/l

0.38

648

Otitis externa, unspecified

287

1.43

1.40

1.1

362.97

383.32

nmol/l

0.23

259

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

714

0.76

1.39

1.2

299.40

322.91

nmol/l

0.43

567

Persistent mood disorders

598

1.29

1.38

1.2

1.1

368.08

374.16

nmol/l

0.09

522

Abnormal involuntary movements

407

1.35

1.37

1.2

1.1

378.02

360.50

nmol/l

0.26

350

Other peripheral vascular diseases

206

1.51

1.37

1.2

289.09

370.01

nmol/l

1.67

189

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

196

1091

1.17

1.37

1.1

1.2

340.41

385.35

nmol/l

2.38

170

939

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

196

1091

1.17

1.37

1.1

1.2

340.41

385.35

nmol/l

2.38

170

939

Hallux rigidus

390

1.36

1.37

1.3

1.1

345.37

344.47

nmol/l

0.01

316

Pain associated with micturition

339

1.39

1.37

1.3

1.1

357.67

369.69

nmol/l

0.13

290

Ulcerative colitis, NAS

390

1.36

1.37

1.2

1.1

362.82

376.38

nmol/l

0.20

353

Other follicular disorders

182

1.54

1.37

1.2

1.1

324.76

400.13

nmol/l

0.87

173

Disorders of ocular muscles, binocular movement, accommodation and refraction

176

1481

1.18

1.37

1.2

1.1

365.50

378.68

nmol/l

0.38

145

1292

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

397

2098

1.12

1.37

1.1

1.2

344.30

376.32

nmol/l

2.38

336

1798

Malignant neoplasm, wide definition for exclusion

397

2098

1.12

1.37

1.1

1.2

344.30

376.32

nmol/l

2.38

336

1798

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

397

2098

1.12

1.36

1.1

1.2

344.30

376.32

nmol/l

2.38

336

1798

Lichen planus

391

1.36

1.35

1.1

1.2

391.97

357.70

nmol/l

0.44

333

Blepharochalasis

119

975

1.22

1.35

1.1

1.2

346.84

336.12

nmol/l

0.20

787

357

1.38

1.35

1.2

1.1

448.98

388.83

nmol/l

1.00

323

Event of undetermined intent

143

1.61

1.35

1.2

1.1

320.53

392.47

nmol/l

0.88

131

Accidental poisoning by and exposure to alcohol

0.00

1.34

0.0

1.1

—

449.88

—

Use of levodopa decarbox-comt-inhibitor

1.79

1.33

1.2

300.06

340.48

nmol/l

0.42

Ankylosing spondylitis, ICD10

224

1.48

1.33

1.2

1.1

348.14

376.66

nmol/l

0.36

204

Direct fill therapy

341

1.38

1.33

1.1

386.63

386.47

nmol/l

0.00

307

Oral lichen ruber planus wide, hypothyreosis or thyroxin

136

1.62

1.32

1.1

443.00

397.42

nmol/l

0.38

119

Lesion of lateral popliteal nerve

113

1.69

1.32

1.1

346.85

401.29

nmol/l

0.42

Disorders resulting from impaired renal tubular function

1.82

1.31

1.2

1.1

231.20

400.37

nmol/l

—

Allergic asthma (mode), excluding more controls

696

1.26

1.31

1.2

1.1

396.49

391.86

nmol/l

0.08

626

Type 1 diabetes, wide definition, subgroup 1

585

1.28

1.30

1.2

347.15

388.88

nmol/l

1.04

537

Colorectal cancer

101

818

1.24

1.29

1.3

1.2

316.97

333.74

nmol/l

0.33

630

Disorders of vestibular function (Vertigo)

194

1658

1.16

1.29

1.2

335.64

352.81

nmol/l

0.57

159

1359

Other diseases of arteries and capillaries

259

1.43

1.29

1.3

1.2

383.41

362.67

nmol/l

0.22

226

Coronary angioplasty

158

1024

1.19

1.29

1.2

323.50

331.30

nmol/l

0.17

111

838

Diabetic retinopathy, excluding more controls

115

528

1.23

1.28

1.2

342.82

372.36

nmol/l

0.68

393

Infections with a predominantly sexual mode of transmission

107

872

1.23

1.28

1.1

430.67

403.76

nmol/l

0.66

809

Chronic periodontitis, complicated

251

1.44

1.28

1.2

1.1

349.89

377.69

nmol/l

0.35

220

Cirrhosis of liver, NAS

122

1.65

1.27

1.4

1.2

272.69

365.46

nmol/l

0.98

103

Other disorders of gingiva or/and edentulous alveolar ridge

122

1.65

1.27

1.1

292.00

350.04

nmol/l

0.62

106

Alzheimer’s disease (Early onset)

162

1.55

1.26

1.1

1.3

345.95

327.21

nmol/l

0.16

127

Cerebral palsy and other paralytic syndromes

328

1.38

1.25

1.1

1.2

341.21

368.76

nmol/l

0.36

289

Myasthenia gravis

2.24

1.24

1.3

1.2

458.50

377.23

nmol/l

—

Pneumonia due to other infectious organisms, not elsewhere classified

1.87

1.24

1.1

317.53

372.10

nmol/l

—

Benign lipomatous neoplasm

118

977

1.21

1.24

1.2

324.26

364.08

nmol/l

1.31

817

Other specified/unspecified arthritis

805

1.23

1.2

1.1

350.20

363.97

nmol/l

0.27

675

Foreign body entering into or through eye or natural orifice

187

1.50

1.23

1.1

1.2

315.48

386.00

nmol/l

0.98

163

Other/unspecified reactive arthropathies

171

1.53

1.23

1.3

1.1

278.10

394.42

nmol/l

1.68

157

Hemiplegia

139

1.59

1.23

1.1

1.2

339.20

380.71

nmol/l

0.41

125

Other disorders of adrenal gland

108

1.67

1.22

1.2

284.54

399.80

nmol/l

1.38

conjunctival haemorrhage

196

1.48

1.21

1.3

1.2

356.73

367.93

nmol/l

0.09

166

COPD, hospital admission 2, with asthma infections

1003

0.82

1.20

1.3

1.2

305.69

332.78

nmol/l

0.67

784

Other noninflammatory disorders of vulva and perineum

222

1.44

1.18

1.3

1.1

408.88

388.05

nmol/l

0.18

189

Agranulocytosis

298

1.38

1.18

1.1

1.2

323.69

376.36

nmol/l

0.74

259

Other disorders of white blood cells

133

1.58

1.17

1.0

1.2

349.44

380.41

nmol/l

0.31

118

Visual field defects

231

1.43

1.17

1.2

306.48

359.24

nmol/l

0.85

199

Other secondary coxarthrosis

1.78

1.17

1.1

1.2

390.25

379.16

nmol/l

—

Malignant neoplasm of prostate

157

843

1.18

1.17

1.1

1.2

334.54

316.90

nmol/l

0.48

119

653

Poisoning by medicine, drug-induced

0.00

1.16

0.0

1.1

—

416.54

—

Other obstetric conditions, not elsewhere classified

116

624

1.21

1.16

1.1

433.38

414.30

nmol/l

0.52

109

602

Other diseases of appendix

0.00

1.16

0.0

1.2

—

383.79

—

Alcohol abuse counselling and surveillance

0.00

1.16

0.0

1.1

—

415.38

—

Fall involving bed

1.73

1.15

1.0

1.1

287.40

383.52

nmol/l

—

Psoriasis (vulgaris), strict definition

1.81

1.15

1.2

324.86

416.19

nmol/l

—

Other disorders of bone

597

1.26

1.15

1.2

1.1

348.06

387.73

nmol/l

0.83

528

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

763

1.22

1.15

1.2

327.92

361.75

nmol/l

0.87

639

Spontaneous abortion

184

1081

1.16

1.14

1.1

380.23

391.61

nmol/l

0.32

173

979

Embedded and impacted teeth

545

1.25

1.13

1.1

387.87

412.14

nmol/l

0.56

517

Sequelae of external causes of morbidity and mortality

805

1.22

1.13

1.2

365.35

354.74

nmol/l

0.17

665

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

621

0.76

1.13

1.1

1.2

358.69

349.33

nmol/l

0.10

505

Osteoporosis with pathological fracture (FG)

225

1.43

1.12

1.2

260.17

348.06

nmol/l

1.95

174

Ankylosing spondylitis

242

1.41

1.11

1.2

1.1

348.14

377.74

nmol/l

0.37

212

Glomerular disorders in diseases classified elsewhere

319

1.35

1.11

1.3

1.2

340.26

361.74

nmol/l

0.28

268

175

1427

1.15

1.09

1.2

316.21

319.74

nmol/l

0.08

133

1096

Dental pulpitis 1, only avohilmo

443

2533

0.91

1.09

1.2

1.1

354.54

370.07

nmol/l

0.84

363

2161

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

818

1.21

1.09

1.2

1.1

396.52

397.42

nmol/l

0.01

727

Fracture of shoulder and upper arm

140

1193

1.17

1.09

1.2

379.85

352.19

nmol/l

0.73

114

975

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

566

1.26

1.09

1.2

298.63

345.83

nmol/l

1.12

459

Hypertrophy of breast in women and men

584

1.25

1.09

1.2

1.1

430.32

395.95

nmol/l

0.78

533

Inflammatory diseases of the central nervous system

218

1.43

1.09

1.4

1.1

365.64

377.62

nmol/l

0.13

199

Urethral stricture

152

1.52

1.09

1.1

1.2

355.74

342.07

nmol/l

0.10

120

Nontoxic multinodular goitre

611

1.25

1.08

1.2

351.20

350.27

nmol/l

0.01

509

Vascular dementia (subcortical)

1.70

1.08

1.6

1.2

295.44

339.95

nmol/l

—

Acute renal failure

675

1.23

1.07

1.3

1.2

291.95

334.60

nmol/l

1.14

528

Abnormal results of function studies

219

1.42

1.06

1.3

1.1

336.04

380.99

nmol/l

0.51

198

Fall on and from stairs and steps

101

839

1.21

1.06

1.2

335.01

359.11

nmol/l

0.60

704

Disorder of thyroid, unspecified

2.14

1.06

1.6

1.2

211.57

386.67

nmol/l

—

Amiodarone users

279

1.37

1.05

1.2

299.96

332.99

nmol/l

0.42

229

Retained placenta and membranes, without haemorrhage

357

1.32

1.05

1.1

347.54

388.98

nmol/l

0.66

327

Horner syndrome

2.08

1.03

1.3

1.2

413.57

381.04

nmol/l

—

Other and unspecified glaucoma

204

1.43

1.03

1.1

1.2

377.17

339.21

nmol/l

0.36

166

Acute nasopharyngitis (common cold)

296

1.35

1.02

1.1

353.86

407.83

nmol/l

1.04

273

Atrophic disorders of skin

429

1.28

1.02

1.2

1.1

375.71

365.54

nmol/l

0.14

373

Pain in thoracic spine

438

1.28

1.02

1.2

1.1

318.46

382.11

nmol/l

1.31

378

Sub-endpoint used in defining T1D endpoints

122

1019

1.18

1.01

1.2

355.49

364.22

nmol/l

0.18

859

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

112

610

1.19

1.01

1.1

430.79

413.42

nmol/l

0.46

105

588

Benign lipomatous neoplasm of other sites/unspecified

264

1.37

1.01

1.2

309.11

351.61

nmol/l

0.68

227

Lichen ruber planus, wide definition including periferal and oral lichen planus

644

1.23

1.01

1.1

395.04

355.51

nmol/l

0.75

551

Other acute lower respiratory infections

216

1825

1.13

1.01

1.2

361.97

357.49

nmol/l

0.11

169

1515

Pedal cyclist injured in transport accident

653

1.23

1.01

1.2

1.1

392.00

379.49

nmol/l

0.24

570

Pre-eclampsia

599

1.24

1.01

1.2

1.1

384.27

402.40

nmol/l

0.32

555

Later onset COPD

869

0.83

1.00

1.3

1.2

274.25

304.50

nmol/l

0.76

645

Diabetic retinopathy

156

851

1.16

0.99

1.2

335.28

347.92

nmol/l

0.27

107

612

Speech and linguistic disorders

165

1.46

0.99

1.2

1.1

379.11

400.30

nmol/l

0.18

154

Allergic asthma (mode)

723

1.21

0.99

1.2

1.1

396.49

387.17

nmol/l

0.16

650

Reactive arthropathies, FINNGEN

189

1.43

0.99

1.3

1.1

289.86

379.63

nmol/l

1.19

169

Otitis externa

674

1.22

0.98

1.1

1.2

355.80

376.54

nmol/l

0.34

575

Redundant prepuce, phimosis and paraphimosis

465

1.26

0.98

1.1

1.2

325.70

371.17

nmol/l

0.92

385

Conjunctivitis (acute, non atopic)

818

1.20

0.97

1.3

1.1

327.81

379.91

nmol/l

2.05

712

Injury of nerves and spinal cord at neck level

1.81

0.97

1.0

1.1

358.11

388.40

nmol/l

—

Primary angle-closure glaucoma

116

1.56

0.96

1.2

331.08

320.85

nmol/l

—

Acute generalized exanthematous pustulosis

108

1.58

0.96

1.1

268.75

384.98

nmol/l

1.95

Other symptoms and signs involving the urinary system

284

1.34

0.96

1.1

1.2

406.93

355.08

nmol/l

0.66

233

Dental caries 2, only avohilmo

286

2035

1.11

0.96

1.1

395.31

384.37

nmol/l

0.42

257

1802

Dental pulpitis 4, only avohilmo

445

2524

0.92

0.96

1.2

1.1

354.47

370.34

nmol/l

0.87

366

2153

Alcoholic liver disease

267

1.35

0.96

1.1

1.2

297.37

348.82

nmol/l

0.99

233

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

406

1.28

0.95

1.2

280.82

315.27

nmol/l

0.61

307

Other and unspecified local infections of skin and subcutaneous tissue

250

1.36

0.95

1.4

1.1

329.36

383.11

nmol/l

0.69

220

Lichen planus, including avohilmo

550

1.24

0.95

1.1

386.76

355.98

nmol/l

0.50

468

Fracture of rib(s), sternum and thoracic spine

115

979

1.18

0.95

1.2

337.70

347.71

nmol/l

0.21

792

Disorders of breast

196

1607

1.13

0.95

1.1

390.09

378.14

nmol/l

0.34

178

1396

Nephropathy related operations

329

0.70

0.94

1.2

334.17

362.62

nmol/l

0.29

279

Other malignant neoplasms of skin (=non-melanoma skin cancer)

235

1658

1.12

0.94

1.2

298.86

331.56

nmol/l

1.63

190

1289

Protozoal diseases

1.78

0.94

1.1

260.50

379.90

nmol/l

—

Malignant neoplasm of breast, HER-negative

686

1.21

0.94

1.2

336.15

352.74

nmol/l

0.30

567

Other local infections of skin and subcutaneous tissue

268

1.35

0.94

1.4

1.1

321.37

379.57

nmol/l

0.83

237

Other factor of the environment

2.24

0.93

1.0

1.1

297.50

432.82

nmol/l

—

Striking against or struck by other objects

110

934

1.18

0.93

1.2

1.1

375.11

382.93

nmol/l

0.14

809

UC patients in KELA-register (code 208), prior to 1994

109

1.57

0.93

1.1

334.50

409.18

nmol/l

0.73

Other strabismus

640

1.22

0.93

1.2

1.1

391.33

386.30

nmol/l

0.07

573

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

391

1.28

0.93

1.1

347.49

373.96

nmol/l

0.38

345

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

123

641

1.17

0.93

1.2

347.18

333.62

nmol/l

0.30

518

Dislocation, sprain and strain of joints and ligaments of knee

222

1841

1.12

0.93

1.1

385.49

387.83

nmol/l

0.06

197

1637

Other symptoms and signs involving the nervous and musculoskeletal systems

163

1428

1.14

0.93

1.2

376.65

363.56

nmol/l

0.37

135

1207

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

312

1.32

0.93

1.3

1.2

337.41

345.19

nmol/l

0.08

254

Use of rivastigmine

533

1.24

0.93

1.2

1.3

378.74

304.81

nmol/l

1.54

402

Adenocarcinoma and papillary adenocarcinoma of stomach

1.72

0.92

1.0

1.1

360.60

350.66

nmol/l

0.08

Disorders of skin appendages

170

1495

1.14

0.91

1.2

1.1

365.79

378.53

nmol/l

0.32

135

1314

Carcinoma in situ of skin

244

1.36

0.91

1.1

1.2

336.04

330.93

nmol/l

0.04

197

Cholecystitis

464

1.25

0.90

1.2

337.90

337.33

nmol/l

0.01

374

Other complications of surgical and medical care, not elsewhere classified

270

1.34

0.90

1.1

381.59

382.06

nmol/l

0.00

239

Umbilical hernia

800

1.19

0.90

1.2

375.07

367.08

nmol/l

0.14

676

Non-allergic asthma (mode), excluding more controls

603

1.22

0.90

1.1

368.80

366.04

nmol/l

0.04

512

Lifestyle-related condition

2.08

0.89

1.0

1.1

297.50

408.30

nmol/l

—

Other specified and unspecified disorders of eye and adnexa

101

0.49

0.89

1.2

495.20

381.86

nmol/l

—

Subarachnoid haemorrhage

347

0.72

0.88

1.4

1.2

294.65

342.68

nmol/l

0.71

285

Emergency coronary revascularization (for ACS)

234

1509

1.11

0.88

1.2

324.57

329.94

nmol/l

0.13

166

1193

Psoriasis vulgaris

556

1.22

0.88

1.2

349.10

369.18

nmol/l

0.32

480

277

0.68

0.88

1.1

423.00

425.48

nmol/l

0.02

266

DVT of lower extremities

638

1.21

0.88

1.2

273.92

339.21

nmol/l

2.20

513

Other disorders of veins

154

1350

1.14

0.87

1.2

336.46

364.40

nmol/l

0.95

121

1137

Contact with sharp object, undetermined intent

1.87

0.87

1.1

404.00

411.70

nmol/l

—

Examination and encounter for administrative purposes

1.58

0.87

1.1

326.30

388.44

nmol/l

—

Other and unspecified psoriasis

169

1.42

0.87

1.2

304.76

383.83

nmol/l

1.33

150

Fracture at wrist and hand level

118

1015

1.16

0.87

1.1

373.13

384.64

nmol/l

0.23

880

Other and unspecified diseases of blood and blood-forming organs

1.73

0.86

1.5

1.2

376.64

378.57

nmol/l

0.01

Other/unspecified enthesopathies, not elsewhere classified

255

1.34

0.86

1.1

1.2

351.68

361.78

nmol/l

0.10

215

Coronary revascularization (ANGIO or CABG)

185

1144

1.13

0.86

1.2

330.91

336.40

nmol/l

0.12

131

940

Benign neoplasm: Adrenal gland

212

1.37

0.86

1.1

1.2

304.96

382.82

nmol/l

0.95

186

Pregnancy with abortive outcome

241

1400

0.90

0.86

1.1

1.2

363.49

378.59

nmol/l

0.53

211

1214

Superficial injury of lower leg

759

1.19

0.85

1.2

1.1

334.79

367.67

nmol/l

0.79

661

Effects of foreign body entering through natural orifice

695

1.20

0.85

1.2

1.1

336.20

377.74

nmol/l

0.99

605

Outcome of delivery

334

0.78

0.84

1.1

401.76

424.60

nmol/l

0.37

316

Ulcerative rectosigmoiditis

213

1.36

0.84

1.1

341.12

396.12

nmol/l

0.82

194

All influenza (not pneumonia)

433

1.25

0.84

1.3

1.1

308.11

367.38

nmol/l

1.65

380

Spontaneous rupture of synovium and tendon

213

1.36

0.84

1.2

1.1

384.20

366.67

nmol/l

0.13

180

Retinal vascular occlusion

389

1.26

0.83

1.2

330.22

329.92

nmol/l

0.00

307

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

398

1.26

0.83

1.1

1.2

347.49

374.14

nmol/l

0.39

345

Need for other prophylactic measures

137

0.58

0.83

1.0

1.1

433.50

387.67

nmol/l

—

123

Dental caries 2 and operation codes

284

2055

1.10

0.83

1.1

395.73

384.79

nmol/l

0.42

255

1816

Pre-eclampsia or eclampsia

643

1.20

0.82

1.2

1.1

382.69

399.75

nmol/l

0.31

596

Abnormal findings on diagnostic imaging of central nervous system

113

1.51

0.82

1.1

1.2

385.00

395.41

nmol/l

0.09

103

Impacted teeth

404

1.25

0.82

1.2

1.1

371.11

416.00

nmol/l

0.96

389

Nonsuppurative otitis media

547

1.20

0.82

1.1

342.18

406.35

nmol/l

2.18

499

Parodontitis

322

2586

0.92

0.82

1.2

381.45

364.72

nmol/l

0.77

244

2207

Other and unspecified disorders of vitreous body

151

1324

1.14

0.81

1.2

401.67

347.45

nmol/l

2.36

132

1093

Type 1 diabetes, wide definition

643

1.20

0.81

1.2

344.98

384.54

nmol/l

1.00

583

Colorectal adenocarcinoma

653

1.20

0.81

1.2

324.74

332.35

nmol/l

0.11

505

Abnormal findings on antenatal screening of mother

213

0.66

0.81

1.1

371.50

422.25

nmol/l

0.63

208

Deep bite

210

1.34

0.81

1.1

426.72

386.31

nmol/l

0.48

196

Retinal vascular disorders

400

1.25

0.80

1.2

330.22

331.95

nmol/l

0.02

314

Chondropathies

445

1.24

0.80

1.2

1.1

323.49

384.33

nmol/l

1.27

402

Diabetic nephropathy, excluding more controls

416

1.23

0.80

1.3

1.2

325.58

362.45

nmol/l

0.65

301

Chronic periodontitis, including avohilmo

321

2584

0.92

0.80

1.2

380.96

364.88

nmol/l

0.72

243

2206

Fibrosis and cirrhosis of liver

181

1.38

0.79

1.4

1.2

251.50

370.05

nmol/l

1.76

161

Hypertrophy of breast

509

1.22

0.79

1.2

1.1

450.91

400.18

nmol/l

1.29

467

Superficial injury of wrist and hand

564

1.21

0.79

1.2

1.1

356.39

394.95

nmol/l

0.79

501

Alzheimer’s disease (Atypical or mixed)

338

1.27

0.78

1.0

1.3

235.50

296.10

nmol/l

1.04

255

Strabismus

802

1.17

0.78

1.2

1.1

385.76

372.43

nmol/l

0.24

699

Other disorders of patella

483

1.22

0.78

1.3

1.1

366.42

399.63

nmol/l

0.55

442

Other viral diseases

830

1.17

0.77

1.1

374.29

393.93

nmol/l

0.41

749

Covid-19 confirmed case

105

907

1.16

0.77

1.2

323.01

365.34

nmol/l

1.34

779

Unspecified acute lower respiratory infection

448

1.23

0.76

1.2

338.32

369.12

nmol/l

0.54

393

Ulcer of lower limb, not elsewhere classified

448

1.23

0.76

1.1

1.2

388.53

329.92

nmol/l

0.89

359

Trigger finger

376

1.25

0.76

1.3

1.1

350.79

374.18

nmol/l

0.32

328

Open wound of lower leg

430

1.23

0.76

1.2

1.1

324.70

362.59

nmol/l

0.61

370

Lumbosacral root disorders, not elsewhere classified

0.00

0.76

0.0

1.1

—

416.17

—

Other peripheral vertigo

261

1.31

0.76

1.3

1.2

329.64

365.29

nmol/l

0.40

224

Venous thromboembolism

220

1935

1.10

0.75

1.2

306.38

348.70

nmol/l

1.85

174

1566

Cellulitis

668

1.18

0.75

1.2

333.28

363.56

nmol/l

0.62

564

Benign neoplasm: Skin of other and unspecified parts of face

350

1.26

0.75

1.2

353.82

359.04

nmol/l

0.05

292

Malignant neoplasm of oesophagus

1.71

0.75

1.1

1.2

316.33

344.59

nmol/l

—

Burns and corrosions

368

1.25

0.75

1.2

1.1

364.55

379.79

nmol/l

0.21

333

Squamous cell neoplasms and carcinomas of the skin

422

1.23

0.75

1.1

1.2

296.81

315.87

nmol/l

0.26

318

Dental caries 2

288

2076

1.09

0.74

1.1

392.25

384.90

nmol/l

0.26

259

1834

Benign neoplasm: Skin of other and unspecified parts of face

351

1.26

0.74

1.2

353.82

356.07

nmol/l

0.02

296

Erythema intertrigo

1.64

0.73

1.2

495.78

402.98

nmol/l

—

Maternal care for known or suspected disproportion

133

1.43

0.73

1.2

1.1

451.47

426.73

nmol/l

0.21

128

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

316

1.27

0.73

1.2

321.81

334.02

nmol/l

0.14

250

Basal cell carcinoma, including avohilmo

238

1707

1.10

0.73

1.2

305.32

330.52

nmol/l

1.13

197

1331

Thyroiditis, unspecified

1.80

0.72

1.3

1.2

392.43

389.06

nmol/l

—

Other benign neoplasms of connective and other soft tissue

272

1.29

0.72

1.1

360.10

376.51

nmol/l

0.20

243

Corneal ulcer

543

1.20

0.72

1.3

1.1

388.54

374.16

nmol/l

0.21

478

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

205

1271

1.11

0.72

1.2

306.59

341.19

nmol/l

1.60

165

1033

Benign neoplasm of mouth and pharynx

317

1.26

0.71

1.2

328.63

364.48

nmol/l

0.66

279

Appendectomy

251

2212

1.09

0.71

1.2

1.1

362.91

382.58

nmol/l

0.86

218

1917

Perichondritis of external ear

1.76

0.71

1.1

1.2

350.00

369.43

nmol/l

—

Other and unspecified effects of external causes

793

1.16

0.71

1.1

363.96

385.48

nmol/l

0.53

701

Other diseases of jaws

194

1.34

0.71

1.3

1.1

400.89

372.43

nmol/l

0.32

175

Glaucoma secondary to other eye disorders

109

1.47

0.71

1.2

460.73

362.24

nmol/l

0.76

Impacted cerumen

282

1.28

0.71

1.1

1.2

313.37

346.94

nmol/l

0.43

230

Tularaemia

1.93

0.71

1.4

1.2

373.40

373.67

nmol/l

—

Bacterial pneumoniae

163

1292

1.12

0.71

1.2

311.71

351.39

nmol/l

1.81

126

1056

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

182

0.66

0.70

1.2

224.43

338.34

nmol/l

—

150

Parodontitis or operation codes

325

2585

0.93

0.70

1.2

381.99

364.42

nmol/l

0.83

247

2206

Pneumonitis due to solids and liquids

247

1.30

0.70

1.4

1.2

318.87

330.79

nmol/l

0.13

199

Beningn neoplasm: Meninges, unspecified

1.72

0.70

1.0

1.2

368.14

364.66

nmol/l

—

Non-allergic asthma (mode)

622

1.18

0.69

1.1

1.2

368.80

362.26

nmol/l

0.10

528

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

221

1.32

0.69

1.1

399.14

411.87

nmol/l

0.15

211

Acute and transient psychotic disorders

320

0.75

0.69

1.3

1.1

310.72

385.77

nmol/l

1.25

293

Viral and other specified intestinal infections

562

0.82

0.69

1.0

1.1

391.25

383.45

nmol/l

0.09

510

1.65

0.68

1.1

365.90

445.62

nmol/l

—

Sequelae of injuries of neck and trunk

1.60

0.68

1.3

1.1

347.73

406.25

nmol/l

0.36

Neovascular glaucoma

110

1.46

0.68

1.2

460.73

367.48

nmol/l

0.71

Use of antiglaucoma preparations and miotics

266

1.28

0.68

1.3

1.2

414.78

321.97

nmol/l

1.88

209

Cutaneous abscess, furuncle and carbuncle

760

1.16

0.67

1.2

1.1

353.58

377.57

nmol/l

0.44

662

Bicipital tendinitis

120

0.58

0.67

1.0

1.2

320.43

380.57

nmol/l

—

104

Malignant neoplasm, without specification of site

0.54

0.67

1.4

1.2

354.20

332.69

nmol/l

—

Plantar fascial fibromatosis

249

1.29

0.67

1.2

1.1

346.04

380.82

nmol/l

0.38

220

Adverse effects, not elsewhere classified

557

1.19

0.67

1.1

364.46

389.38

nmol/l

0.50

499

Appendicitis, broad definition

291

2459

1.08

0.67

1.2

1.1

372.10

380.02

nmol/l

0.27

250

2117

Coronary artery bypass grafting

110

734

1.14

0.67

1.2

335.55

322.00

nmol/l

0.24

593

Retinal detachments and breaks

136

1212

1.12

0.66

1.2

357.28

341.68

nmol/l

0.39

108

974

malignant neoplasm of female genital organs

517

0.81

0.66

1.1

1.2

377.64

344.41

nmol/l

0.41

428

Benign mammary dysplasia

457

1.21

0.66

1.2

1.1

332.40

351.79

nmol/l

0.26

391

Injury of unspecified body region

188

1.33

0.66

1.1

374.74

377.92

nmol/l

0.02

166

Other aneurysm

145

1.38

0.66

1.3

333.92

342.84

nmol/l

0.06

119

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

128

1.41

0.65

1.2

1.3

376.73

339.00

nmol/l

0.21

107

Dental caries 3, only avohilmo

367

2014

0.93

0.65

1.2

342.31

365.80

nmol/l

1.43

297

1697

Benign paroxysmal vertigo

109

959

1.14

0.65

1.3

1.2

338.84

349.75

nmol/l

0.24

781

Disorders of refraction and accommodation

741

1.16

0.65

1.1

366.71

389.50

nmol/l

0.50

663

Persons encountering health services in circumstances related to reproduction

162

1219

0.90

0.65

1.1

436.57

403.50

nmol/l

1.49

157

1101

Disorders of vitreous body and globe

188

1665

1.10

0.65

1.2

395.15

346.62

nmol/l

2.35

159

1357

Viral infections characterized by skin and mucous membrane lesions

150

1346

1.11

0.64

1.2

340.52

368.87

nmol/l

1.06

127

1141

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

104

913

1.14

0.64

1.2

1.1

347.89

367.04

nmol/l

0.44

766

Parodontitis and operation codes

302

2530

0.93

0.64

1.2

1.1

381.55

365.54

nmol/l

0.69

230

2158

Disorders of vitreous body

181

1607

1.10

0.64

1.2

395.58

346.02

nmol/l

2.33

154

1314

Calculus of kidney and ureter

113

998

1.13

0.64

1.2

331.79

352.64

nmol/l

0.52

814

Malignant neoplasm of breast

205

1348

1.10

0.64

1.1

1.2

340.27

372.33

nmol/l

1.47

178

1145

Dental caries 1, only avohilmo

351

1927

0.93

0.64

1.2

342.79

362.94

nmol/l

1.08

285

1614

Poisoning by medicine

597

1.17

0.64

1.2

1.1

323.59

398.56

nmol/l

2.51

549

Acute peritonitis

172

1.34

0.63

1.3

1.1

333.17

374.46

nmol/l

0.50

145

Malignant neoplasm

383

2123

1.07

0.63

1.1

1.2

343.60

374.23

nmol/l

2.22

324

1801

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

116

614

1.13

0.63

1.2

335.50

328.19

nmol/l

0.15

494

Acute bronchitis

164

1453

1.11

0.63

1.2

364.89

353.19

nmol/l

0.28

127

1184

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

1.52

0.62

1.0

1.3

360.60

352.15

nmol/l

0.07

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

378

1.22

0.62

1.3

1.2

315.71

336.60

nmol/l

0.29

293

Other/unspecified disorders of vestibular function

104

1.45

0.62

1.4

1.1

382.90

367.15

nmol/l

—

Postmenopausal osteoporosis with pathological fracture

199

1.31

0.62

1.2

263.56

335.42

nmol/l

1.12

167

Corns and callosities

188

0.69

0.62

1.3

1.1

260.00

392.29

nmol/l

2.99

168

Disorders of muscles

270

1.26

0.62

1.2

1.1

280.38

367.45

nmol/l

1.79

236

Basal cell carcinoma

231

1691

1.09

0.62

1.2

304.67

330.71

nmol/l

1.16

191

1317

Pre-eclampsia or poor fetal growth

103

905

1.14

0.61

1.2

1.1

392.16

404.17

nmol/l

0.26

839

Other and unspecified visual disturbances

253

1.27

0.61

1.1

395.33

378.12

nmol/l

0.20

223

COPD, hospital admissions 1, only main diagnosis

114

1092

0.89

0.60

1.2

323.66

328.97

nmol/l

0.09

853

Gender identity disorders

0.00

0.60

0.0

1.2

—

442.70

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

175

0.68

0.60

1.3

1.2

224.43

338.71

nmol/l

—

142

Non-small cell lung cancer, adenocarcinoma

175

0.68

0.60

1.3

1.2

224.43

338.71

nmol/l

—

142

Degenerative myopia

0.00

0.60

0.0

1.1

—

341.38

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

853

1.14

0.60

1.1

382.14

397.61

nmol/l

0.34

783

Urolithiasis

120

1070

1.12

0.60

1.2

329.36

350.91

nmol/l

0.58

870

Bacterial pneumonia, not elsewhere classified

155

1240

1.11

0.60

1.2

313.85

348.03

nmol/l

1.38

121

1010

Poisoning by drugs, medicaments and biological substances

676

1.15

0.59

1.2

1.1

327.29

399.47

nmol/l

2.62

618

Carcinoma in situ of skin

263

1.26

0.59

1.1

1.2

336.04

325.50

nmol/l

0.09

211

Malignant neoplasm of breast, HER2-negative

198

1331

1.09

0.59

1.1

1.2

340.55

371.28

nmol/l

1.33

173

1126

Injuries to the abdomen, lower back, lumbar spine and pelvis

153

1375

1.11

0.59

1.2

339.25

355.16

nmol/l

0.43

124

1124

Other respiratory disorders and diseases

686

1.15

0.59

1.2

327.88

331.18

nmol/l

0.05

536

Other diseases of the respiratory system

686

1.15

0.59

1.2

327.88

331.18

nmol/l

0.05

536

Immunodeficiency with predominantly antibody defects

1.57

0.58

1.4

1.1

328.40

402.60

nmol/l

—

Undetermined asthma, excluding more controls

381

1.21

0.58

1.1

342.38

369.88

nmol/l

0.52

322

COPD, early/later onset

151

1407

0.91

0.58

1.2

319.39

329.12

nmol/l

0.23

112

1120

Skin changes due to chronic exposure to nonionizing radiation

159

1365

1.10

0.58

1.3

1.2

314.89

319.08

nmol/l

0.09

121

1040

Open wound of forearm

228

1.27

0.58

1.3

1.2

270.67

373.92

nmol/l

1.96

201

Injury of nerves at wrist and hand level

1.46

0.58

1.2

1.1

304.39

405.57

nmol/l

1.33

Pregnancy examination and test

318

0.82

0.57

1.1

420.43

423.15

nmol/l

0.04

301

Dental caries 2 and operation codes, only avohilmo

258

1483

1.08

0.57

1.1

1.2

390.45

375.43

nmol/l

0.60

232

1276

Other disorders of the genitourinary system

402

1.20

0.56

1.3

1.1

324.19

351.81

nmol/l

0.51

341

Bronchitis

458

2840

1.06

0.56

1.2

356.91

369.71

nmol/l

0.66

381

2412

Lung cancer and mesothelioma

553

0.85

0.56

1.2

299.35

329.77

nmol/l

0.56

439

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

681

1.15

0.55

1.2

324.74

335.46

nmol/l

0.17

531

Glaucoma suspect

137

1239

1.11

0.55

1.1

1.2

348.65

339.27

nmol/l

0.21

116

987

Acute appendicitis

270

2373

1.07

0.55

1.2

1.1

373.97

380.47

nmol/l

0.20

231

2059

Dialysis, with operation codes

340

0.79

0.54

1.2

316.27

363.01

nmol/l

0.57

290

DVT of lower extremities and pulmonary embolism

165

1502

1.10

0.54

1.2

308.33

344.00

nmol/l

0.99

126

1197

Focal epilepsy, strict definition

607

1.15

0.54

1.1

1.2

308.55

357.12

nmol/l

1.46

503

Benign neoplasm of mouth and pharynx

330

1.21

0.54

1.2

328.63

369.47

nmol/l

0.77

286

Peroneal tendinitis

1.58

0.54

1.0

1.1

392.67

433.47

nmol/l

—

Glomerular diseases

533

1.16

0.54

1.3

1.2

356.38

354.78

nmol/l

0.02

449

Schizophrenia or delusion, excluding more controls

819

0.87

0.54

1.2

1.1

341.17

382.99

nmol/l

0.95

727

Injuries to the wrist and hand

399

2728

1.06

0.54

1.2

1.1

362.79

374.05

nmol/l

0.50

332

2344

MS-disease / Multiple Sclerosis

204

1.28

0.54

1.0

1.1

407.24

398.64

nmol/l

0.07

193

Foreign body on external eye

358

1.20

0.53

1.1

356.97

391.02

nmol/l

0.44

316

Diseases of appendix

291

2479

1.07

0.53

1.2

1.1

372.10

379.11

nmol/l

0.24

250

2135

Tobacco use

125

1.36

0.53

1.2

1.1

241.63

380.14

nmol/l

—

113

Foreign body in respiratory tract

125

1.36

0.53

1.2

1.1

417.27

391.29

nmol/l

0.14

111

Dislocation of lens

1.54

0.53

1.2

278.67

312.73

nmol/l

—

Urethritis and urethral syndrome

1.46

0.53

1.4

1.1

368.44

402.21

nmol/l

—

Other disorders starting during childhood or adolecense, excluding more controls

1.45

0.53

1.2

1.1

435.44

427.71

nmol/l

—

Benign neoplasm of meninges

295

1.22

0.52

1.1

1.2

338.86

368.72

nmol/l

0.39

247

Malignant neoplasm of stomach

143

1.33

0.52

1.1

1.2

331.06

333.23

nmol/l

0.02

115

Nontoxic goitre/thyroid nodule

115

1034

1.11

0.52

1.1

1.2

335.72

355.15

nmol/l

0.45

868

Contusion of toe(s) without damage to nail

1.43

0.52

1.1

371.00

432.60

nmol/l

—

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

259

1.24

0.52

1.2

433.88

340.98

nmol/l

1.12

214

Seborrhoeic keratosis

737

0.87

0.52

1.1

1.2

376.11

340.15

nmol/l

0.66

598

Malignant neoplasm of liver and intrahepatic bile ducts

1.45

0.52

1.2

1.3

330.33

327.81

nmol/l

—

Injuries to the ankle and foot

253

2148

1.07

0.51

1.2

1.1

361.39

386.02

nmol/l

1.07

212

1887

Certolizumab pegol

1.50

0.51

1.0

1.1

316.33

418.11

nmol/l

—

Abnormalities of gait and mobility

369

1.19

0.51

1.2

363.97

338.03

nmol/l

0.35

294

Injuries to unspecified part of trunk, limb or body region

260

1.23

0.51

1.1

367.32

365.03

nmol/l

0.02

228

Benign neoplasm of ovary

575

0.85

0.51

1.3

1.1

325.40

361.64

nmol/l

0.70

484

Benign neoplasm: salivary glands, exclude unknown (D119)

242

1.24

0.51

1.2

377.70

386.37

nmol/l

0.08

209

Actinic keratosis

154

1337

1.09

0.50

1.3

1.2

313.04

318.36

nmol/l

0.12

118

1017

Exposure to other specified factors

277

2432

1.07

0.50

1.2

1.1

361.53

376.89

nmol/l

0.67

246

2080

Localized swelling, mass and lump of skin and subcutaneous tissue

113

1018

1.11

0.50

1.2

325.61

357.17

nmol/l

1.01

860

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

444

1.17

0.50

1.1

1.3

296.81

320.55

nmol/l

0.34

337

Allergic rhinitis

877

1.12

0.50

1.2

1.1

384.93

399.47

nmol/l

0.29

806

Carcinoma in situ of skin of other and unspecified parts of face

269

0.78

0.50

1.0

1.2

365.57

315.52

nmol/l

0.44

210

Stenosis and insufficiency of lacrimal passages

288

1.22

0.50

1.1

358.58

355.08

nmol/l

0.04

248

Erosion of teeth, including avohilmo

510

1.16

0.50

1.1

417.77

376.89

nmol/l

0.78

461

Benign neoplasm: Cerebral meninges

270

1.22

0.49

1.1

1.2

339.77

367.88

nmol/l

0.34

228

Other chronic obstructive pulmonary disease, including avohilmo

180

1622

0.92

0.49

1.2

331.57

335.19

nmol/l

0.08

134

1298

Demyelinating diseases of the central nervous system

243

1.24

0.49

1.0

1.1

393.67

396.93

nmol/l

0.03

229

Other and unspecified tonsillitis

108

824

1.11

0.49

1.1

413.23

415.39

nmol/l

0.04

768

Benign lipomatous neoplasm of other sites/unspecified

298

1.21

0.49

1.2

309.11

358.46

nmol/l

0.83

251

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

197

1254

1.08

0.48

1.2

311.98

340.05

nmol/l

1.14

163

1017

Beningn neoplasm: Meninges, unspecified

1.53

0.48

1.0

1.2

368.14

403.53

nmol/l

—

Carcinoma in situ of skin of other and unspecified parts of face

267

0.78

0.48

1.0

1.3

365.57

313.12

nmol/l

0.46

209

Superficial injury of abdomen, lower back and pelvis

456

1.16

0.47

1.2

1.1

349.09

375.67

nmol/l

0.39

400

Congenital malformations, deformations and chromosomal abnormalities

206

1834

1.08

0.47

1.1

396.50

382.83

nmol/l

0.45

181

1618

Undetermined asthma

391

1.18

0.47

1.1

342.38

368.11

nmol/l

0.48

333

Other hearing loss

108

959

1.11

0.47

1.3

1.2

289.43

337.25

nmol/l

2.09

753

Idiopathic pulmonary fibrosis

236

1.23

0.46

1.1

1.2

275.41

333.45

nmol/l

0.75

185

Artificial joint re-operation

191

1.26

0.46

1.3

1.2

296.50

353.19

nmol/l

0.87

159

Other and unspecified rosacea

237

1.23

0.45

1.3

1.1

322.86

387.13

nmol/l

1.35

214

Pregnancy, childbirth and the puerperium

114

658

0.91

0.45

1.2

356.01

361.97

nmol/l

0.11

101

550

Other arthritis (FG)

110

998

1.10

0.45

1.2

1.1

347.92

369.54

nmol/l

0.53

836

Other and unspecified injuries of lower leg

183

1.26

0.44

1.1

329.89

395.95

nmol/l

0.86

167

Suppurative and necrotic conditions of lower respiratory tract

141

0.71

0.44

1.1

1.2

328.60

367.35

nmol/l

—

119

COPD, hospital admissions

152

1395

0.92

0.44

1.3

1.2

318.68

328.53

nmol/l

0.23

112

1108

Procedures for purposes other than remedying health state

1.45

0.44

1.0

1.2

413.60

425.41

nmol/l

—

Other and unspecified myopathies

247

1.22

0.44

1.2

355.80

351.11

nmol/l

0.04

207

Inflammatory disorders of breast

174

0.75

0.43

1.2

1.1

383.23

401.16

nmol/l

0.12

163

Complications of labour and delivery

203

1214

0.93

0.43

1.1

401.42

390.91

nmol/l

0.31

190

1093

Other disorders of pigmentation

104

1.35

0.43

1.2

1.1

287.88

389.12

nmol/l

—

Shoulder region

1.62

0.43

1.2

428.02

380.08

nmol/l

—

Malignant neoplasm of bladder

230

1.22

0.42

1.2

1.3

295.50

313.31

nmol/l

0.17

172

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

193

1241

1.07

0.42

1.2

310.31

338.54

nmol/l

1.12

158

1004

Open wound of wrist and hand

142

1297

1.08

0.41

1.2

1.1

350.39

382.41

nmol/l

1.11

122

1126

Other disorders of cornea

249

1.21

0.41

1.1

336.29

380.23

nmol/l

0.74

217

Retinal detachment with retinal break

413

0.85

0.41

1.2

398.26

349.06

nmol/l

0.62

343

Focal epilepsy

670

1.12

0.41

1.1

1.2

314.76

360.19

nmol/l

1.32

559

Ill-defined and unknown causes of mortality

217

0.78

0.41

1.4

1.2

283.45

315.59

nmol/l

0.31

173

Benign neoplasm: Cerebral meninges

277

1.19

0.41

1.1

1.2

339.77

375.01

nmol/l

0.45

234

Other disorders of the musculoskeletal system and connective tissue

454

1.15

0.41

1.3

1.2

356.43

353.61

nmol/l

0.03

387

Complications predominantly related to the puerperium

747

1.11

0.41

1.1

377.80

404.87

nmol/l

0.57

697

Urticaria

101

919

1.10

0.40

1.1

381.07

381.30

nmol/l

0.00

826

Acute appendicitis, with complications

643

1.12

0.40

1.2

400.35

360.67

nmol/l

0.81

545

Pruritus

333

1.17

0.40

1.1

355.60

385.49

nmol/l

0.39

295

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

445

1.15

0.40

1.2

1.1

341.07

406.02

nmol/l

1.62

415

Other and unspecified vascular occlusions

296

1.18

0.40

1.1

1.2

332.70

332.06

nmol/l

0.01

238

Atopic dermatitis, strict definition with reimbursement

817

1.10

0.40

1.2

1.1

393.17

413.03

nmol/l

0.42

761

Other shoulder lesions

250

1.20

0.40

1.2

1.1

346.46

382.90

nmol/l

0.56

223

Benign neoplasm of ovary

561

0.87

0.40

1.3

1.1

325.40

357.33

nmol/l

0.59

483

Myocarditis

1.36

0.40

1.0

1.1

494.92

386.84

nmol/l

0.80

Mental and behavioural disorders due to sedatives or hypnotics

160

0.75

0.39

1.3

1.1

361.00

396.10

nmol/l

—

150

Major anomalies of jaw size

1.31

0.39

1.0

1.1

479.62

398.36

nmol/l

—

Endometriosis diagnosis and infertility diagnosis occurring together

306

1.18

0.39

1.1

423.83

412.77

nmol/l

0.14

289

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

418

1.15

0.39

1.1

1.2

343.82

341.88

nmol/l

0.02

340

Malignant neoplasm of skin

251

1783

1.06

0.39

1.2

301.85

335.91

nmol/l

1.92

205

1408

Memory loss

251

1.20

0.39

1.2

361.04

347.87

nmol/l

0.12

202

Tuberculosis, IBD comorbidity

237

0.80

0.39

1.1

1.3

366.64

340.80

nmol/l

0.18

189

Immunodeficiencies

115

1.31

0.39

1.4

1.2

364.27

399.18

nmol/l

0.31

106

Nasal polyp

579

1.12

0.38

1.0

1.2

321.10

349.13

nmol/l

0.60

484

Cardiodefibrillation

135

1247

1.08

0.38

1.2

310.94

333.25

nmol/l

0.62

976

Respiratory insufficiency

251

1.19

0.38

1.3

1.2

285.48

327.16

nmol/l

0.58

193

Herpesviral [herpes simplex] infections

335

1.17

0.38

1.1

370.47

382.11

nmol/l

0.12

299

Benign neoplasm: Parotid gland

215

1.21

0.38

1.2

391.20

381.58

nmol/l

0.09

188

Idiopathic gout

252

1.19

0.37

1.3

1.2

359.40

318.94

nmol/l

0.50

199

Superficial injury of ankle and foot

308

1.17

0.37

1.3

1.1

369.35

394.30

nmol/l

0.31

283

Later onset COPD, excluding more controls

571

1.11

0.37

1.2

280.11

313.28

nmol/l

0.73

440

Hydrocele

327

1.16

0.37

1.2

274.08

338.01

nmol/l

1.10

245

Acute alcohol intoxication

798

0.90

0.36

1.2

332.60

366.10

nmol/l

0.65

670

Retinal breaks without detachment

459

1.13

0.36

1.2

380.17

357.81

nmol/l

0.33

382

Diseases of peritoneum

309

1.17

0.36

1.2

328.13

361.15

nmol/l

0.54

263

Acute upper respiratory infections

451

2713

1.04

0.36

1.2

372.80

367.46

nmol/l

0.22

386

2287

234

0.81

0.35

1.2

319.25

324.60

nmol/l

0.04

186

Acute appendicitis, no complications

198

1860

1.06

0.35

1.2

1.1

364.71

384.61

nmol/l

0.74

171

1632

Perforation of tympanic membrane

282

1.17

0.35

1.4

1.1

356.25

383.62

nmol/l

0.26

250

Vitreous haemorrhage

292

1.17

0.34

1.2

463.50

355.77

nmol/l

1.73

247

Other ill-defined and unspecified causes of mortality

189

0.79

0.34

1.4

1.2

284.50

319.61

nmol/l

—

147

Injury of muscle and tendon at lower leg level

426

0.87

0.34

1.1

384.17

374.27

nmol/l

0.12

370

Fracture of lumbar spine and pelvis

775

1.10

0.34

1.3

1.2

329.15

333.97

nmol/l

0.07

614

Puerperal sepsis

358

1.15

0.34

1.1

358.87

385.08

nmol/l

0.27

328

Alcohol use disorder, ICD-based

142

1326

1.07

0.33

1.2

334.17

372.13

nmol/l

1.47

110

1127

Abnormal blood-pressure reading, without diagnosis

109

1.29

0.33

1.0

1.1

350.56

387.28

nmol/l

—

Dental caries 1

354

1890

0.96

0.33

1.2

342.74

363.00

nmol/l

1.08

283

1585

Pregnancy hypertension

143

1204

1.07

0.33

1.2

1.1

388.36

399.07

nmol/l

0.27

130

1106

Early onset COPD

688

0.90

0.33

1.2

366.13

362.80

nmol/l

0.04

570

Benign neoplasm of meninges

312

1.16

0.33

1.1

1.2

338.86

374.21

nmol/l

0.48

261

Benign neoplasm of other and unspecified sites

0.70

0.33

1.0

1.2

354.67

412.60

nmol/l

—

Insulin, fast-acting (human)

435

0.87

0.33

1.1

368.73

382.12

nmol/l

0.15

395

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

216

1669

1.06

0.32

1.1

372.80

383.87

nmol/l

0.37

191

1470

Dental caries, including avohilmo

354

1889

0.96

0.32

1.2

341.46

363.14

nmol/l

1.19

283

1584

Dental caries 3

371

1977

0.96

0.32

1.2

343.12

366.15

nmol/l

1.39

299

1669

Parodontitis or/and operation codes

218

1368

0.95

0.32

1.2

391.17

370.58

nmol/l

0.77

166

1192

Bacterial pneumonia (organism specified)

177

1519

1.06

0.32

1.2

310.06

344.50

nmol/l

1.50

134

1225

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

160

1315

1.06

0.32

1.2

1.1

384.24

398.92

nmol/l

0.42

140

1208

Persons encountering health services in other circumstances

128

1193

1.07

0.32

1.3

1.1

339.87

376.47

nmol/l

1.49

120

1009

Maternal care related to the fetus and amniotic cavity and possible delivery problems

146

918

0.94

0.32

1.1

404.78

414.04

nmol/l

0.24

140

855

Status post-ami

251

0.85

0.31

1.3

1.2

314.47

311.72

nmol/l

0.02

186

Other benign neoplasms of connective and other soft tissue

304

1.15

0.31

1.1

1.2

360.10

374.55

nmol/l

0.17

267

Other pleural conditions

323

1.15

0.31

1.1

1.2

321.00

332.10

nmol/l

0.12

252

Abnormal findings in secretions and smears from cervix uteri vagina vulva

157

1312

0.94

0.31

1.1

394.97

397.55

nmol/l

0.06

147

1192

COPD related to multimorbidity

135

1214

0.94

0.31

1.3

1.2

317.08

325.50

nmol/l

0.18

950

Alcohol use disorder, Swedish definition

196

1723

1.06

0.31

1.2

354.80

367.89

nmol/l

0.40

154

1461

Other benign neoplasms of skin

139

1278

1.07

0.30

1.2

346.32

354.47

nmol/l

0.18

116

1061

Poor fetal growth

347

0.86

0.30

1.1

409.07

420.92

nmol/l

0.14

335

206

1795

1.05

0.30

1.2

359.10

365.98

nmol/l

0.18

158

1530

Alcohol withdrawal state with delirium

175

1.20

0.30

1.0

1.2

320.00

364.21

nmol/l

0.34

154

Other diseases of intestine

334

1.14

0.30

1.0

1.2

337.68

354.26

nmol/l

0.21

274

Other fall from one level to another

648

1.10

0.30

1.2

329.67

369.17

nmol/l

1.01

560

Dental pulpitis 3, only avohilmo

159

0.83

0.29

1.1

375.39

423.54

nmol/l

0.48

152

Abnormal serum enzyme levels

102

936

1.08

0.29

1.2

380.96

335.91

nmol/l

1.11

756

Certain disorders involving the immune mechanism

564

1.10

0.28

1.2

359.04

371.05

nmol/l

0.20

488

Ascites

195

1.18

0.28

1.0

1.2

319.44

365.69

nmol/l

0.59

169

Other disorders of penis

223

1.17

0.28

1.2

261.59

350.89

nmol/l

1.27

177

Peritonsillar abscess

555

1.10

0.28

1.1

369.89

382.60

nmol/l

0.17

500

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

407

0.88

0.28

1.3

1.2

352.38

344.49

nmol/l

0.07

325

Acute alcohol intoxication, ICD10

564

0.90

0.27

1.2

1.1

360.06

379.23

nmol/l

0.22

489

Other maternal disorders predominantly related to pregnancy

190

1257

0.95

0.27

1.1

406.11

399.70

nmol/l

0.17

174

1159

Divergent concomitant strabismus

205

1.17

0.27

1.0

1.1

373.59

391.17

nmol/l

0.14

190

Premature rupture of membranes

484

0.91

0.27

1.1

363.62

416.60

nmol/l

1.47

464

Hodgkin lymphoma, hilmo

1.23

0.27

1.4

1.1

370.88

409.16

nmol/l

—

Other congenital malformations of the digestive system

1.29

0.27

1.1

347.45

392.01

nmol/l

0.25

Focal epilepsy, mode (most common among epilepsy diagnosis)

576

1.09

0.26

1.1

1.2

302.98

360.21

nmol/l

1.64

484

Pulmonary heart disease, diseases of pulmonary circulation

119

1117

1.07

0.26

1.3

1.2

327.07

338.85

nmol/l

0.17

883

Benign neoplasm of other and unspecified female genital organs

113

1.24

0.26

1.5

1.1

429.36

397.03

nmol/l

0.20

103

Follicular cysts of skin and subcutaneous tissue

552

0.91

0.26

1.4

1.2

335.21

367.07

nmol/l

0.46

471

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

289

0.86

0.26

1.3

1.2

355.76

336.92

nmol/l

0.16

235

Exposure to other and unspecified animate mechanical forces

1.20

0.26

1.0

1.1

335.50

412.97

nmol/l

—

COPD (mode)

113

841

1.07

0.26

1.2

1.1

318.04

338.15

nmol/l

0.45

688

Vasomotor rhinitis (mode)

197

1.17

0.25

1.2

1.1

367.39

384.77

nmol/l

0.15

177

Other benign neoplasms of skin

139

1314

1.06

0.25

1.2

346.32

349.19

nmol/l

0.06

116

1073

Benign neoplasm of major salivary glands

282

1.14

0.25

1.2

380.33

367.98

nmol/l

0.13

244

Rubella [German measles]

1.23

0.25

1.1

1.2

454.33

414.34

nmol/l

—

Long labour

614

1.08

0.25

1.0

1.1

425.67

401.20

nmol/l

0.47

581

Embedded teeth, including avohilmo

207

1.16

0.25

1.0

1.1

385.88

409.03

nmol/l

0.27

196

Other otitis externa (chronic)

179

1.17

0.25

1.0

1.1

427.80

384.55

nmol/l

0.33

159

Dermatophytosis

378

1.11

0.24

1.2

371.99

357.67

nmol/l

0.14

321

Problems related to lifestyle

264

1.14

0.24

1.2

1.1

304.00

396.65

nmol/l

1.68

243

Thoracic aortic aneurysm

359

1.12

0.24

1.3

1.2

374.43

340.29

nmol/l

0.51

284

Schizoaffective disorder

191

0.84

0.24

1.0

1.1

270.33

392.98

nmol/l

—

181

Suppurative and unspecified otitis media

102

963

0.94

0.24

1.0

1.1

369.45

398.95

nmol/l

0.79

872

In situ neoplasms

135

1219

1.06

0.24

1.2

370.19

354.06

nmol/l

0.36

107

1009

Benign neoplasm of other and unspecified sites

0.70

0.24

1.0

1.2

354.67

384.81

nmol/l

—

Diseases of middle ear and mastoid

200

1567

1.05

0.24

1.1

366.88

382.44

nmol/l

0.54

162

1376

Melanocytic naevi

931

0.93

0.24

1.1

396.82

370.67

nmol/l

0.55

803

Acute upper respiratory infections of multiple and unspecified sites

277

2153

0.96

0.23

1.1

1.2

363.41

374.91

nmol/l

0.44

238

1848

Delivery, wide proxy

123

693

0.94

0.23

1.2

367.04

375.57

nmol/l

0.18

110

586

Diagnoses used for exclusion with ILD

852

1.07

0.23

1.3

1.2

341.09

348.34

nmol/l

0.14

694

Other diseases of pleura

172

1454

1.05

0.23

1.2

313.30

332.02

nmol/l

0.58

136

1146

Urticaria and erythema

124

1173

1.06

0.23

1.1

372.08

373.37

nmol/l

0.02

1026

Disorders of continuity of bone

237

1.14

0.23

1.3

1.1

348.45

389.82

nmol/l

0.49

216

Gestational diabetes (for exclusion)

118

788

1.06

0.23

1.1

426.01

413.14

nmol/l

0.30

105

756

Atopic dermatitis, strict definition

788

1.07

0.23

1.2

1.1

398.87

406.00

nmol/l

0.12

732

Acute poliomyelitis

1.28

0.23

1.4

1.2

185.60

373.09

nmol/l

—

Toxic effect of contact with venomous animals

1.24

0.23

1.0

1.1

416.00

403.44

nmol/l

0.12

Ptosis of eyelid

327

0.89

0.22

1.3

1.2

350.53

355.23

nmol/l

0.04

267

Other viral diseases, not elsewhere classified

523

1.09

0.22

1.1

367.71

388.51

nmol/l

0.29

474

Tuberculosis, wide

253

0.87

0.22

1.0

1.3

391.60

336.79

nmol/l

0.44

203

Other chronic obstructive pulmonary disease

150

1309

0.95

0.22

1.2

320.50

330.60

nmol/l

0.24

111

1042

Acute epiglottitis

1.25

0.22

1.0

1.2

319.40

374.41

nmol/l

—

Inflammation of lacrimal passages (acute and unspecified)

1.25

0.22

1.6

1.2

765.40

356.29

nmol/l

—

Toxic effects of substances chiefly nonmedicinal as to source

295

1.12

0.22

1.2

1.1

385.62

393.04

nmol/l

0.08

271

Presbyopia

172

1.16

0.22

1.1

413.93

392.71

nmol/l

0.15

163

Melanocytic naevi of trunk

347

0.89

0.22

1.2

1.1

411.84

382.65

nmol/l

0.28

308

Intracerebral haemorrhage

410

1.10

0.22

1.1

1.2

358.72

323.42

nmol/l

0.52

318

Cardiomyopathy

534

0.92

0.21

1.2

1.1

371.87

343.62

nmol/l

0.37

430

Aneurysms, operations, SAH

534

0.92

0.21

1.3

1.2

364.67

348.54

nmol/l

0.21

440

Laparoscopic left hemicolectomy

1.19

0.21

1.0

1.1

430.20

384.91

nmol/l

—

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

1.19

0.21

1.0

1.2

306.80

406.44

nmol/l

—

Tracheo-bronchomalasia

0.00

0.21

0.0

1.1

—

419.30

—

Ulcerative colitis (strict) with PSC

0.00

0.21

0.0

1.3

—

441.36

—

Injury of muscle and tendon at shoulder and upper arm level

107

1131

0.95

0.21

1.2

1.1

379.73

349.11

nmol/l

0.86

927

Cleft lip and cleft lip and palate

0.00

0.21

0.0

1.2

—

476.67

—

Pyothorax

102

0.78

0.21

1.1

1.2

358.63

358.42

nmol/l

—

Secondary and unspecified malignant neoplasm of lymph nodes

220

1.14

0.21

1.1

1.2

393.75

357.81

nmol/l

0.41

186

Sequelae of injuries of upper limb

249

1.13

0.20

1.3

1.1

378.37

392.65

nmol/l

0.10

225

Macular pucker

439

0.91

0.20

1.3

1.2

307.03

324.65

nmol/l

0.20

339

Maternal care for known or suspected malpresentation of fetus

405

0.92

0.20

1.1

381.84

423.94

nmol/l

0.91

389

Benign lipomatous neoplasm of skin and subcutaneous tissue of other and unspecified sites

0.00

0.20

0.0

1.2

—

422.21

—

Valvular operations

441

1.09

0.20

1.3

1.2

340.85

333.61

nmol/l

0.09

352

ILD, hospital admission 2, with pulmonary infections

282

0.89

0.20

1.1

1.2

281.58

334.52

nmol/l

0.67

229

Acute sinusitis

186

1666

1.04

0.20

1.1

382.72

383.20

nmol/l

0.01

160

1456

Superficial injury of forearm

240

1.13

0.20

1.1

387.05

403.82

nmol/l

0.14

224

Keratoconus

1.23

0.20

1.2

1.1

324.00

405.29

nmol/l

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

313

0.89

0.20

1.3

1.2

362.45

341.73

nmol/l

0.20

250

Melanocytic naevi

923

0.94

0.20

1.1

1.2

396.82

375.40

nmol/l

0.43

795

Mental and behavioural disorders due to alcohol, excluding acute intoxication

152

1453

1.05

0.20

1.2

343.58

372.85

nmol/l

1.00

117

1234

Maltreatment syndromes

114

0.79

0.20

1.0

1.1

388.44

416.69

nmol/l

—

107

Other specified/unspecified deforming dorsopathies

1.20

0.19

1.3

1.1

427.17

474.29

nmol/l

—

Dental pulpitis 2, only avohilmo

336

1771

0.97

0.19

1.2

351.72

358.47

nmol/l

0.24

272

1483

Disorders of optic nerve, not elsewhere classified

1.18

0.19

1.3

1.2

488.83

389.27

nmol/l

—

Other keratitis

298

1.11

0.19

1.2

1.1

433.86

388.64

nmol/l

0.54

268

Gestational [pregnancy-induced] hypertension

761

1.06

0.19

1.1

417.01

407.23

nmol/l

0.18

709

Benign neoplasm: Vulva

1.16

0.19

1.3

1.2

506.00

372.81

nmol/l

—

Graves ophthalmopathy, strict

1.16

0.19

1.0

1.1

335.00

401.38

nmol/l

—

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

152

1279

1.04

0.19

1.1

1.2

320.43

346.37

nmol/l

0.83

116

1042

Certain conditions originating in the perinatal period

127

0.84

0.18

1.1

461.17

398.16

nmol/l

0.56

119

Viral agents as the cause of diseases classified to other chapters

1.13

0.18

1.0

1.2

339.00

398.25

nmol/l

—

Sarcoidosis

395

1.09

0.18

1.2

1.1

352.35

369.56

nmol/l

0.25

349

Erectile dysfunction

238

0.88

0.18

1.0

1.2

314.60

318.86

nmol/l

0.03

173

Hypertrophic scar

132

0.83

0.18

1.1

314.55

395.58

nmol/l

0.73

125

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

185

1.14

0.18

1.2

332.50

350.85

nmol/l

0.11

147

Retinal haemorrhage

1.17

0.18

1.1

1.2

395.71

396.71

nmol/l

—

Ménière disease

300

1.10

0.17

1.1

324.46

366.66

nmol/l

0.48

252

Adenocarcinoma and papilloma adenocarcinoma of rectum

278

0.90

0.17

1.3

1.2

355.76

328.38

nmol/l

0.26

227

Other disorders involving the immune mechanism, not elsewhere classified

0.76

0.17

1.2

1.1

373.00

401.68

nmol/l

—

Burns and corrosions of external body surface, specified by site

272

1.10

0.17

1.3

1.1

363.36

382.65

nmol/l

0.20

246

Malignant neoplasm of kidney, except renal pelvis

253

1.11

0.16

1.1

1.2

334.20

339.82

nmol/l

0.05

201

Benign neoplasm: Choroid

173

0.87

0.16

1.3

1.2

398.73

377.60

nmol/l

0.18

150

Benign neoplasm: Parotid gland

234

1.11

0.16

1.2

391.20

377.96

nmol/l

0.12

204

Malignant neoplasm of urinary organs

282

1.10

0.16

1.2

337.40

336.59

nmol/l

0.01

223

Recurrent dislocation of patella

141

0.85

0.16

1.2

1.1

421.33

409.37

nmol/l

0.07

136

Rosacea

321

1.09

0.16

1.3

1.1

311.30

388.33

nmol/l

1.66

287

Gingivitis and periodontal diseases

379

2002

0.98

0.15

1.2

1.1

376.02

362.84

nmol/l

0.61

320

1704

Pleural plaque

312

1.09

0.15

1.4

1.3

270.59

314.97

nmol/l

0.89

226

Aortic aneurysm

747

0.95

0.15

1.2

340.51

324.82

nmol/l

0.27

591

Myocardial infarction, unclassifiable

796

0.95

0.15

1.3

1.2

300.61

314.41

nmol/l

0.25

591

L02BG Aromatase inhibitors

943

0.95

0.15

1.1

1.2

343.13

359.06

nmol/l

0.35

794

Hydrocephalus

234

0.90

0.15

1.3

1.2

347.00

351.16

nmol/l

0.03

191

Transient global amnesia

234

0.90

0.15

1.0

1.2

355.53

344.48

nmol/l

0.08

189

Other disorders of eye and adnexa

391

1.07

0.14

1.3

1.1

379.34

377.77

nmol/l

0.02

350

Other disorders of optic [2nd] nerve and visual pathways

160

1.13

0.14

1.2

403.17

384.23

nmol/l

0.17

142

Other condition

383

1.07

0.13

1.2

1.1

344.28

381.03

nmol/l

0.51

344

Labour and delivery complicated by umbilical cord complications

151

1.13

0.13

1.1

360.54

381.20

nmol/l

0.18

143

Benign neoplasm of major salivary glands

296

1.08

0.13

1.2

380.33

363.83

nmol/l

0.18

254

Melanocytic naevi of trunk

335

0.92

0.13

1.2

1.1

411.84

387.68

nmol/l

0.23

297

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

108

0.83

0.13

1.1

1.2

450.33

391.31

nmol/l

—

Chronic tubulo-interstitial nephritis

110

0.82

0.13

1.1

1.2

262.33

371.80

nmol/l

—

Viral pneumonia (unknown virus, not influenza)

161

1.12

0.13

1.1

402.38

392.61

nmol/l

0.07

147

Sequelae with surgical and medical care as external cause

638

1.05

0.12

1.2

382.75

347.70

nmol/l

0.60

527

Alcohol abuse, main dg

427

0.94

0.12

1.2

1.1

379.06

375.18

nmol/l

0.04

377

Contraceptive management

135

918

1.03

0.12

1.1

441.34

411.19

nmol/l

1.10

128

841

Chronic suppurative otitis media, including avohilmo

200

0.90

0.12

1.1

1.2

377.54

368.16

nmol/l

0.06

175

Atopic dermatitis

186

1544

1.03

0.12

1.2

1.1

382.28

394.22

nmol/l

0.38

172

1389

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

303

0.92

0.12

1.3

1.2

362.45

344.45

nmol/l

0.17

241

Alcohol abuse, main dg, excluding more controls

375

1.07

0.12

1.2

1.1

379.06

388.61

nmol/l

0.11

336

Dermatographic urticaria

181

1.11

0.12

1.2

1.1

380.20

406.25

nmol/l

0.22

169

Nonalcoholic fatty liver disease

239

1.09

0.12

1.1

378.76

388.53

nmol/l

0.07

216

Fracture of skull and facial bones

620

1.05

0.12

1.2

1.1

319.60

373.47

nmol/l

1.69

533

Pulmonary embolism

105

1014

1.04

0.11

1.3

1.2

335.70

340.74

nmol/l

0.06

809

Acute suppurative otitis media

635

0.96

0.11

1.0

1.1

405.67

410.74

nmol/l

0.07

600

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

240

1.08

0.11

1.1

428.19

399.90

nmol/l

0.28

228

Lung diseases due to external agents

445

0.94

0.11

1.4

1.2

308.01

335.38

nmol/l

0.45

355

Disorders of eyelid in diseases classified elsewhere

1.16

0.11

1.5

1.1

251.10

382.39

nmol/l

—

Sequelae of infectious and parasitic diseases

221

1.09

0.11

1.1

312.73

366.13

nmol/l

0.47

196

L04AA Selective immunosuppressants

622

1.05

0.10

1.1

320.61

380.00

nmol/l

1.64

547

Single spontaneous delivery

145

794

0.97

0.10

1.2

355.06

380.87

nmol/l

0.74

126

690

Dental caries 3 and operation codes

404

2105

0.98

0.10

1.2

348.23

366.70

nmol/l

1.07

333

1779

Diabetic retinopathy, strict definition

573

1.04

0.10

1.2

364.64

350.07

nmol/l

0.18

407

Dental pulpitis 2

342

1722

1.02

0.10

1.2

351.84

359.72

nmol/l

0.28

276

1443

Zoster [herpes zoster]

604

1.04

0.10

1.4

1.2

325.73

342.92

nmol/l

0.30

485

Malignant neoplasm of corpus uteri

271

1.07

0.09

1.0

1.2

351.63

346.34

nmol/l

0.05

223

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

330

0.94

0.09

1.0

1.2

342.04

352.73

nmol/l

0.11

265

ILD, hospital admissions 3, with pneumonia sepsis

248

0.93

0.09

1.1

1.2

287.56

331.69

nmol/l

0.49

190

Inguinal hernia, bilateral

291

1.07

0.09

1.2

367.54

331.67

nmol/l

0.48

224

Pulmonary heart disease

105

1019

1.03

0.09

1.3

1.2

335.70

340.29

nmol/l

0.05

816

Papilloedema, unspecified

1.04

0.09

1.0

1.2

396.20

392.28

nmol/l

—

Preterm labour and delivery

777

0.96

0.09

1.1

402.62

396.10

nmol/l

0.10

716

Substance abuse

199

1864

1.02

0.09

1.2

349.48

371.23

nmol/l

0.82

156

1593

Disorders of lacrimal system and orbit in diseases classified elsewhere

1.11

0.09

1.0

1.1

335.00

375.56

nmol/l

—

Infective dermatitis

321

1.06

0.09

1.1

365.06

377.71

nmol/l

0.11

279

Melanocytic naevi of other and unspecified parts of face

165

0.91

0.09

1.0

1.2

422.13

402.13

nmol/l

0.16

150

Hypertrophic disorders of skin

144

0.90

0.08

1.1

346.38

398.12

nmol/l

0.42

134

Carcinoma in situ of skin of lower limb, including hip

0.83

0.08

2.0

1.3

401.40

355.16

nmol/l

—

Carcinoma in situ of skin of lower limb, including hip

0.83

0.08

2.0

1.2

401.40

352.71

nmol/l

—

COPD

159

1339

0.98

0.08

1.2

317.70

330.93

nmol/l

0.35

117

1068

Diabetes mellitus in pregnancy

102

680

0.97

0.08

1.1

416.73

416.66

nmol/l

0.00

655

Alcohol dependence

825

1.03

0.08

1.2

329.26

365.87

nmol/l

1.08

695

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

244

1.07

0.08

1.1

428.19

399.30

nmol/l

0.28

233

Care involving dialysis

205

0.93

0.08

1.1

1.2

336.86

362.94

nmol/l

0.23

184

Unspecified mental disorder

136

1330

1.02

0.08

1.1

361.95

380.40

nmol/l

0.47

100

1168

Gonococcal infection

0.83

0.07

1.5

1.1

432.50

404.75

nmol/l

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

0.81

0.07

1.0

1.1

364.50

400.86

nmol/l

—

Hodgkin lymphoma

1.08

0.07

1.4

1.1

370.88

400.15

nmol/l

—

Malignant neoplasm of brain

1.04

0.07

1.0

1.2

280.00

412.60

nmol/l

—

Suicide or other Intentional self-harm

708

1.03

0.07

1.2

1.1

355.77

391.36

nmol/l

0.82

643

In situ neoplasms

135

1322

1.02

0.07

1.2

370.19

349.24

nmol/l

0.51

107

1064

Golimumab

1.03

0.07

1.1

346.13

422.45

nmol/l

—

Male infertility

1.03

0.07

1.4

1.1

412.13

408.92

nmol/l

—

Chronic lymphocytic leukaemia, helper endpoint

0.86

0.07

1.1

1.2

499.29

367.63

nmol/l

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

0.86

0.07

1.1

1.2

499.29

367.63

nmol/l

—

Cluster headache, strict

0.84

0.07

1.0

1.1

486.14

411.79

nmol/l

—

Burn and corrosion of wrist and hand

0.83

0.07

1.6

1.1

377.00

398.88

nmol/l

—

Other juvenile arthritis

1.06

0.07

1.1

413.22

406.33

nmol/l

—

Injury of eye and orbit

373

1.05

0.07

1.2

1.1

389.56

382.51

nmol/l

0.07

333

SLE (Finngen)

1.02

0.07

1.4

1.1

322.52

403.04

nmol/l

—

Secondary uncertain malignant neoplasm

397

0.96

0.06

1.2

377.58

334.01

nmol/l

0.70

321

Early onset COPD, excluding more controls

600

1.03

0.06

1.2

1.1

366.13

360.76

nmol/l

0.07

510

211

1861

1.02

0.06

1.2

362.80

366.20

nmol/l

0.08

163

1590

Abdominal aortic aneurysm (AAA)

343

0.95

0.06

1.2

1.3

279.40

318.10

nmol/l

0.53

251

Nontraumatic intracranial haemmorrhage

700

0.97

0.06

1.2

332.28

338.41

nmol/l

0.09

542

Mental and behavioural disorders due to psychoactive substance use

205

1905

1.02

0.06

1.2

1.1

351.24

371.03

nmol/l

0.71

158

1632

Acute bronchiolitis

0.89

0.06

1.3

1.1

362.89

398.15

nmol/l

—

Malignant neoplasm of eye, brain and central nervous system

103

0.87

0.06

1.2

260.00

390.03

nmol/l

—

Fracture of foot, except ankle

710

0.97

0.06

1.3

1.1

359.57

378.47

nmol/l

0.34

627

Dental pulpitis 3

168

0.94

0.05

1.0

1.1

379.55

430.14

nmol/l

0.61

161

Kela-code for severe mental illness

117

1192

0.98

0.05

1.1

358.92

379.13

nmol/l

0.48

1040

SLE, strict definition

1.11

0.05

1.4

1.2

302.67

406.56

nmol/l

—

SLE, ICD10

1.11

0.05

1.4

1.2

302.67

406.56

nmol/l

—

Perineal laceration during delivery

414

1.03

0.05

1.0

1.1

388.79

412.73

nmol/l

0.41

396

Methotrexate

445

1.03

0.05

1.1

1.2

349.36

359.83

nmol/l

0.12

383

Injury of muscle and tendon at wrist and hand level

356

1.04

0.05

1.2

1.1

386.72

383.55

nmol/l

0.03

312

Nail disorders

208

1.06

0.05

1.2

1.1

502.82

393.87

nmol/l

1.18

190

Juvenile arthritis (FINNGEN)

100

1.10

0.05

1.2

1.1

433.91

409.66

nmol/l

0.15

Dental operations, only avohilmo

326

1686

0.99

0.05

1.2

359.28

358.14

nmol/l

0.03

275

1376

Maternal care for other conditions predominantly related to pregnancy

606

1.03

0.05

1.1

412.37

413.42

nmol/l

0.01

580

Pyogenic arthritis

179

1.06

0.04

1.2

1.1

282.10

356.77

nmol/l

—

157

Glomerulonephritis

268

1.05

0.04

1.1

1.2

385.75

365.44

nmol/l

0.26

237

Mental and behavioural disorders due to alcohol

168

1656

0.99

0.04

1.2

357.27

371.39

nmol/l

0.37

128

1411

L02BB Anti-androgens

278

1.04

0.04

1.1

1.3

367.32

299.73

nmol/l

0.86

203

Pleural effusion

504

0.97

0.04

1.3

1.2

333.37

335.47

nmol/l

0.02

395

Substance use, excluding alcohol

554

0.97

0.04

1.2

1.1

319.45

391.70

nmol/l

2.54

502

Other respiratory diseases principally affecting the interstitium

576

1.02

0.04

1.2

315.24

334.35

nmol/l

0.28

457

Tuberculosis

210

1.05

0.03

1.1

1.3

396.92

330.35

nmol/l

0.49

168

Dental pulpitis 1

471

2461

0.99

0.03

1.2

1.1

354.61

371.95

nmol/l

1.03

383

2102

Dental pulpitis 4

471

2460

0.99

0.03

1.2

1.1

354.61

371.96

nmol/l

1.03

383

2101

D07AA Corticosteroids, weak (group I)

428

1.03

0.03

1.1

416.34

388.61

nmol/l

0.40

386

Other inflammation of eyelid

381

0.97

0.03

1.3

1.1

377.65

364.59

nmol/l

0.15

323

Malignant neoplasm of rectum

280

0.96

0.03

1.3

1.2

331.82

331.63

nmol/l

0.00

230

Other coagulation defects

191

1.05

0.03

1.2

1.1

377.79

396.78

nmol/l

0.16

172

Superficial injury of shoulder and upper arm

320

1.03

0.03

1.2

1.1

398.69

366.31

nmol/l

0.37

278

Contact with nonpowered hand tool

102

1.08

0.03

1.4

1.2

374.45

399.70

nmol/l

0.12

COPD-related respiratory insufficiency

380

1.03

0.02

1.3

1.2

281.38

323.02

nmol/l

0.58

296

Brain meningioma

132

1.06

0.02

1.1

296.00

385.87

nmol/l

—

116

Other interstitial pulmonary diseases

480

0.98

0.02

1.1

1.2

295.19

337.58

nmol/l

0.70

379

Diabetic nephropathy

592

1.02

0.02

1.3

1.2

325.58

339.02

nmol/l

0.19

413

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

208

1411

1.01

0.02

1.2

308.70

352.75

nmol/l

2.57

172

1161

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

110

1087

1.01

0.02

1.2

1.1

380.05

398.73

nmol/l

0.40

991

Inguinal or femoral hernia, bilateral

302

1.03

0.02

1.2

367.54

334.18

nmol/l

0.44

231

Disorders of tooth development and eruption

110

1.06

0.01

1.0

1.1

431.92

390.31

nmol/l

0.36

104

All dysplastic lesions of the cervix uteri, vagina or vulva

855

1.01

0.01

1.1

402.86

403.61

nmol/l

0.01

793

Delivery

149

794

0.99

0.01

1.1

1.2

360.94

380.87

nmol/l

0.54

130

690

Diseases of pulp and periapical tissues, including avohilmo

472

2459

1.00

0.01

1.2

1.1

354.91

371.94

nmol/l

1.00

383

2102

Interstitial lung disease

478

0.98

0.01

1.1

1.2

295.19

337.63

nmol/l

0.70

379

Interstitial lung disease endpoints

478

0.98

0.01

1.1

1.2

295.19

337.63

nmol/l

0.70

379

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

116

934

1.01

0.01

1.1

1.2

343.41

378.33

nmol/l

1.17

100

792

Dental caries 1 and operation codes

396

2026

1.00

0.01

1.2

348.54

364.58

nmol/l

0.86

325

1703

Cluster headache, wide,, including avohilmo

124

1.05

0.00

1.0

1.1

502.15

405.49

nmol/l

0.86

116

L02BX Other hormone antagonists and related agents

146

0.96

0.00

1.1

1.2

475.11

318.93

nmol/l

—

109

Medicines for HER+ breast cancer

122

1195

0.99

0.00

1.1

1.2

348.07

368.01

nmol/l

0.54

105

1011

L02BA Anti-estrogens

524

1.01

0.00

1.2

1.1

361.68

369.71

nmol/l

0.10

458

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

252

0.99

0.00

1.1

1.2

356.45

387.52

nmol/l

0.32

227

Suggestive for eosinophilic asthma

262

0.99

0.00

1.0

1.2

395.37

367.61

nmol/l

0.37

226

Melanocytic naevi of other and unspecified parts of face

155

0.97

0.00

1.0

1.1

422.13

399.89

nmol/l

0.18

141

Other sexually transmitted chlamydial diseases

155

1.03

0.00

1.1

1.0

503.56

417.34

nmol/l

1.47

148

Benign neoplasm: Choroid

149

1.01

0.00

1.3

1.2

398.73

379.54

nmol/l

0.16

129

Congenital malformations of heart and great arteries

295

1.02

0.00

1.1

387.92

383.30

nmol/l

0.04

270

Cardiomyopathies, Primary/intrinsic

345

0.99

0.00

1.2

1.1

364.83

348.06

nmol/l

0.16

277

ILD, hospital admissions 1, main diag only

415

1.01

0.00

1.2

267.45

335.45

nmol/l

1.49

330

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

116

1.03

0.00

1.2

360.92

383.06

nmol/l

0.12

101

Cluster headache, strict, including avohilmo

116

1.03

0.00

1.0

1.1

496.17

398.58

nmol/l

0.78

108

False labour

600

0.99

0.00

1.1

386.11

423.13

nmol/l

1.15

574

Failed induction of labour

156

1.03

0.00

1.3

1.1

399.44

407.73

nmol/l

0.07

150

Other medical care

132

1292

1.00

0.00

1.1

1.2

341.27

345.60

nmol/l

0.08

102

1089

Cardiomyopathy (excluding other)

354

0.99

0.00

1.2

376.77

348.72

nmol/l

0.29

281

Tubulo-interstitial nephritis, not specified as acute or chronic

215

0.98

0.00

1.0

1.2

376.33

355.43

nmol/l

0.11

184

Malignant neoplasm of breast, HER-positive

115

1135

1.00

0.00

1.1

1.2

343.83

366.17

nmol/l

0.62

960

Haemorrhage in early pregnancy

836

1.00

0.00

1.1

390.94

396.61

nmol/l

0.09

773

Other and unspecified urticaria

582

1.00

0.00

1.1

380.08

382.34

nmol/l

0.03

523

Sequelae of injuries of lower limb

249

1.00

0.00

1.2

1.1

480.72

382.93

nmol/l

1.14

227

ILD, hospital admissions

469

1.00

0.00

1.1

1.2

295.19

337.06

nmol/l

0.68

371

Pneumonia due to Streptococcus pneumoniae

1.02

0.00

1.1

260.00

380.66

nmol/l

—

Brain meningioma, excluding all cancers (controls excluding all cancers)

153

0.98

0.00

1.1

1.2

286.00

381.01

nmol/l

—

134

Paralytic strabismus

177

1.02

0.00

1.2

370.77

368.99

nmol/l

0.01

154

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

227

1.01

0.00

1.1

1.2

367.72

385.96

nmol/l

0.15

205

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

253

0.99

0.00

1.1

349.89

392.39

nmol/l

0.45

228

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

1.05

0.00

1.3

1.2

298.10

336.20

nmol/l

—

Benign neoplasm of other and unspecified female genital organs

135

1.04

0.00

1.5

1.2

429.36

388.96

nmol/l

0.27

119

Other disorders of bone density and structure

0.94

0.00

1.2

1.1

345.33

409.51

nmol/l

—

Chronic drug-induced interstitial lung disorders

0.00

0.0

1.0

—

418.50

—

Femoral hernia, bilateral

0.00

0.0

1.4

—

305.13

—

Use of peginterferon beta-1a

0.00

0.0

1.2

—

454.80

—

Benign neoplasm: Lymph nodes

0.00

0.0

1.4

—

430.20

—

Maxillary prognathism

0.00

0.0

1.3

—

468.50

—

Carcinoma in situ of skin of eyelid, including canthus

0.00

0.0

1.5

—

428.67

—

Complications of anaesthesia during pregnancy

0.00

0.0

1.2

—

488.60

—

Phlebitis and thrombophlebitis of superficial vessels of lower extremities, drug-induced

0.00

0.0

1.0

—

371.00

—

Systemic sclerosis

0.86

0.00

1.4

1.2

365.00

391.84

nmol/l

—

Femoral hernia, unilateral

1.01

0.00

1.1

1.2

412.29

361.14

nmol/l

—

Cluster headache, wide

0.90

0.00

1.0

1.1

497.13

404.27

nmol/l

—

Aortic arch syndrome [Takayasu]

0.00

0.0

1.2

—

280.60

—

Granulosa cell carcinoma of ovary, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.1

—

392.86

—

ILD-related respiratory insufficiency

0.96

0.00

1.0

1.2

296.33

348.40

nmol/l

—

Congenital malformations of ear causing impairment of hearing

0.00

0.0

1.4

—

463.00

—

Carcinoma in situ of skin of lip

0.00

0.0

1.6

—

329.80

—

Systemic lupus erythematosus

0.98

0.00

1.4

1.2

322.52

408.93

nmol/l

—

Ovarian dysfunction, other/unspecified

0.00

0.0

1.1

—

452.14

—

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

0.92

0.00

1.1

450.33

380.51

nmol/l

—

Malignant neoplasm of vagina, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.3

—

311.44

—

Cicatricial pemphigoid

0.00

0.0

1.1

—

402.43

—

Cystic kidney disease

0.89

0.00

1.0

1.1

405.71

391.07

nmol/l

—

Other specified disorders of kidney and ureter

0.95

0.00

1.3

1.1

400.88

380.50

nmol/l

—

Benign neoplasm: Vulva

0.97

0.00

1.3

1.2

506.00

386.39

nmol/l

—

Graves ophthalmopathy

0.98

0.00

1.0

1.1

335.00

393.95

nmol/l

—

Maternal care for (suspected) damage to fetus from alcohol

0.00

0.0

1.2

—

506.60

—

Small kidney of unknown cause

0.00

0.0

1.4

—

484.80

—

Complications specific to multiple gestation

0.00

0.0

1.1

—

437.13

—

Colour vision deficiencies

0.00

0.0

1.3

—

428.50

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

0.88

0.00

1.2

1.1

373.00

401.73

nmol/l

—

Palatinal maxillary canine

0.00

0.0

1.2

—

418.33

—

Meningitis, viral

0.00

0.0

1.0

—

444.20

—

Embolism and thrombosis of abdominal aorta

0.00

0.0

1.5

—

311.18

—

Sexual assault by bodily force

0.00

0.0

1.0

—

416.00

—

Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

0.00

0.0

1.0

—

405.60

—

Changes in corneal membranes

0.00

0.0

1.0

—

315.20

—

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

0.94

0.00

1.6

1.2

235.84

381.43

nmol/l

—

Eccrine sweat disorders

0.00

0.0

1.0

—

336.40

—

Other and unspecified cicatricial alopecia

0.00

0.0

1.0

—

405.83

—

Dronedarone medication

0.89

0.00

1.2

1.1

373.83

332.15

nmol/l

—

Inguinal of femoral hernia, unilateral

1.01

0.00

1.1

1.2

412.29

361.14

nmol/l

—

Precocious puberty

0.00

0.0

1.4

—

357.00

—

Chronic lymphocytic leukaemia

1.00

0.00

1.1

499.29

349.55

nmol/l

—

Retrobulbar neuritis in diseases classified elsewhere

0.00

0.0

1.0

—

470.50

—

Cleft lip and palate

0.00

0.0

1.3

—

480.75

—

Other congenital malformations of male genital organs

0.00

0.0

1.0

—

516.20

—

Systemic sclerosis, icd10

0.85

0.00

1.4

1.2

365.00

386.67

nmol/l

—

Bursitis of shoulder

0.88

0.00

1.0

1.1

387.40

411.56

nmol/l

—

Systemic lupus erythematosus, unspecified

0.92

0.00

1.6

1.1

334.10

403.74

nmol/l

—

Palatinal maxillary operation

0.00

0.0

1.1

—

366.00

—

Systemic sclerosis (FG)

1.00

0.00

1.4

1.1

365.00

411.65

nmol/l

—

Fat embolism (traumatic)

0.00

0.0

1.2

—

413.80

—

Inguinal hernia, unilateral

1.01

0.00

1.1

1.2

412.29

361.14

nmol/l

—

Effects of other external causes

0.88

0.00

1.0

1.2

273.80

404.92

nmol/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Folate [Moles/volume] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS